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Abstract
Autophagy is widely regarded to function as a host cell defence system during 
intracellular infections. However, not all pathogens are degraded by 
autophagy. Some inhibit autophagy preventing their degradation, whilst 
others utilise components of the pathway for their advantage. Poliovirus is 
thought to require autophagy-derived membranes for replication and utilise 
mature autophagosomes as a pre-lytic exit strategy. Using a range of 
microscopy and siRNA techniques, we investigated whether the replication of 
two other picornaviruses, Foot-and-Mouth Disease virus (FMDV) and Bovine 
Enterovirus (BEV) also require autophagy-components. Here we show that 
FMDV infection induces the rearrangement of the autophagy marker LC3, into 
a unique perinuclear structure (termed FIALLS), which could be reproduced 
by the expression of the FMDV proteins 2BC or 2C in the absence of 
infection. Formation of this structure was dependant upon an intact 
microtubule network, and inhibition of its formation using Scriptaid, led to a 
decrease in virus yield by roughly one log. However, infection of autophagy- 
deficient cells (treated with Beclin or Atg5 siRNA), had very little effect on 
FMDV yield. In contrast to PV and FMDV, BEV yields actually increased (5- 
10 fold) in autophagy-deficient cells, suggesting it is partially degraded by 
autophagy. We therefore propose that FMDV and BEV do not require 
autophagy membranes for replication, and may be inefficiently targeted for 
degradation by the autophagy pathway. Furthermore, FMDV may avoid 
degradation by inducing the formation of FIALLS, restricting autophagy 
function to a small area of the cytoplasm allowing FMDV to replicate freely in 
autophagy-free cytoplasm.
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Chapter 1: Introduction
Pathogens replicating within the cytoplasm of cells generally interact with a 
range of host cell components, and often utilise them for stages of their 
replication cycle. This thesis concentrates on the cellular degradation 
pathway autophagy, in this context.
1.1 Cellular protein degradation
Protein levels in cells are carefully controlled by a balance between protein 
synthesis and degradation. Proteasomes and lysosomes represent the two 
main sites of protein degradation in cells.
1.1.1. Proteasomes
Proteasomes are ATP-dependant proteases distributed throughout the cell, 
which eliminate misfolded proteins or proteins that have specific sequences 
that act as signals for degradation. Proteins targeted for the proteasome 
pathway are normally marked for degradation by covalent conjugation to 
ubiquitin via ubiquitin-activating enzyme (E1) and an ubiquitin-conjugating 
enzyme (E2). E2 works in conjunction with accessory molecules (E3) 
creating a ubiquitin-ligase complex which produces a polyubiquitin chain 
which facilitates the transit of the protein through the proteasome pathway 
(Boyer and Lemichez, 2004) (diagram 1.1).
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Activation of Ubiquitin molecules 
by ubiquitin activating enzyme E1
The activated ubiquitin is 
transferred to the ligase complex 
(E2:E3) producing a chain of ubiquitin 
molecules on the targeted protein
Ubq
Ubq
Ubq
protein 
Ubq Ubq
protein 
The ubiquitin chain is recognised by 
the proteasome, which degrades the 
tagged-protein
Diagram 1.1 Representation of the ubiquitin-proteasome pathway
Ubiquitin is activated by the E1 ubiquitin-activating enzyme, and transferred to the ligase 
complex, consisting of an ubiquitin-conjugating enzyme (E2) and an accessory molecule 
(E3). This produces a chain of ubiquitin molecules conjugated to a mis-folded protein. The 
ubiquitin chain is recognised by receptors in the proteasome and the tagged protein is 
subsequently degraded
1.1.2. Lvsosomes.
Lysosomes are membrane vacuoles enclosing a number of hydrolytic 
enzymes, and are the principle site for degradation of long-lived proteins, 
which are delivered from the cytosol, and degradation of exogenous proteins 
delivered by endocytosis and phagocytosis. Of particular interest in this 
thesis is the method by which cytoplasmic material is delivered to lysosomes, 
a pathway termed autophagy.
2
1.2 Autophagy
1.2.1. The Three Types of Autophagy
There are three types of autophagy, microautophagy, macroautophagy and 
chaperone-mediated autophagy as reviewed in (Marino and Lopez-Otin, 
2004). They are described briefly below (diagram 1.2)
Microautophagy involves the invagination of the limiting membrane of the 
lysosome to surround a portion of the cytoplasm, which is engulfed for 
degradation.
During chaperone-mediated autophagy proteins that appear ‘unfolded’, for 
example by exposing hydrophobic residues, are recognised by chaperones 
and delivered into the lumen of the lysosomes by passing through a pore in 
the lysosome membrane (diagram 1.2.B).
Macroautophagy involves engulfment of cytoplasmic material by double 
membrane vacuoles termed autophagosomes. These fuse with lysosomes, 
and deliver their content into the lysosome (diagram 1.2.C).
This report deals with the process of macroautophagy, which will be referred 
to as autophagy.
3
C. MACROAUTOPHAGY
Lysosome
B. CHAPERONE-MEDIATED  
AUTOPHAGY
v
A. MICROAUTOPHAGY
Diagram 1.2 Three types of Autophagy
A. Invagination of the lysosomal membrane engulfs cytoplasmic contents, which are 
degraded within the lysosome. B. Chaperones facilitate the delivery of proteins through 
pores in the lysosomal membrane, where they are subsequently degraded. C. Cytoplasmic 
material is sequestered within autophagosomes, which fuse with lysosomes and are 
degraded along with their contents.
1.2.2. Cellular Functions of Autophagy
Most of the work defining the proteins and pathways involved in autophagy 
has been carried out using yeast genetics with Saccharomyces cerevisiae. 
Significantly, homologues of the yeast proteins important for autophagy have 
been found in plants and mammals, showing that the pathway is conserved. 
In yeast, autophagy is primarily a survival mechanism that is up-regulated to 
protect cells in times of nutrient starvation, facilitating the degradation of long- 
lived proteins as well as whole organelles such as mitochondria (Takeshige 
et al., 1992; Wu et al., 2006). Increased degradation of non-essential 
proteins and/or organelles provides the cell with an internal source of amino
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acids, thus autophagy is essential for long-term cell survival in nutrient 
depleted media (Thumm et al., 1994; Tsukada and Ohsumi, 1993).
Autophagy is also up-regulated in mammalian cells in response to amino- 
acid starvation but also appears to have more diverse roles, being implicated 
in numerous cellular processes including maintaining cellular homeostasis, 
and cell death (Kanazawa et al., 2004; Klionsky, 2004; Levine and KJionsky, 
2002; Mizushima et al., 2004; Munafo and Colombo, 2001; Munafo and 
Colombo, 2002; Tassa et al., 2003; Yu et al., 2004; Yue et al., 2003). 
Numerous reports have demonstrated the autophagic degradation of 
damaged mitochondria (Lemasters et al., 1998; Wu et al., 2006) which may 
reduce the cellular damage caused by the release of free radicals.
The role of autophagy in cell death appears to a careful balance between 
preventing apoptosis and facilitating cell death in overly-stressed cells. 
Initially the distinction between apoptosis and autophagic cell death was 
disputed. It is reasonable to assume that an increase in autophagic activity 
prior to cell death may indicate a failure of autophagy to maintain cellular 
integrity and protect the cell from undergoing programmed cell death 
(Gonzalez-Polo et al., 2005). Indeed inhibition of autophagy by small 
interfering RNA (siRNA) molecules targeting essential autophagy proteins 
resulted in an increase of apoptotic cell death in nutrient-deprived cells, 
suggesting autophagy is required to prevent cell death (Boya et al., 2005). 
However, clear morphological distinctions between apoptosis and autophagic 
cell death have been identified (Bursch et al., 2000; Otto et al., 2004). Whilst
5
the two processes share similar signalling pathways (Guimaraes and Linden, 
2004; Yu et al., 2004), they are generally accepted as two separate 
processes.
Autophagy also facilitates the degradation of toxic cytoplasmic contents such 
as protein aggregates and intracellular pathogens (Nakagawa et al., 2004; 
Ravikumar et al., 2004; Talloczy, Virgin, and Levine, 2006). This latter 
function of autophagy is of particular interest in this thesis, and is discussed 
later in more depth.
1.2.3. Structures involved in autophagy
Autophagy begins with the formation of a cup-shaped single lipid bilayer 
membrane known as the isolation membrane or £re-autophagosomal 
structure (PAS). The origin of this membrane is still disputed; there is 
evidence for both de novo formation and the use of organelles such as the 
endoplasmic reticulum (ER) (Novikoff and Shin, 1978), or Golgi apparatus 
(Locke and Sykes, 1975). However the lack of organelle-associated 
membrane proteins in the PAS has made this a difficult question to answer. 
During maturation, the isolation membrane elongates and the two ends curve 
in towards each other around cytosol until they fuse, thus forming an 
immature autophagosome with a double membrane. Autophagosomes are 
thought to be able to fuse with endosomes, probably facilitated by the Rab24 
and Rab7 proteins (Gutierrez et al., 2004a; Munafo and Colombo, 2002) 
which may be required for the normal progression of autophagy (Egami et al.,
6
2005; Gutierrez et al., 2004b). Autophagosomes eventually fuse with 
lysosomes producing an autolysosome, and the contents are degraded.
Encapsulation of
aggregates/cytoplasmic
contents
Fusion with endosome 
supplying markers for 
lysosomal fusion. o Fusion with lysosomes and delivery of degradati on-hydro lases
Elongation of the double-membrane, An Autophagosome (double Fusion with lysosomes and the
isolation membrane, sequestering membraned vesicle) is formed acquisistion of lysosomal hydroases
cytoplasmic contents and matures through fusion with forms an Autolysosome (single
endosomes membrane vesicle).
Diagram 1.3 Structures involved in Autophagy
A double membrane structure of disputed origin elongates and curves around cytoplasmic 
contents. The two ends of this membrane fuse together forming a double membrane vesicle 
termed an autophagosome. The autophagosome matures and fuses with other vesicles 
including endosomes. Finally the mature autophagosome fuses with a lysosome, where it 
gains lysosomal hydrolases and its contents are degraded
Autophagosomes have also been proposed to ‘kiss’ lysosomes whereby total 
fusion is avoided but the transfer of lysosomal markers and hydrolases can 
occur. These events lower the pH within the autophagosome enough to 
denature the inner membrane, which can be degraded, creating a mature 
autophagosome with a single membrane (diagram 1.3).
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1.2.4. Regulation of autophagy
Over-active autophagy can lead to type-ll programmed cell death so it is 
important that autophagy is carefully regulated. (Kanazawa et al., 2004). 
Amino acids are the main products of autophagy, and these appear to 
provide a negative-feedback system that suppresses autophagy through the 
mTOR kinase (mammalian Jarget of Rapamycin). Under resting conditions 
mTOR is activated by amino acids such as leucine, phenylalanine and 
tyrosine, and hormones such as glucagons and insulin (Sarbassov, Ali, and 
Sabatini, 2005; Shigemitsu et al., 1999) and this activates a phosphorylation 
cascade which results in the continuous phosphorylation and suppression of 
the autophagy protein Atg13 (Tanida et al., 2002). In the absence of 
nutrients mTOR activity decreases allowing Atg13 to interact with autophagy 
protein Atg1 which is thought to initiate the formation of the isolation 
membrane.
Whilst autophagy is primarily a response to amino acid starvation, this 
pathway can also be regulated by phosphoinositide 3-kinases (PI3K), 
specifically class III (Petiot et al., 2000), and trimeric GI3 proteins (Ogier- 
Denis et al., 1997). Interestingly, PKR (double-stranded-RNA-activated 
protein kinase) has also been suggested to play a role in regulating 
autophagy (Talloczy et al., 2002). PKR is activated by IFN-y, and bacterial 
and viral infections. Once activated, PKR phosphorylates several 
downstream targets including, eukaryotic initiation factor elF2a, and a 
regulatory subunit of protein phosphatase 2A, both of which have been 
identified as up-regulators of autophagy.
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1.2.5. Autophagy Proteins
The nomenclature of proteins/genes involved in the autophagy pathway has 
varied over the years, but are now commonly identified as ‘Atg’ (Klionsky et 
al., 2003). Mammalian homologues of proteins identified in yeast are shown 
in Table 1 along with proposed functions
Yeast Atg Protein Mammalian
Homoloaue
Function
Atg1 ULK1 Protein Kinase, interacts with Atg13 and Atg17, locates 
to PAS. involved in induction
Atg2 Atg2 locates to PAS. Involved in formation
Atg3 Atg3 E2-like conjugating enzyme, involved information
Atg4 Alg4a/Alg4b Cysteine protease, C-terminal hydrolase and 
deconjugase, involved in formation
Aig5 Atg5 Conjugated to Atg12, required for isolation membrane 
elongation, involved in formation
Atg6 Beclin 1 Subunit of PI3-kinase complex, involved in formation
Atg7 Atg7 Atg12-activating enzyme (E1-like) involved in formation
Atg8 LC3/GATE-16
GABARAP
Localises to PAS and autophagosomes involved in 
formation and completion
> (Q CO Atg9 Transmembrane protein, involved in formation
Atg10 Atg10 Atg12-Atg5 conjugation enzyme, involved in formation
Atg12 Atg12 Conjugated to Atg5, required for isolation membrane 
formation and elongation
Atg13 Subunit of Atg1 complex, de-phosphorylated upon 
autophagy induction
Atg14 Subunit of PI3-kinase complex, involved in formation
Atg16 Atg16L Interacts with Atg5 and Atg12, involved in formation
Ata17 Interacts with Ata1. involved in induction
Table 1.1: Mammalian homologues of yeast autophagy proteins
The table presents the autophagy-specific proteins identified by yeast genetics, their 
mammalian homologues, and a brief description of their function in the autophagy pathway.
In yeast, the interaction of two autophagy proteins, Atg 13 and Atg1 are 
thought to be key to the formation of the isolation membrane (Tanida et al., 
2002). Under normal conditions Atg 13 is hyperphosphorylated and interacts 
weakly with Atg1. Dephosphorylation of Atg 13 occurs when TOR is inactive 
and this increases the affinity of Atg1 for Atg13 and this also increases the
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kinase activity of Atg1 and the formation of autophagosomes. Similar protein 
interactions are thought to occur in both yeast and mammalian cells, as 
described below.
The formation and elongation of the isolation membrane involves four main 
proteins; Atg12, Atg5, Atg16 and Atg8/LC3. Atg12 binds to Atg7 (an E1 -like 
ubiquitin enzyme) via a thioester bond; the hydrolysis of ATP by Atg7 
activates Atg12 which is transferred to Atg5 through Atg10 which acts as an 
E2-like enzyme (Shintani et al., 1999). Atg12 covalently binds to the lysine- 
149 of Atg5 via its C terminal glycine. The Atg12:Atg5 complex then 
covalently binds specifically to a small coiled coil protein Atg 16 (Mizushima et 
al., 2003). Upon conjugation, Atg16 then undergoes self multimerisation 
forming a 350kDa complex, targeted to the isolation membrane (Kuma et al., 
2002). The protein complex remains associated with the elongating isolation 
membrane, but dissociates once an autophagosome is formed (diagram 1.4).
ATG16
IA T G 1 0  I 
ATG1? G.
ATG7
ATG12 >G ATG1? G ATG1?
ATG 12 activated by ATG7 ATG12 activated ATG12 is transferred via ATG10 ATG12:ATG5 binds with
and is conjugated to ATG5 ATG16 and localises to the
isolation membrane
Diagram 1.4 Atg12-Atg5 conjugation system
Atg12 is activated by Atg7 and transferred to Atg10. Atg10 facilitates the conjugation of 
Atg 12 (via its c-terminal glycine) to an internal lycine residue of Atg5. The resulting 
Atg12:Atg5 complex covalently binds to Atg16, which undergoes self-multimerisation, 
forming a large complex. This complex is targeted to the isolation membrane.
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Atg5, Atg 12 and Atg 16 can be found on the forming isolation membrane, but 
are soon lost when an autophagosome is formed. Of particular interest is the 
protein Atg8, which binds isolation membranes and stays associated with the 
membranes until they mature into autolysosomes, making Atg8 an important 
marker of autophagy.
Three mammalian homologues of Atg8 have been identified, microtubule- 
associated light chain 3 (LC3), a 16kDa Golgi-associated ATPase enhancer, 
GATE-16 and a y aminobutyric-acid-type-a (GABAA)-receptor associated 
protein (GABARAP), all of which have been suggested to localise to 
autophagic membranes (Kabeya 2004) however the involvement of LC3 in 
autophagy is better understood.
LC3 is present in cells predominantly in two forms; cytosolic LC3-I and the 
membrane bound form LC3-II, the formation of LC3-II from LC3-I is a multi- 
step process. In both yeast and mammalian cells, full length Atg8/LC3 is 
cleaved just after its C-terminal glycine-120 by a cystein 2 endopeptidase, 
Atg4 in yeast (Kirisako et al., 2000) and it’s homologue Atg4B in humans 
(Kabeya et al., 2004) producing LC3-I. The exposed glycine is then targeted, 
by Atg7, and is bound by a thioesther bond. This second interaction allows 
the transfer of LC3-I to Atg3, an E2-like enzyme (Ichimura et al., 2004; 
Tanida et al., 2002). Atg3 facilitates the conjugation of LC3-I with a 
phospholipid producing LC3-II. In both yeast the phospholipid has been 
identified as phosphatidylethanolamine (PE) (Ichimura et al., 2004). Whilst it
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is thought to be the same in mammals, this has not yet been conclusively 
proven (Kabeya et al., 2004) (diagram 1.5). This final form of LC3 is 
anchored to autophagic membranes throughout the autophagosome 
maturation process and can thus be used as a marker to identify autophagy 
vesicles (diagram 1.6).
 ^
ATG4 aA ATG7 | ATG3 , )
LC3-1  ► LC3-II n  -» - i r?  h G . * LCt-11 G
LC3 is cleaved by ATG4 LC3 exposed glycine is ATG3 facilitates conjugation LC3-PE localises to the
at its C-terminus targeted by ATG7 of LC3 with PE isolation membrane
Diagram 1.5 LC3 processing
Cytoplasmic LC3-I is cleaved after its c-terminal glycine by Atg4, producing LC3-II. The 
exposed glycine is targeted by Atg7 and transferred to Atg3, which facilitates the conjugation 
of phosphatidylethanolamine (PE) to the c-terminal glycine of LC3-II. LC3-PE is then 
targeted to the isolation membrane.
LC3 is generally believed to be degraded when autophagosomes fuse with 
lysosomes. Interestingly, the membrane-bound LC3-II is susceptible to 
cleavage by Atg4, which removes PE from LC3-II (Kirisako et al., 2000). This 
may allow Atg4 to remove LC3 from autophagosomes prior to fusion with 
lysosomes allowing it to be re-used in the formation of new autophagosomes. 
Recycling LC3 in this manner would make a lot of sense for a cell utilising 
this pathway under times of starvation.
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Diagram 1.6 Localisation of proteins to autophagosomal structures
The Atg12, Atg5, Atg16 protein complex and the processed form of LC3 (LC3-II) are located 
on the elongating isolation membrane. Atg 12, Atg5 and Atg 16 are lost from the membrane 
when an autophagosome is formed. LC3-II remains associated to the membranes of 
autophagosomes, which can also gain Rab proteins, and some lysosomal markers such as 
LAMP. Autolysosomes label strongly for lysosomal markers (i.e. LAMP) and LC3 is 
gradually lost from the limiting single membrane.
The limiting membranes of autophagosomes contain relatively low levels of 
protein. To date, only LC3 has been identified on isolation membranes 
through to the maturation of the autophagosome. As such, LC3 has provided 
an indispensable marker for autophagy, and has allowed the involvement of 
autophagy in a number of cellular processes to be identified.
1.2.6. Biochemical manipulation of autophagy.
Autophagy is up-regulated during nutrient deprivation and these conditions 
can be easily replicated within the lab. However, autophagy can also be 
induced with rapamycin, which specifically inhibits mTOR (diagram 1.7).
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Autophagy can also be Inhibited by inhibitors of PI3-kinases such as 3- 
Methyladenine (3-MA), Wortmannin or LY294002 (Blommaart et al., 1997) 
and all three compounds inhibit the formation of the isolation membrane.
Maturation of the autophagosome can be inhibited with either Nocodazole or 
Vinblastine (Stromhaug et al., 1998; Webb, Ravikumar, and Rubinsztein, 
2004), which depolymerise the microtubule network, and cause an 
accumulation of autophagosomes within the cytoplasm. The accumulation of 
autophagosomes is thought to be caused by the inhibition of the fusion and 
degradation of autophagosomes with endosomes and lysosomes, as their 
movement along microtubules is restricted.
Further maturation of the autophagosome into an autolysosome can be 
inhibited with vacuolar-type H+-ATPase inhibitors such as Bafilomycin A1 
(Yoshimori et al., 1991). This inhibits the acidification of the autophagosome, 
thus preventing the degradation of the autophagosome contents.
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Diagram 1.7 Regulation of different steps of the autophagy pathway with 
pharmacological agents
Formation of the isolation membrane may be induced by the removal of amino acids from 
the culture medium, or the addition of Rapamycin. Treatment of cells with PI3-kinase 
inhibitors such as, Wortmannin, LY294002 or 3-MA, or the knock-down of autophagy 
proteins with siRNA, inhibits the formation of the isolation membrane. Maturation of an 
autophagosome is prevented by the microtubule-depolymerising agents, Vinblastine or 
Nocodazole, which inhibit the fusion of autophagosomes with endosomes and lysosomes. 
The acquisition of lysosomal hydrolases can also be inhibited by treatment with Bafilomycin 
A or Concanamycin A.
The effects of the above pharmacological agents may not be restricted to 
autophagy, and if used in isolation their effects on autophagy should be 
interpreted with caution or supplemented with studies where expression of 
proteins important for autophagy is suppressed by silencing RNA 
technologies.
Nocodazole
Vinblastine
Fusion with 
endosomes
Bafilomycin A 
Concanamycin A Fusion with 
lysosomes
15
1.3 Autophagy as a host cell defence system
The protective role of autophagy in times of nutrient stress is well established 
(Komatsu et al., 2005; Mizushima et al., 2004). As proteins essential for the 
autophagy process have been discovered and specific markers for 
autophagosomes identified, evidence for the involvement of autophagy in 
other processes has emerged. As discussed below, numerous studies have 
presented autophagy as an intracellular defence, facilitating the degradation 
of potentially toxic residents of the cytoplasm, such as protein-aggregates 
and intracellular pathogens.
1.3.1. Removal of protein aggregates by autophagy.
Mis-folded proteins typically expose hydrophobic amino acids resulting in 
aggregation, ubiqutination and degradation by proteasomes. Many protein 
aggregates are degraded poorly by proteasomes and accumulate in the 
cytoplasm at perinuclear inclusions called aggresomes. Numerous reports 
suggest that autophagy mediates the degradation of protein-aggregates that 
evade the ubiquitin-proteasome pathway (Bjorkoy et al., 2005; Iwata et al., 
2005a).
Aggresomes are the principal pathological hallmark of protein-conformational 
diseases such as Huntington’s and Parkinson’s. Aggresomes form next to 
the microtubule-organising centre (MTOC) by the retrograde transport of 
protein aggregates along microtubules (Johnston, Ward, and Kopito, 1998; 
Webb, Ravikumar, and Rubinsztein, 2004). They often contain ubiquitinated
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proteins and molecular chaperones (Kegel et al., 2000; Taylor et al., 2003), 
and induce the collapse of the intermediate filament protein, vimentin, into a 
cage surrounding the aggregates (Johnston, Ward, and Kopito, 1998). The 
recruitment of molecular chaperones, ubiquitin and autophagosomes to 
aggresomes helps to facilitate the efficient clearance of the protein 
aggregates by concentrating the factors required for correct folding of 
proteins or their degradation (Diagram 1.8).
Diagram 1.8 Recruitment of autophagosomes to aggresomes
Protein aggregates are transported by Histone Deacetylase 6 (HDAC6) along microtubules 
towards the MTOC where they form a single inclusion body termed an aggresome. The 
aggresome is typically surrounded by a vimentin cage and molecular chaperones are 
recruited to facilitate the refolding of proteins held within the aggresome. Autophagy 
machinery is also recruited to aggresomes, and is transported along microtubules, this is 
thought to be facilitated by HDAC6. Protein aggregates are sequestered by 
autophagosomes which facilitate their degradation within lysosomes.
Molecular
Chaperones
Vimentin-cage
2. Autophagosomes are
recruited to aggresomes, 
facilitated by HDAC6
1. Protein Aggregates are 
transported along microtubules 
towards the MTOC. This is facilitated 
by HDAC6.
MTOC
3. Protein aggregates are degraded 
within autolysosomes/^ —v
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The recruitment of autophagy proteins such as LC3 and Atg 12 to 
aggresomes is thought to indicate the accumulation of autophagosomes to 
these structures (Iwata et al., 2005a; Ravikumar et al., 2004). Consistent 
with this theory, numerous EM studies have demonstrated an accumulation 
of electron-dense double-membrane vacuoles, (consistent autophagic 
morphology), in areas containing aggresomes (Kegel et al., 2000; Taylor et 
al., 2003; Webb et al., 2003).
The retrograde transport of protein aggregates to aggresomes is facilitated 
by Histone Deacytalase 6 (HDAC6). HDAC6 is a microtubule associated 
deacetylase that can bind to both ubiquitin and dynein (Kawaguchi et al., 
2003). As protein aggregates are tagged with ubiquitin, this facilitates their 
specific targeting into the aggresome. More recently, the recruitment of LC3 
to aggresomes was also demonstrated to be facilitated by HDAC6 (Iwata et 
al., 2005b), as the knock-down of HDAC6 protein expression with the use of 
siRNA, inhibited the recruitment of LC3-structures to inclusion bodies. LC3 
has not yet been shown to interact directly with ubiquitin, thus how HDAC6 
contributes to the transport of LC3-structures to inclusion bodies is not yet 
known.
Two separate studies demonstrated that inhibition of autophagy with 3-MA 
reduced the degradation of protein aggregates (Ravikumar, Duden, and 
Rubinsztein, 2002; Webb et al., 2003). Consistently, up-regulation of 
autophagy by nutrient starvation or rapamycin, led to an increase in the 
degradation of protein aggregates. Furthermore, inhibition of autophagy with
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siRNA against Atg5 or LC3 inhibited the reduction of protein aggregates seen 
over time compared to control cells (Iwata et al., 2005a). This is likely due to 
the inhibition of aggregate degradation and not an increase in formation, as 
inhibiting protein synthesis in these cells did not abrogate the effect of the 
siRNA.
1.3.2. Bacterial Clearance by autophagy
As previously mentioned, PKR has been implicated as a regulatory factor of 
autophagy activity (Talloczy et al., 2002). PKR is activated by IFN-y which is 
produced during viral and bacterial infections, suggesting the up-regulation of 
autophagy during pathogen infections. As the autophagy pathway provides a 
mechanism for a cell to degrade cytoplasmic contents, it is plausible that 
autophagy may function to degrade intracellular pathogens replicating within 
the cytoplasm.
An interaction between intracellular pathogens and autophagy has been 
demonstrated for Mycobacterium tuberculosis, salmonella and Streptococcus 
pyogenes (diagram 1.9).
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Diagram 1.9 Overview of the sequestration of bacteria by autophagy
Mycobacterium tuberculosis enters the cell via phagocytosis, and a small portion of the 
bacteria-containing phagosomes fuse with an autophagosome. The bacteria are 
subsequently degraded when the autophagosome fuses with a lysosome. Salmonella and 
group A streptococcus also enter the cell via phagocytosis. These bacteria escape the 
phagosome and enter the cytosol where they are sequestered by the autophagy pathway 
and degraded within lysosomes. Shigella and Listeria monocytogenes escape the 
phagosome in a similar manner and enter the cytosol. However, they are able to escape 
sequestration by the autophagy pathway and degradation within a lysosomes (see main 
text).
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Mycobacterium tuberculosis
Mycobacterium tuberculosis multiplies within a phagosome, and is usually 
able to interfere with the fusion of the phagosome with a lysosome preventing 
acidification and degradation. Up-regulation of autophagy in infected cells 
with either amino acid starvation or rapamycin resulted in the increased 
accumulation of lysosomal markers such Lysotracker, Cathepsin D and 
LAMP 1 within the phagosome, suggesting increased acidification of this 
structure (Gutierrez et al., 2004a). Furthermore it was found that the up- 
regulation of autophagy reduced mycobacterial viability, and this could be 
reversed by 3-MA or wortmannin, which inhibit autophagy (Gutierrez et al., 
2004a). These data suggested that autophagy is a defence mechanism, 
mediating the degradation of mycobacterium. Indeed, increased co­
localisation of the autophagy marker GFPLC3 and mycobacterium was seen 
following amino acid starvation, and electron microscopy analysis showed 
partially degraded mycobacterium in multivesicular vacuoles indicative of 
maturing autophagosomes (Gutierrez et al., 2004a). Moreover the up- 
regulation of autophagy by Interferon-y (IFN-y) also reduced viability of 
mycobacterium tuberculosis, thus demonstrating that mycobacterium 
tuberculosis inhibition of phagosome-lysosome fusion can be overcome by 
the pharmacological and physiological stimulation of autophagy promoting 
the degradation of the invading pathogen.
Salmonella
Salmonella typhimurium primarily replicates within a vesicular compartment 
within host cells, however a small proportion of bacteria are released from
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this vacuole and reside free in the cytoplasm, where they are targeted by 
autophagy for degradation (Birmingham et al., 2006). Using 
immunofluorescence microscopy, cytoplasmic salmonella were seen to co- 
localise with GFPLC3, and this co-localisation was inhibited by Wortmannin. 
A role for autophagy in reducing the viability of Salmonella was demonstrated 
by the increase of colony forming units (CFU) after infection of Atg5'/_ cells 
compared to wild type cells (Birmingham et al., 2006). Thus it would appear 
that cytoplasmic salmonella are directed by autophagy to lysosomes where 
they are degraded, providing a host cell defence mechanism.
Streptococcus pyogenes
Streptococcus pyogenes (or group A streptococcus, GAS) invades non- 
phagocytic cells. The stimulation of autophagy by GAS infection was 
demonstrated by an increase in LC3-II:LC3-I ratio and the co-localisation of 
intracellular GAS with LC3-positive vacuoles (Nakagawa et al., 2004). The 
authors designated these LC3-positive vacuoles; GAS-containing LC3- 
positive autophagosome-like vacuoles, GcAVs. Electron microscopy showed 
GcAVs shared characteristics with maturing autophagosomes as they had 
double membranes and contained partially degraded GAS. GcAVs were not 
formed in Atg5'/_ cells, and a slight increase in intracellular GAS numbers was 
also observed compared to wild type cells. In addition, the number of GAS in 
wild type cells, could be increased to similar numbers as that found in the 
Atg5"/_ cells by the addition of lysosomal inhibitors, indicating that decrease of 
intracellular GAS required the fusion of autophagosomes with lysosomes 
(Nakagawa et al., 2004). These data suggest a functional autophagy
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pathway was required for the association of GAS with LC3, and this 
association indicated the targeting of GAS for lysosomal degradation. The 
authors suggest that the killing of GAS in this manner is not protective 
towards the cell as cell death still occurs, and its purpose is to reduce the 
number of GAS that is released from the cell thus reducing their cytotoxic 
effects on surrounding tissues and cells. It is however possible that 
autophagic degradation of GAS is required for cell survival, but GAS 
multiplication occurs at such a fast rate that it overcomes the defence 
response provided by autophagy. The efficiency of autophagic degradation 
of GAS in other, phagocytic cell lines was not investigated in this study, so 
the possibility that autophagic degradation of GAS is protective in other cell 
lines cannot be excluded.
Shigella
In contrast, direct avoidance of autophagic degradation has been 
demonstrated by experiments with Shigella, which actively secretes proteins 
to camouflage recognition by autophagy (Ogawa et al., 2005). Ogawa et al 
demonstrated that LC3 did not co-localise with wild type bacteria, but 
GFPLC3 co-localised with a Shigella mutant, AlcsB. IcsB, is one of the 
shigella effector proteins, which are secreted by the bacteria to interfere with 
host cell functions. Infection with AlcsB resulted in reduced intracellular 
growth compared to wild-type shigella. The involvement of autophagy in 
reducing intracellular growth was substantiated by the observation that co­
localisation of GFPLC3 and the AlcsB bacteria increased following amino 
acid starvation, was reduced by the inhibition of autophagy with 3-MA, and
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completely abrogated in Atg5'7' cells. In addition, the intracellular growth of 
AlcsB shigella increased to the level of wild-type shigella in Atg5‘7' cells, 
suggesting that the AlcsB mutant was directly targeted by the autophagy 
pathway. The mechanism of AlcsB shigella targeting by the autophagy 
pathway was elucidated by the observation that the AlcsB bacteria lacked 
actin tails. Shigella manipulate host cell actin to mediate bacterial mobility 
and allow cell-to-cell spread, the manipulation of actin is directly associated 
with the bacterial surface protein VirG. Ogawa et al (2005) demonstrated 
that the growth defect of AlcsB, could be recovered to the level of wild type 
with a AlcsBAVirG mutant. VirG-GST pull-down experiments showed that 
VirG pulled down Atg5, and the presence of IcsB reduced the Atg5 pull down 
in a dose-dependant manner (Ogawa et al., 2005). The authors concluded 
the shigella protein VirG is a specific target for autophagy through its affinity 
with Atg5. IcsB is able to interfere with this interaction thus acting as 
bacterial camouflage, protecting it from the autophagic pathway.
Listeria monocytogenes
A similar evasion of autophagy may be used by Listeria monocytogenes. 
Listeria enters cells by phagocytosis and exits the phagosome to replicate 
within the cytoplasm. The inhibition of bacterial protein synthesis by the 
addition of chloramphenicol, results in the accumulation of Listeria within 
vacuoles which were distinct from the initial phagosomes as they have the 
double membranes suggesting an autophagic origin (Rich, Burkett, and 
Webster, 2003). The incubation of cells with 3MA or wortmannin reduced the 
accumulation of Listeria within these vacuoles, whereas up-regulation of
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autophagy by amino acid starvation increased the numbers of bacteria within 
the double membrane vesicles, suggesting increased sequestration of 
bacteria in autophagosomes. (Rich, Burkett, and Webster, 2003). The 
authors do not suggest a reason why the inhibition of bacterial protein 
synthesis would leave Listeria susceptible to autophagy, but it is likely that in 
a similar manner to Shigella, Listeria produce effector proteins that either 
camouflage the bacteria from recognition or interfere with the autophagy 
pathway itself.
1.3.3. Virus Clearance bv autophagy
Intracellular viruses are also thought to be targets for autophagic 
degradation. Many viral infections expose double stranded RNA to the 
cytosol and this can activate antiviral responses, which are primarily 
regulated by PKR. PKR is a serine threonine kinase, which is activated upon 
binding double stranded RNA (dsRNA), or stem-loop structures of some 
single-stranded RNA (ssRNA). PKR phosphorylates downstream targets 
including eukaryotic initiation factor elF2-a leading to inhibition of host cell 
translation and up-regulation of NFkB leading to up-regulation of IFN-p. 
Significantly, elF2-a has been implicated in the activation of autophagy 
(Talloczy et al., 2002) making it feasible that viral infections that produce 
dsRNA also activate autophagy. Many viruses have evolved to inhibit the 
phosphorylation of PKR, and the activation of elF2-a. Reovirus, Adenovirus 
and Vaccinia virus all encode proteins to modulate PKR activity, (for a review 
see (Jacobs and Langland, 1996), which as well as protecting from the IFN 
response, may also indicate the potential inhibition of autophagy. There is
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direct evidence for the autophagic degradation of Herpes Simplex Virus-1 
(HSV-1), Sindbis Virus and Parvovirus (Table 1.2. and below).
Degradation of Viruses l>y Autoplmgy
Virus Family Evidence
HSV-1 herpesvirus Viral protein ICP34.5 counteracts the action 
of PKR by dephosphorylating elF4a. Thus 
inhibiting autophagy and preventing 
autophagic degradation of HSV-1 virions. 
Infection with virus lacking ICP34.5 results in 
decreased virus yields and an increase in 
double membrane vesicles.
Sindbis Virus alphavirus Over expression of beclin leads to decreased 
virus yield and increased survival rate of 
infected mice.
Parvovirus B19 parvovirus Increase in L C 3 -I: LC3-II ratio. Inhibition of 
autophagy with 3-MA treatment led to 
increased cell death
Table 1.2 Summary of the viruses proposed to be targets for autophagy degradation
Herpes-Simplex Virus
A link between inhibition of autophagy and virulence has been established for 
herpes virus and explains the mode of action of the HSV-1 neurovirulence 
gene ICP34.5. The HSV-1 ICP34.5 protein (Chou et al., 1990) enables HSV- 
1 to cause lethal infection of mouse brain, and viruses lacking ICP34.5 are 
avirulent upon cerebral inoculation of mice. The mode of action is complex 
but it does link virulence with autophagy.
During starvation, cells attempt to conserve stores of amino acids by 
increasing protein degradation through autophagy and by blocking m-RNA 
translation to slow protein synthesis. This response is regulated by stress- 
activated kinases such as PKR that stop translation by phosphorylation and 
inactivation of translation initiation factor elF2a. Stress activated kinases 
also activate autophagy but the precise mechanism remains unclear.
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ICP34.5 binds to protein phosphatase 1a and causes it to dephosphorylate 
and activate elF2a. In this way ICP34.5 counteracts the action of PKR 
(Blommaart et alM 1997) and consequently inhibits autophagy (Talloczy et al., 
2002). ICP34.5 also prevents autophagic degradation of HSV virions, and 
PKR-dependent degradation of HSV-1 proteins. Moreover, viruses lacking 
ICP34.5 are susceptible to autophagy and are avirulent (Talloczy et al.,
2002). Thus autophagy is a defence against herpes virus infection and 
virulence results when herpes virus suppresses autophagy.
Infection of mouse cells with a mutant HSV that lacks the ICP34.5 gene 
(HSVAICP34.5) results in decreased virus yields, suggesting that ICP34.5 is 
required for optimum productive infection (Jing et al., 2004; Talloczy, Virgin, 
and Levine, 2006). ICP34.5 binds to a protein phosphatase, and
HSVAICP34.5 virus yields were restored to the levels of wild-type virus when 
cells were depleted of PKR (PKR'7') or elF2-a (elF2-a'7') proteins by siRNA 
(Talloczy, Virgin, and Levine, 2006). Thus the role of ICP34.5 in viral 
replication appears to relate to the inhibition of the PKR-pathway.
The role of autophagy in decreasing these virus yields was indicated by ultra- 
structural studies of infected cells. These studies demonstrated that infection 
of HSVAICP34.5 led to an increase in the number of virions observed in 
double membrane vesicles compared to wild-type virus (Talloczy, Virgin, and 
Levine, 2006). These vesicles were distinct from the single membrane 
vesicles involved in virus egress, and had similar morphology to
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autophagosomes. The numbers of HSVAICP34.5 virions observed within 
double membrane vesicles in PKR'7' cells were similar to wild-type virus. 
These data suggest that the reduced virus yield produced by HSVAICP34.5, 
could be attributed to the increased degradation of virions by autophagy. 
Additionally, the sequestration of HSV within autophagosomes was mediated 
by the PKR-signalling pathway, which can be inhibited by viral protein 
ICP34.5. This theory was substantiated by the accelerated degradation of 
viral proteins observed with HSVAICP34.5 compared to wild-type virus 
(Talloczy, Virgin, and Levine, 2006). Concurrent with ICP34.5 inhibiting 
autophagic-degradation of virus, an increase in long-lived protein degradation 
was also observed in HSVAICP34.5-infected cells compared to wild-type 
virus infection (Talloczy et al., 2002; Talloczy, Virgin, and Levine, 2006). The 
degradation of long-lived proteins is specific to autophagy, and indicated the 
up-regulation of autophagic activity.
Thus it appears that HSV is targeted for sequestration by autophagosomes 
and up-regulation of autophagy during HSV-infection is a result of the 
antiviral response mediated by PKR and elF2-a. Under normal conditions, 
HSV is able to escape degradation by inhibiting the antiviral response 
through the actions of ICP34.5.
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Sindbis Virus
The survival rate of mice infected with Fatal Sindbis virus can be enhanced 
by the over-expression of beclin (Liang et al., 1998). Beclin is a subunit of 
PI3-kinases thought to be required for autophagy (see table 1). Sindbis virus 
infects neurons and results in cell death and encephalitis. When mouse 
brains were studied further, the virus titres recovered from mice over­
expressing beclin were reduced, as were the number of apoptotic nuclei 
observed. This suggests that the protective function of beclin acts in 
reducing the production of virus (perhaps by facilitating their degradation) 
and possibly preventing apoptosis.
Parvovinis
Autophagy has also been proposed to enhance the survival of cells infected 
with parvovirus (Nakashima et al., 2006). EM analysis showed that infection 
induces two different cell populations; one consisted of small apoptotic cells, 
and the other of enlarged cells with autophagic-like vesicles. Western blot 
analysis demonstrated that infection caused an increase in the ratio of LC3- 
ll-l, consistent with an accumulation of autophagosomes and up-regulation of 
autophagy. Additionally, the inhibition of autophagy with 3-MA greatly 
increased the number of dead cells observed. These data suggest that 
autophagy enhances the survival of cells infected with parvovirus. Although 
the effect of 3-MA on virus titre was not investigated in this study, it is 
possible that autophagy protects the cell by facilitating the degradation of 
intracellular virus, thus minimising intracellular stress and the activation of 
apoptosis.
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1.4. Subversion of Autophagy by Pathogens
The autophagy pathway appears to provide cells with an intracellular defence 
mechanism by targeting intracellular pathogens and degrading them within 
lysosomes. Interestingly, a number of pathogens have been reported to use 
components of the autophagy pathway to their benefit. The evidence 
provided for the subversion of autophagy by bacteria and viruses is dealt with 
separately.
1.4.1. Bacterial subversion of autophagy
Recent reports have provided evidence that a number of bacteria subvert the 
autophagy pathway and use its components to create a niche within the cell 
for replication; such is thought to be the case for Polymorphus gingivalis, 
Coxiella bumetti (Rickettsiae) and Brucella abortus (diagram 1.10).
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Diagram 1.10 Overview of the subversion of autophagy for bacterial replication
Coxiella burnetti enters the cell by phagocytosis, the resulting bacteria-containing 
phagosome fuses with an autophagosome. C. burnetti controls the maturation of the 
autophagosome, replicating within the vacuole, thus inhibiting its degradation within a 
lysosome. A similar strategy has been proposed for Listeria pneumophila. Brucella abortus 
is thought to traffic through the early autophagy pathway, but actually replicates within an 
ER-like compartment (see main text).
Polymorphus gingivalis
Polymorphus gingivalis is a gram negative bacterium which, once 
internalised within a cell, replicates within vacuoles with double membranes 
(Dorn, Dunn, and Progulske-Fox, 2001). When autophagy was inhibited by
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3-MA or Wortmannin, P. gingivalis and its partially-degraded fragments were 
observed in vacuoles distinct from autophagosomes as they had only a 
single membrane, which also accumulated the lysosomal marker cathepsin 
L. A decrease in bacterial persistence was also detected by CFU counts 
(Dorn, Dunn, and Progulske-Fox, 2001). These data suggested that active 
autophagy was beneficial for P. gingivalis infection, and that inhibition of 
autophagy led to the degradation of bacteria, possibly by lysosomes. The 
authors proposed that P. gingivalis enters the cell and traffics through the 
autophagy pathway, somehow blocking the fusion of autophagosomes with 
lysosomes thus establishing a replication niche within an autophagosome. 
The inhibition of autophagy prevents this process and results in the trafficking 
of P. gingivalis through the endocytic pathway resulting in its degradation 
within lysosomes. The method by which the bacterium prevents the 
maturation of an autophagosome into an autolysosome has not yet been 
established.
Coxiella burnetii (Rickettsiae)
There is conflicting evidence as to the role of autophagy during Rickettsiae 
infection Rickettsiae were one of the first bacteria to be identified within 
vesicles resembling autophagosomes (Rikihisa, 1984). The acidic nature of 
these vesicles was demonstrated by the presence of acid phosphatase, and 
degraded fragments of bacteria were observed within the vesicles (Burton et 
al., 1978; Rikihisa, 1984). From these data it was interpreted that Rickettsiae 
were degraded by autophagy as a host cell defence mechanism.. However, 
recent reports suggest that the Rickettsiae, Coxiella burnetii, can survive in
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phagolysosomes (Akporiaye et at., 1983; Heinzen et al., 1998). Furthermore, 
inhibition of the acidification of the parasitophorous vacuole by Bafilomycin A 
completely inhibited the growth of Coxiella burnetii, suggesting that 
acidification was required for replication (Heinzen et al., 1998). A role for 
autophagy in the establishment of a replicative niche for Coxiella burnetii was 
reported when it was shown that the limiting membrane of the 
parasitophorous vacuole labelled strongly with GFPLC3, and the inhibition of 
autophagy with 3-MA or Wortmannin inhibited Coxiella burnetii infection 
(Beron et al., 2002).
The conflicting data may indicate the inability of Coxiella burnetii to 
completely control the autophagy pathway. It is possible that the Coxiella 
use autophagosomes for replication, but may not be able to fully control the 
fusion with lysosomes, thus a small population of bacteria are degraded by 
the autophagy pathway.
Brucella abortus
Whilst Brucella abortus is not thought to replicate within autophagosomes 
themselves, transit of the bacteria through the autophagic pathway is thought 
to provide access to the final multiplication compartment, with ER-like 
characteristics (Pizarro-Cerda' et al., 1998a; Pizarro-Cerda' et al., 1998b). 
Replication of brucella is increased after amino acid starvation and 
decreased by 3-MA or Wortmannin (Pizarro-Cerda' et al., 1998b). Early in 
infection Brucella abortus was associated with the early endosome marker 
EEA1, bacteria were subsequently observed in LAMP 1 and LAMP 2 positive
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vacuoles staining with monodansylcadaverine (MDC) but not cathepsin D. 
MDC is sometimes used as an autophagy marker, as it locates to acidic 
vesicles, but cannot distinguish them from other non-autophagic acidic 
vesicles such as lysosomes. However as cathepsin D (which is associated 
with lysosomes) is not found in bacteria-containing vacuoles, these data 
indicated that Brucella abortus is able to avoid fusion with lysosomes and 
probably transits through late autophagosomes which can acquire LAMP 1 
(Pizarro-Cerda' et al., 1998a). Peak multiplication of Brucella abortus occurs 
at about 24hpi onwards and at this time Brucella abortus is found in ER-like 
compartments that label with the ER marker PDI by both 
immunofluorescence and immunogold labelling of EM sections (Pizarro- 
Cerda' et al., 1998a). Brucella abortus is thus thought to enter the cell and 
resides temporarily within an early phagosome. The phagosome fuses with 
an autophagosome, where the bacterium is able to avoid lysosomal fusion 
and degradation. Brucella abortus is then thought to escape from the 
autophagosome and multiply within an ER-like vacuole, although the 
mechanism of this process is not clear.
Furthermore it has been shown using bacterial mutants that the trafficking of 
Brucella abortus is dependant upon functional VirB, which is involved in the 
type-IV related secretion system. When type-IV secretion is compromised 
they cannot prevent fusion of autophagosomes with lysosomes, and they are 
degraded (Comerci et al., 2001; Delrue et al., 2001).
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Legionella pneumophila
L. pneumophila is a gram-negative bacillus that replicates within fresh water 
amoebae, and alveolar macrophages. In both cases, replication occurs 
within a vacuolar compartment that resembles autophagosomes. These 
have double membranes but label with the ER protein BiP (Swanson and 
Isberg, 1995).
Stimulation of autophagy by amino acid starvation enhanced bacterial growth 
in macrophages (Swanson and Isberg, 1995), and bacteria replicate in acidic 
compartments containing cathepsin D and LAMP 1 (Sturgill-Koszycki and 
Swanson, 2000), which could indicate late autophagosomes or late 
endosomal/lysosomal origin.
Recent work with autophagy-mutants in amoebae have however indicated 
that autophagy components were not required for the formation of the 
replication compartment (Otto et al., 2004). Otto et al demonstrated that 
bacterial growth was unaffected by the functional defective mutations of atg5, 
atg7, atg8, atgl and atg6, and EM analysis showed no difference between 
the bacterial compartments formed in apgl mutants and wild type cells. 
Furthermore, no association was seen between the vacuoles containing 
bacteria and the autophagy marker GFP-Atg8. These data suggest that 
autophagy is not required for L. pneumophila replication in D. discoideum, 
however it is possible that replication in macrophages does require functional 
autophagy.
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1.4.2. Viral subversion of autophagy
The replication of positive strand RNA viruses is associated with the 
proliferation of membranes in the host cell cytoplasm. These membranes 
accumulate at perinuclear sites and are called replication complexes. They 
control the replication and assembly of the virus, and autophagy has been 
proposed as a possible source of these membranes for picornaviruses and 
coronaviruses.
Subversion of Autophagy by Viruses
Virus Family Evidence
Poliovirus picomavirus Infection induces formation of double 
membrane vesicles. Virus replicase proteins 
colocalise with LC3. Decrease in virus yields 
in cells treated with Atg5 or LC3 siRNA
Mouse Hepatitis virus coronavirus Infection induces formation of double 
membrane vesicles. Virus replicase proteins 
colocalise with LC3. Decreased virus yields 
in Atg5 ^  cells.
SARS coronavirus Infection induces formation of double 
membrane vesicles. Virus replicase proteins 
colocalise with LC3
Table 1.3. Summary of the viruses proposed to subvert the autophagy pathway to aid 
their replication.
Poliovirus
Picornaviruses are all positive-strand RNA viruses, and one of the best 
studied is Poliovirus (PV). Early biochemical data suggested that the 
membranes recruited to the PV replication complex were derived from ER 
and Golgi (Schlegel et al., 1996). More recently, electron microscopy 
revealed that many PV-induced vesicles were double membrane, apparently 
originating from the autophagy pathway (Suhy, Giddings, and Kirkegaard, 
2000). Further investigations into the replication of PV, indicated a strong 
link between replication and autophagy (Jackson et al., 2005). The PV
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protein 3A, a known component of the PV replication complex, was found to 
co-localise with the autophagy marker LC3, and infection with PV and 
another picornavirus, Rhinovirus, increased the co-localisation of LC3 and 
LAMP-1, suggesting the stimulation of the maturation of autophagosomes. 
The co-localisation of LC3 and LAMP-1 and induction of the double 
membrane vesicles seen in infection was reconstituted by the expression of 
the PV proteins; 3A and 2BC in the absence of infection (Suhy, Giddings, 
and Kirkegaard, 2000).
The importance of autophagy in promoting viral replication was demonstrated 
when inhibition of autophagy by 3-MA or interfering-RNA targeted against 
LC3 or Atg12, significantly diminished PV yields and stimulation of autophagy 
with rapamycin increased virus yields. Interestingly, inhibition of autophagy 
had a greater effect on the extracellular yield than the intracellular yield. PV 
is not an enveloped virus and is generally considered to be released during 
cell lysis. However there are cases of persistent infection by picornaviruses 
where virus can be propagated without evidence for cell lysis ‘in vitro’ or 
inflammation ‘in vivo’. This led the authors to propose that autophagy may 
facilitate non-lytic release of PV. PV is an enterovirus and resistant to low pH 
and proteases. It is possible that virions could survive in autophagosomes 
and fusion of the autophagosome with the plasma membrane would allow the 
release from the cell (diagram 1.11). Although this is not the normal route for 
autophagy, autophagosomes are thought to fuse with recycling endosomes, 
and may be subverted along this pathway.
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Diagram 1.11 Pathway of Autophagosome Formation, Autophagic Degradation, and 
Proposed Steps of Pathway Subversion by Poliovirus and Related Viruses. 
Reproduced from (Jackson et al., 2005)
Double membrane autophagosomes form either from ER membrane or de novo, 
encapsulating cytosol; the action of many gene products, including Atg5p and Atg12p, are 
required. LC3 protein (the Atg8 homolog) is associated with ‘sequestration crescents’ as 
well as fully formed double-membrane autophagosomes. LAMP1 acquisition is a hallmark of 
the maturation of these structures, which eventually fuse with lysosomes to produce mature 
autophagosomes with single membranes and electron dense contents. We hypothesize that 
infection by poliovirus or rhinovirus induces accumulation of autophagosomes to promote 
viral RNA replication by accelerating the formation of autophagosome-like structures from 
ER membranes, blocking the maturation of these structures to degradative organelles, or 
both (upper dotted line). The double-membrane topology makes the extracellular release of 
virions trapped in the cytosolic lumen topologically plausible, providing a mechanism for viral 
release in the absence of cell lysis. This could occur either from double-membrane structure 
or from one in which only one of the membranes remained (dotted lines).
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Coronaviruses
Infection of cells with Mouse Hepatitis Virus (MHV) or Severe Acute 
Respiratory Syndrome (SARS) virus causes extensive proliferation of double 
membrane vesicles (DMVs), thought to be the site of viral replication 
(Goldsmith et al., 2004; Gosert et al., 2002). Replicase proteins of both 
viruses co-localise with LC3 (Prentice et al., 2003; Prentice et al., 2004), 
reinforcing the theory that replication occurs in association with 
autophagosomes. The requirement of autophagosomes in MHV replication 
was further demonstrated by a failure to produce double-membrane vesicles 
and a reduction of viral replication in cells lacking Atg5. (Prentice et al.,
2003). In the same study, it was shown that MHV infection up-regulated 
autophagy and increased long-lived protein degradation, indicating that the 
fusion of autophagosomes with lysosomes was not inhibited during infection. 
Interestingly, the up-regulation of long-lived protein degradation by MHV 
infection was not inhibited by 3-MA. This would suggest that unlike PV, MHV 
is able to induce autophagy via a unique pathway not affected by 3-MA 
inhibition, or it may be able to complement the steps inhibited by 3-MA 
(Prentice et al., 2003).
The data for two coronaviruses and picornaviruses using autophagy as a 
membrane source for replication suggest that viral replication strategies are 
highly conserved. It is therefore possible that other Picornaviruses, such as 
FMDV require components of the autophagy pathway for replication.
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1.5 Foot-and-Mouth Disease Virus
1.5.1. Foot-and-Mouth-Disease
Foot-and-Mouth Disease (FMD) is a vesicular disease of cloven-footed 
mammals including cows, swine and goats. Infection typically results in the 
appearance of vesicular lesions in the mouth and on the feet, resulting in 
reduced appetite and lameness. The severity of the disease results in long­
term reduction of milk and meat yields; abortion is also common. As FMD is 
highly contagious, disease-free status is required for international trading. 
Thus FMD presents as a major economically important threat.
1.5.2. Foot and Mouth Disease virus.
FMD was the first animal disease demonstrated to be caused by a filterable 
agent (Loeffler and Frosch, 1897). The causative agent of FMD was 
identified as a virus; Foot-and-Mouth Disease Virus (FMDV). FMDV is an 
RNA virus and a member of the family picomaviridae genus Apthovirus. Like 
other picornaviruses, FMDV contains a single-stranded, positive-sense RNA 
genome, which is infectious independent of other viral components.
Virus Structure
The single-stranded positive-sense RNA genome of FMDV is surrounded by 
a non-enveloped icosahedral capsid. The capsid is assembled from 60 
copies each of four structural proteins, VP1, VP2, VP3 and VP4, which are 
encoded by the P1 region of the polyprotein (see below). Where VP1-3 are 
exposed on the outer surface of the capsid, VP4 is located on the inner
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surface, possibly acting as a scaffold between the capsid and the genome. 
VP1-3 are exposed on the outer surface of the virion capsid, and display an 
eight-stranded anti-parallel p-barrel folding motif, which is seen throughout 
the picornavirus family. VP1 also has a G-H loop that extends out from the 
surface of the virion. The G-H loop is an antigenic site of FMDV and its 
sequence is highly variable except for a conserved region spanning the 
residues 145-147, Arginine, Glycine, Asp, also known as the RGD motif. The 
RGD motif of FMDV is thought to mediate virus-cell binding and receptor- 
mediated endocytosis.
1.5.3. Cell Entry of FMDV
FMDV enters cells by receptor-mediated clathrin-dependent endocytosis 
(Berryman et al., 2005). Receptor interactions are mediated by the 
conserved RGD motif of VP1. The cellular receptors for many picornaviruses 
have been identified as members of a large family of transmembrane, cellular 
adhesion molecules known as integrins. Integrins are heterodimeric 
molecules located at the cell surface, and are involved in cell-cell 
interactions, signal transductions and interactions with the extracellular 
matrix. They are composed of two covalently-linked subunits a and p, and 
varying combinations of these two subunits varies the affinity between 
integrins and different ligands. FMDV appears to be able to use a number of 
integrins, including avp8, avpl, and avp6 (Jackson et al., 2004; Jackson et 
al., 2002; Jackson et al., 2000).
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Association of FMDV with the cellular receptor initiates clathrin-dependent 
endocytosis, and the virus is delivered to early or recycling endosomes 
(Berryman et al., 2005). For replication to continue, the viral RNA must be 
released from the virion into the cytoplasm. For many picornaviruses this is 
facilitated by a structural transformation induced by the binding of the virus to 
the receptor ligand. This transformation produces the ‘altered’ or A particle 
which combined with exposure to low pH allows the release of the viral 
genome. To date, there has been no evidence for the formation of an FMDV 
A particle. Unlike other picornaviruses the capsid of FMDV is highly sensitive 
to acid, and is dissociated at pHs just below neutral (Curry et al., 1995). The 
low pH of the endosomes is thought to cause the dissociation of the FMDV 
capsid and the release of the viral RNA, although the precise mechanism of 
entry to the cytoplasm is not known.
1.5.4 FMDV replication
Once in the cytoplasm, the RNA genome is translated to produce the 
polyprotein which is then rapidly processed into its mature protein products. 
The FMDV genome is approximately 8500 nucleotides in length encoding a 
single polyprotein. This is followed by a 3’ un-translated region (UTR), which 
contains a poly A tract. The polyprotein is preceded by a 5’ UTR, which ends 
with a small viral protein, Vpg. One of the distinctions between the FMDV 
genome and that of other picornaviruses is it encodes three copies, rather 
than one copy of the Vpg protein. The 5’ UTR also contains a poly C tract 
and multiple AUG codons, which result in an extensive secondary hairpin 
structure. This structure is termed the internal ribosome entry site (IRES)
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and facilitates the cap-independent binding of ribosomes and translation of 
the genome.
The polyprotein itself is co-translationally processed into three polypeptides 
P1, P2 and P3, these are further processed to produce the four capsid 
proteins VP1-4, and the non-structural proteins required for replication. 
Processing of the polyprotein is mediated by three virus-encoded 
proteinases; the Leader or L proteinase, 2A and 3C (diagram 1.12). The 
proteins produced interact with other cellular components to inhibit antiviral 
responses and generate the membrane rearrangements required for the 
formation of the replication complex.
5’UTR
(IRES)
Vpg
/
P1 P2 P3
3’UTR 
(Poly A tract)
Leader
protein VP4 VP2 VP3 VP1 2A 2B 2C 3A 3B 3C 3D
VPO VP3 VP1 2A 2B 2C 3A 3B 3C 3D
VP4 VP2 2B 2C 3A 3B 3C 3D
Capsid Proteins Non-structural Proteins
Diagram 1.12 Overview of FMDV polyprotein and the protein products
The FMDV polyprotein is cleaved into three polypeptides P1, P2, and P3. P1 is further 
cleaved into the structural proteins VP3 and VP1 and the precursor protein VPO. A second 
cleavage event produces the other two structural proteins VP4 and VP2 from VPO. The P2 
region is cleaved into the non-structural protein 2A and the precursor protein 2BC, which is 
subsequently cleaved to produce 2B and 2C. P3 produces two precursor proteins 3AB and 
3CD, subsequent cleavage events produce the non-structural proteins 3A, 3B, 3C and 3D.
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1.5.5. The proteinases/cleavaae events
The L proteinase (Lpro) is the first translated protein of the viral genome, and 
is a papain-like proteinase. (Lpro) cleaves itself from the rest of the 
polyprotein, and also cleaves the host translation initiation factor elF4G 
(Gradi et al., 2004), which is required for host cell cap-dependant translation. 
Cleavage of elF4G inhibits translation of host cell mRNAs and can block the 
synthesis of antiviral cytokines such as Interferon-p (IFN-p) (de los Santos et 
al., 2006). As the RNA genome of FMDV lacks a cap-binding structure, 
translation is mediated by the IRES, thus translation of the viral genome is 
unaffected by this cleavage of elF4G.
In picornaviruses such as enteroviruses and rhinoviruses these primary 
cleavage events are carried out by the 2A proteinase, which separates the 
P1 region from the rest of the polyprotein. All further cleavage events 
(except for that generating VP2 and VP4 from VPO) are carried out by the 3C 
proteinase.
The initial cleavage by the 3C proteinase generates VPO (un-cleaved VP4 
and VP2) and VP3 and VP1. VPO, VP3 and VP1 form a protomer, and five 
protomers assemble to form a 14S pentamer which associate with viral RNA 
to form the 150S provirion. A second cleavage event produces VP4 and VP2 
from VPO and capsid maturation.
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1.5.6. P2
The P2 region consists of 2A, 2B, 2BC and 2C. 2A is involved in processing 
the polyprotein, whilst 2B, 2C and 2BC possess membrane targeting 
sequences. Indeed, PV 2B, 2C or 2BC have been shown to cause 
rearrangements of host cell membranes when expressed alone in cells 
(Suhy, Giddings, and Kirkegaard, 2000). It is possible that 2C and 2BC may 
target the replication complex to cellular membranes, and in this way help to 
facilitate RNA replication.
1.5.7. P3
The proteins encoded by the P3 region are involved in polyprotein processing 
and RNA replication. As previously mentioned, 3C and its precursor 3CD act 
as proteinases and facilitate the processing of the polyprotein. 3C and 3CD 
are also involved in RNA replication where 30 and 3D proteins function 
independently from each other, as well as in their precursor form 3CD. 3D is 
an RNA-dependant RNA polymerase responsible for the synthesis of new 
RNA genomes. FMDV encodes three copies of 3B (also known as Vpg), 
which is covalently bound to the 5’ end of both positive and negative strand 
RNA and is thought to play a role in RNA recognition. 3BA/pg is thought to 
be targeted to the replication complex in its precursor form 3AB, where 3A 
has the hydrophobic residues necessary for membrane association. 3AB 
may also be involved in the recruitment of other viral factors required for 
replication. 3D of PV has, for example, been shown to interact with 3AB. 3D 
lacks membrane targeting sequences so the interaction with 3AB may recruit 
3D to the replication complex (Richards and Ehrenfeld, 1998). The 3C of PV
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has been shown to contain an RNA-binding motif and 3CD forms a complex 
at the 5’ end of positive strand RNA. It is thought that both 3C and 3CD are 
able to bind to RNA, but it is the 3CD form that is required for the replication 
of the genome (Crotty et al., 2004).
Receptor-mediated endocytosis
Release of virus progeny via llli 
cell lysis
(•)
Alteration of FMDV capsid
and release of viral RNA
Production of empty virus 
capsids
Insertion of viral RNA 
Into capsid and 
production of 
/  Infectious particle
✓ w translation of RNA genome and 
processing of the polyprotein
/ w / WReplication of infectious RNA 
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Diagram 1.13 Overview of FMDV replication cycle
FMDV enters the cell via receptor-mediated endocytosis. Viral RNA is released into the 
cytoplasm where translation and processing of the polyprotein occurs. Newly synthesised 
RNA genomes are packaged into viral capsids producing an infectious particle. Virus is 
released from the cell after cell lysis.
1.5.8 Membrane rearrangements
In addition to being involved in replication, picornavirus proteins 2B, BC and 
3A also induce rearrangement of intracellular membranes when expressed 
alone in cells. The membrane rearrangements induced during PV-infection 
are the most well studied of the picornaviruses. Infection causes the
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clustering of large and small vesicles with cytoplasmic lumen in perinuclear 
regions. Many of the vesicles are bound by double membranes, though 
single membrane vesicles are also observed. FMDV membrane 
rearrangements have been less studied. Clustering of numerous vesicles in 
perinuclear regions is also observed. However, the vesicles are 
predominantly bound by a single membrane. The precise mechanism by 
which these proteins rearrange intracellular membranes during the formation 
of the replication complex is not clear but is an area of active research.
Membrane rearrangements caused by 3A
PV 3A has been implicated in the inhibition ER to Golgi trafficking. 
Expressed alone in cells, PV 3A localises to ER membranes and induces 
swelling of the ER cisternae (Doedens, Giddings, and Kirkegaard, 1997). 
The absence of accumulated vesicles in these cells indicates it is likely that 
ER to Golgi trafficking is inhibited at the stage of vesicle formation/budding. 
It is however thought that this inhibition may somehow contribute in the 
formation of the membrane vesicles required for replication (see following 
section). PV 3A has also been shown to reduce the expression of major 
histocompatability complex I (MHC class I) on the cell surface, thus 
interfering with the host immune response (Dietz et al., 2000). Infection of 
cells with FMDV has also been shown to reduce MHC class I surface 
expression, however the protein(s) responsible for this have not yet been 
identified (Sanz-Parra, Sobrino, and Ley, 1998).
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FMDV 3A protein has also been shown to localise to membranes likely to 
originate from the ER when expressed alone in cells (Moffat et al., 2005a). 
However, expression of FMDV 3A in cells does not appear to inhibit the 
protein secretory pathway. It would therefore appear that PV and FMDV 
non-structural proteins differ in their function.
Membrane Rearrangements caused by 2BC
The analysis of cells expressing PV 2BC revealed that two distinct 
membrane morphologies were produced. The majority of cells contained 
clusters of empty vesicles, limited by a single membrane. A smaller 
population of cells had produced a number of vesicles morphologically similar 
to those seen in PV-infection, intensely clustered and limited by double 
membranes (Suhy, Giddings, and Kirkegaard, 2000). The precise 
mechanism by which these proteins rearrange intracellular membranes and 
form these vesicles is not clear. However, a combination of both 2BC and 3A 
expression is required to induce membrane rearrangements with a 
morphology closely resembling that seen in PV-infected cells.
The expression of FMDV non-structurals in the absence of infection indicated 
that both 2B and 2BC localise to membranes indicative of ER. FMDV 2C 
also appears to associate with ER membranes, but a small portion also 
associated with Golgi-like compartments (Moffat et al., 2005a). Interestingly 
it was found that the co-expression of 2B and 2C or 2BC alone resulted in the 
inhibition of ER-Golgi trafficking in a similar manner to PV 3A (Moffat et al., 
2005a; Moffat et al., 2007). Independent expression of 2B or 2C had no
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effect on the secretory pathway. Furthermore, it was shown that the site of 
transport inhibition was directed by the localisation of 2B.
To date the FMDV proteins required to replicate the membrane 
rearrangements observed in FMDV-infected cells have not been identified. 
The mechanism and origin of these vesicles also remains elusive, and is the 
focus much current research.
1.5.9 Picornaviruses and Autophagy
RNA viruses require membrane scaffolds to form replication complexes. The 
model picornavirus, Poliovirus, induces the clustering of numerous double 
membrane vesicles thought to provide this scaffolding. Double membrane 
vesicles are a characteristic feature of the autophagy pathway, and this 
observation has prompted numerous studies into whether autophagic 
membranes provides a source of membranes for RNA virus replication 
(Jackson et al., 2005; Prentice et al., 2003; Prentice et al., 2004). Strong 
evidence for the requirement of autophagy during PV infection was provided 
by the decrease in virus yield caused by the inhibition of autophagy with 
autophagy-specific siRNA (Jackson et al., 2005). As PV is the archetype 
picornavirus, these data may indicate that FMDV also requires the autophagy 
pathway for replication.
Infection with FMDV also causes a mass proliferation of vesicles. However, 
in contrast to the data for PV, the vesicles induced by FMDV appear to have 
single membranes and do not cluster as intensely (Monaghan et al., 2004).
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Single membrane vesicles are not specifically characteristic of the 
autophagosomes, but mature autophagosomes can appear to have single 
membranes. Thus autophagy cannot be excluded as a source of these 
membrane vesicles from this observation. FMDV may utilise the autophagy 
pathway at a different stage of maturation. It is also possible that FMDV 
utilises a different cellular source for membrane vesicles than PV, which 
would have implications on the use of PV as an archetype picornavirus. This 
thesis looks specifically at the role of autophagy in FMDV infection.
1.6 Summary
Autophagy is a process by which cytoplasmic material is engulfed by double 
membrane vesicles and subsequently delivered to the lysosome where it is 
degraded. In this manner, autophagy has also been implicated as a host cell 
defence mechanism, facilitating the degradation of cytoplasmic pathogens. 
However, an increasing number of pathogens have been reported to avoid 
degradation by autophagy, and furthermore utilise components of the 
autophagy pathway for replication. The evidence for PV, suggests this virus 
utilises membranes from the autophagy pathway as scaffolds for the 
formation of replication complexes. FMDV and BEV belong to the same 
family as PV, and as such may also utilise autophagy components. The 
purpose of this thesis was to investigate whether FMDV or BEV, also subvert 
the autophagy pathway to provide the membrane vesicles required for RNA 
replication.
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Chapter 2: Materials and Methods
2.1 Media, buffers and solutions
All chemicals were purchased from Sigma-Aldrich (Dorset, England) unless 
otherwise stated. Buffers, enzymes, reagents and kits for molecular biology 
were purchased from Promega, USA.
2.1.1 Cell culture media
HEPES-DMEM: N-2-hydroxyethylpiperazine-N-2-ethanesulphonic acid
(HEPES) buffered Dulbecco's Modified Eagles Medium (DMEM) 
supplemented with 10% (v/v) foetal calf serum (FCS), 100units/ml 
streptomycin, 100units/ml penicillin and 20mM L-glutamine.
RPMI: Roswell Park Memorial Institute medium (RPMI) containing 2 or 10% 
(v/v) FCS, 100units/ml streptomycin, 100units/ml penicillin and 20mM L- 
glutamine.
HANKS Solution: Hanks’ Balanced Salt Solution Modified 
EDTA-trypsin: 136mM NaCI, 5.3mM KCI, 5.5mM NaHCC>3 , 0.02% (w/v) 
trypsin, 0.01% (w/v) ethylenediaminetetraacetic acid (EDTA), and 0.1% (w/v) 
phenol red.
Acid Wash: 0.1 M Citric acid, 280mM NaCI.
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2.1.2 Protein analysis buffers
Cell Ivsis buffers
1000x small proteases inhibitor cocktail (SPI): 1mgml'1 leupeptine, 1mgml'1 
pepstatin, 1mgml'1 antipain, 1mgml‘1 chymostatin.
10x Immunoprecipitation lysis buffer (IPB): 50mM Tris pH7.5, 1mM EDTA, 
0.15M NaCI, 1% (v/v) Brij-35, 10mM iodoacetamide, 1mM
phenylmethyfsulphonyl fluoride PMSF, 1ug/ml SPI.
Sodium-dodecvlsulphate polyacrylamide electrophoresis (SDS PAGE)
4X resolving gel buffer: 1.5M Tris, 0.4% (w/v) SDS, pH 8.8
2X stacking buffer: 0.5M Tris, 0.2% SDS (w/v), pH 6.8
10X running buffer: 250mM Tris, 2M Glycine, 0.1% SDS (w/v), pH 8.3
5X sample preparation buffer (SPB): 25% (v/v) glycerol, 7.5% (w/v) SDS,
13.5% (v/v) p-mercaptoethanol, 0.1% (w/v) bromophenol blue, 62.5mM Tris
pH 6.8.
Western blot buffers
Phosphate buffered saline (PBS): 10mM Na2HP04, 150mM NaCI, pH 7.5. 
Blocking buffer: 5% (w/v) skimmed milk powder, 0.1% (v/v) Tween-20 in 
PBS.
Washing buffer: 0.1% (v/v) Tween-20 in PBS.
Antibody incubation buffer: 10% (v/v) normal goat serum (NGS) in blocking 
buffer.
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Transfer buffer: 33% (v/v) methanol, 1/20 10X running buffer in water.
2.1.3 Immunofluorescence microscopy buffers
Paraformaldehyde fixative: 4% (w/v) paraformaldehyde (PFA) in PBS, pH 
7.5-8.0.
Permeabilisation Buffer: 0.1% (v/v) Triton X100 in PBS 
Blocking buffer: 0.1% (w/v) Bovine Serum Albumen (BSA) in PBS.
Washing buffer: PBS
Permeabilisation Buffer for UH1 Antibody: 0.5% (w/v) Saponin in PBS 
Blocking buffer for UH1 Antibody: 0.1% (w/v) Saponin in Blocking buffer 
Washing buffer for UH1 Antibody: 0.1% (w/v) Saponin in PBS
2.2 Cell lines and viruses
2.2.1 Cell lines
Chinese Hamster Ovary cells (CHO) expressing GFP-tagged LC3 was a kind 
gift from Dr Zvulun Elazar of the Weizmann Institute of Science and were 
grown at 37°C in HEPES-RPMI supplemented with 10% FCS, and 0.1 pg/ml 
geneticin (G418).
Vero African green monkey kidney (VERO) cells (ECACC 84113001), L929 
mouse fibroblast cells (ECACC 85011425), Chinese Hamster Ovary (CHO- 
K1) cells (ECACC 85051005) and BHK TK- Syrian hamster kidney fibroblasts 
(ECACC 85011423) were obtained from the European Collection of Animal 
Cell Cultures (Porton Down, UK). BHK, VERO and mouse L929 cells were
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grown at 37°C in HEPES-DMEM supplemented with 10% FCS. CHO cells 
were grown at 37°C in RPMI supplemented with 10% FCS.
2.2.2 Viruses
The strain 01/BFS/1860 of Foot-and-mouth disease virus (FMDV) was used 
in all FMDV infections.
Bovine enterovirus (BEV), serotype one was used in BEV infection studies.
2.2.3 Preparation of BEV and FMDV stock
Prior to infection, BHK cells were washed in serum-free medium. Appropriate 
inoculum of the relevant virus were added to a 175cm2 flask of cells. Cells 
were then incubated at 37°C for 30 minutes to allow virus adsorption. The 
virus inoculum was then removed and replaced with DMEM supplemented 
with 2% FCS. Cells were incubated at 37°C until 100% cytopathic effects 
were observed, typically within 12 hours for FMDV 01/BFS, and within 24 
hours for BEV serotype 1. Viruses were extracted by freeze-thawing at -  
70°C. Finally, cell debris was removed by centrifugation at 1500g for 10 
minutes and the virus containing supernatant was stored at -70°C.
Titration of virus stocks
Ten-fold serial dilutions of working virus stocks recovered from overnight 
virus preparations were prepared in PBS. BHK cells were grown in 60mm 
dishes to sub-confluency, washed thoroughly with PBS and infected with 
100pl of diluted virus and incubated at 37°C, 5% C 02 for 30 minutes. Three
millilitres of Eagles overlay medium containing 20% Tryptone phosphate 
buffer (TPB), 2% FCS, 0.6% Indubiose agar (Bioserpa, Spain) plus 
antibiotics was added. The agar was allowed to set by incubation at room 
temperature for 5-10 minutes, then the dishes were transferred to 37 °C, 5% 
CO2 and incubated for 48 hours. Monolayers were fixed in 10% 
formaldehyde solution in PBS overnight and stained with saturated 
methylene blue (10mg/litre ethanol) for a minimum of 4 hours. Plaques were 
then counted allowing the virus titre to be calculated.
2.2.4 Virus infection for immunofluorescence and protein analysis.
Cells were washed with serum free medium and appropriate virus inoculum 
was added, followed by incubation at room temperature for 30 minutes to 
allow adsorption onto the cell surface. The virus inoculum was then removed 
and replaced with appropriate medium containing 10% FCS and warmed to 
37°C. Infection was allowed to progress for the indicated time.
2.2.5 Virus infection for Growth Curves
Cells were washed with serum free medium and appropriate virus inoculum 
was added, followed by incubation at room temperature for 60 minutes to 
allow adsorption. Virus inoculum was removed and excess virus neutralised 
with either a 2 minute incubation with FCS in the case of BEV or a 2 minute 
acid wash in the case of FMDV, followed by extensive washing with FCS free 
medium. The appropriate media containing 2% FCS was warmed to 37°C 
and added to cells. The cells were incubated at 37°C, at indicated times 
samples of supernatant were removed for virus titre analysis. The virus titre
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data were tested for statistical significance using two-way analysis of 
variance.
2.3 Antibodies
Antibodies to viral proteins
A number of antibodies were used to detect FMDV: the mouse antibody 1D6 
recognises FMDV protein 3C, 4A3 is a mouse antibody against the FMDV 
capsid protein VP2, 3F7 (a mouse antibody (IgG^) against FMDV non- 
structural protein 2C) and 2C2 (a mouse antibody (lgG2/0 that recognises the 
FMDV non-structural protein 3A). These were a kind gift of E. Brocchi 
(Istituto Zooprofilattico Sperimentale della Lombardia e deH’Emilia, Brescia, 
Italy). Monoclonal antibody B2 (lgGGi) recognizes a linear epitope (the GH 
loop) within VP1 and consequently binds intact virions and their pentameric 
subunits (De Diego et al 1997). The mouse 11C5 anti-BEV antibody was a 
kind gift from Paul Duprex (Dublin).
Antibodies to cellular proteins
Monoclonal antibodies against y-tubulin (GTU-88), actin (clone AC-40) and 
vimentin (clone V9) were purchased from Sigma. Antibody to ERP60 was 
raised in rabbits to the synthetic peptide PIIQEEKPKKKKKAQEDL 
corresponding to the C-terminus of the protein and was described previously 
(Rouiller et al., 1998). Rabbit antibody to A/-&-COP was raised to the chicken 
synthetic peptide CKKEAGELKPEEEITVGPVQK. Polyclonal antibody to 
APG5L was purchased from Abeam (UK). Mouse monoclonal antibody to
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Beclin was purchased from BD Biosciences. Mouse antibody UH1, against 
LAMP 3 was purchased from The Developmental Studies Hybridoma Bank.
Antibodies to common epitopes
The rabbit anti-GFP antibody was purchased from Abeam. Mouse anti-V5 
was purchased from Invitrogen (UK).
Conjugated antibodies and dyes
Goat anti-mouse and anti-rabbit Alexa488 (green), Alexa568 (red), anti-mouse 
IgGoi Alexa488 (green) and lgG2A Alexa594 (red) conjugates were purchased 
from Invitrogen. Goat anti-rabbit and anti-mouse horseradish-peroxidase 
(HRP) conjugates were purchased from Promega (UK). Donkey anti-chicken 
horseradish peroxidise conjugate was purchased from Affinity BioReagents 
(USA). 4'-6-diamidino-2-phenylindole (DAPI) was purchased from Sigma. 
Lysotracker red was purchased from Invitrogen, and used at a final 
concentration of 50nM in tissue culture medium.
2.4 Cell culture techniques
2.4.1 Protein Transfections
Cells were grown to 70% confluency on 24 well plates and were transiently 
transfected with a plasmid using a liposomal transfection system, Transfast 
(Promega, UK). 1.3pl of Transfast and 150pl of serum-free DMEM/RPMI 
were mixed with 1pg of plasmid per well. The mixture was vortexed and left 
for 10 minutes at RT. In the meantime, cells were washed three times with
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serum-free DMEM/RPMI, and incubated with the transfection mixture at 37°C 
for one hour. 1ml tissue culture medium supplemented with 10% FCS was 
then added to the cells, which were then returned to 37°C.
2.4.2 DNA Plasmids
The PMRFPLC3 and PEGFPCD63 constructs were a kind gift from Dr. Aviva 
M. Tolkovsky (University of Cambridge, UK) and has been described before 
(Bampton et al., 2005). pEGFP-N1-wild type rhodopsin and pEGFP-N1- 
P23H rhodopsin were kindly provided by Dr. Michael Cheetham and are 
described elsewhere (Saliba et al., 2002). The FMDV proteins 2Bv5 
(containing a V5 C-terminal tag), 2BC, 2C, 3A, and IRES-eGFP were 
expressed using pcDNA, were generated in our lab and described elsewhere 
(Moffat etal., 2005b).
GFP-Huntingtin aggroprobes Q17 and Q72 were a kind gift and have been 
described elsewhere Sittler et al. (2001) HMG v10 p1307.
2.4.3 Drug treatments
All drugs were dissolved in DMSO for a stock solution, generally 100-1000x 
working solution concentration.
In order to depolymerise microtubules, nocodazole (Sigma), was added into 
the culture medium at a final concentration of 10pg/ml. Cyclohexamide, used 
to inhibit protein synthesis, was added into the culture medium to a final 
concentration of 1pg/ml. Rapamycin inhibitor of mTOR, commonly used for 
autophagy stimulation, was added to culture medium at a final concentration
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of 0.2|jg/ml. 3-methyladenine, PI3 kinase inhibitor, commonly used for 
inhibition of autophagy, was used in the culture medium at a final 
concentration of 10mM.
Concanamycin A (Fluka) was used in culture medium at a final concentration 
of 3nM to inhibit the acidification of lysosomes
Scriptaid (Calbiochem, Germany), an inhibitor of Histone-Deacetylase 
(HDAC), commonly used to inhibit the formation of aggresomes, was used in 
the culture medium at a final concentration of 50pM.
2.5 Microscopy
2.5.1 Indirect immunofluorescence
Cells were cultured on 13-millimetre glass coverslip in DMEM or RPMI 
medium to approximately 80% of confluency. Cells were then washed with 
PBS and fixed with 4% PFA for 40 minutes with shaking at RT. Cells were 
washed with PBS three times, permeabilised in 0.1% (v/v) Triton-X-100 or 
0.5% (v/v) Saponin for 15 minutes, washed three times and blocked in 
blocking buffer for 30 minutes. Cells were incubated with the primary 
antibody in blocking buffer for one hour with shaking. Cells were then washed 
in PBS and incubated with the Alexa conjugated secondary antibody at 1.200 
dilution in blocking solution for 60 minutes in the dark. Cells were washed 
three times in PBS before being incubated for 5 minutes with a 1:20,000 
dilution of a 5mg/ml stock of DAPI in PBS to label DNA. Cells were finally 
washed once with PBS and once with distilled water. Coverslips were
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mounted onto Superfrost slides (BDH, UK) using Vectashield (Vectalabs, 
USA) and sealed with nail varnish.
2.5.2 Image analyses
In most studies, preparations were viewed at 63X with a Leica SP2 confocal 
microscope with 405, 488, 568 and 633 lasers.
2.5.3 Live cell microscopy analysis
Cells for live analysis were cultured onto 35-mm diameter glass-based dishes 
(Iwaki, UK). At the specified time of analyses, dishes were placed on a Leica 
DMIRBE inverted microscope equipped with the scanning head of the Leica 
TCS NT confocal microscope. A temperature chamber built around the 
microscope maintained the cells at 37°C. Preparations were analysed with 
40 or 63X lenses and fluorescent and Differential Image Contrast (DIC) 
images taken at each timepoint. Frames were usually collected every 30 
seconds. Movie files were created using Leica software.
2.5.4 Preparation of EM samples
EM samples were prepared with the aid of Jennifer Simpson Pippa Hawes 
and Paul Monaghan (IAH, Pirbright, UK) as follows.
Conventional section analyses
Cells were plated onto Thermanox coverslips and infected with BEV or 
FMDV for the indicated time. They were fixed in situ with 2% glutaraldehyde
60
in 0.05M phosphate buffer (pH 7.2 -  7.4, osmotic pressure adjusted to 350 
mosmols with sucrose) for a minimum of 2 hrs. Samples were post-fixed in 
1% osmium tetroxide in phosphate buffer for a minimum of 4 hrs, dehydrated 
through a graded series of ethanol and embedded in Agar 100 resin (Agar 
Scientific, UK). After overnight polymerisation at 60°C, the coverslips were 
peeled from the resin block leaving the cells embedded in the resin. Sections 
were cut parallel to the coverslip surface on a Diatome diamond knife (Leica 
Microsysytems, UK) and contrasted with uranyl acetate and lead citrate with 
an EM Stain (Leica Microsysytems). They were imaged in an FEI Tecnai 12 
electron microscope at 100 kV.
High Pressure Freezing
Samples were frozen as described in (Monaghan et al., 2004). Breifly, cells 
grown on 3mm sapphire discs were high pressure frozen in a Bal-Tec 
HAM010 high pressure freezer and then stored in liquid nitrogen.
The frozen discs were freeze substituted in acetone containing 2% uranyl 
acetate and embedded in Lowicryl HM20. Sections were cut as for 
conventially processed cells and imaged without additional contrasting.
2.6 Protein analysis techniques
Whole cell lysate production
Cells were either scraped or detached using versene trypsin, pelleted at 
3,000g for 5 minutes, washed twice in PBS and then tumbled in lysis buffer at 
4°C for at least one hour.
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2.6.1 Sodium-dodecvlsulphate polyacrylamide electrophoresis (SDS-PAGE)
The general protocol for gel preparation is outlined below.
Table 2.1: Composition of a general SDS-PAGE gel
Separating gel x%* Stacking gel 2.5%
Separating buffer 4ml Stacking buffer 5ml
Acrylogel 2.6 solution 
(BDH): 40% 
acrylamide, 2.6 % bis- 
acrylamide (final 
ratio: 37:1)
0.4x ml Acrylogel 2.6 solution 1ml
dH20 11.9 - (0.4x) 
ml
dH20 3.9ml
10% ammonium 
persulphate
150jul 10% ammonium 
persulphate
100pl
Temed 15pl Temed 15pl
* Where x is the percentage content of acrylamide in the resolving gel. 
For example a 10% resolving gel would require 4ml Acrylogel 2.6 solution 
and 7.9ml dH20.
2.6.2 Immunoprecipitation
Lysates were pre-cleared with insoluble protein A at 4°C for 1 hour with 
tumbling. Unlysed materials and insoluble protein A were removed by 
centrifugation (10,000g, 4°C, 10 minutes). Antigens were
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immunoprecipitated from the lysates by overnight incubation with antibodies 
immobilised with protein A coupled to Sepharose beads (Sigma). Prior to 
use, beads (Protein A- Sepharose and 0.5pl of purified antibody or 2pl of 
antiserum) were tumbled overnight at 4°C and washed in lysis buffer five 
times. Finally, the beads were washed 5 times in lysis buffer and boiled for 3 
minutes in SPB. In most studies, proteins were resolved at 120V by SDS- 
PAGE using 10% gels.
2.6.3 Western blot analyses
Proteins were resolved by SDS-PAGE and transferred onto Protan BA85 
nitrocellulose membranes (Scleicher and Schuell, Germany) using a wet 
protein transfer unit (Biorad, USA) for 1 hour. Membranes were blocked for 
one hour at room temperature in blocking buffer. After two washes in 
washing buffer, the membrane was incubated with the primary antibody 
(diluted in antibody incubation buffer) for 1 hour at room temperature or 
overnight at 4°C with shaking. Membranes were washed for 1.5 hours and 
incubated with the secondary antibody conjugated with HRP for 1 hour at RT. 
The membranes were extensively washed and incubated according to the 
instructions for the Super Signal kit (Pierce Chemical Co, USA). After 3 
minutes, membranes were wrapped with Saran wrap for fluorography and 
exposed to X-ray film (Kodak, UK). When a membrane was required for re­
probing with another antibody, it was washed extensively in washing buffer, 
before proceeding from the blocking step.
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2.7 siRNA techniques
2.7.1 siRNA Reagents
Pre-designed human onTARGETplus siRNA SMARTpools against Atg5 and 
negative controls siCONTROL non-targeting siRNA pool and siGLO RISC- 
free siRNA were purchased from Dharmacon.
RNAi oligoribonucleotides corresponding to the mouse Beclin 1 cDNA 
sequence CAGTTTGGCACAATCAATA has been published elsewhere (Yu 
et al., 2004), and was also obtained from Dharmacon
2.7.2 Transfection Reagents
For the transfection of Beclin siRNA into mouse L929 cells, DharmaFECT 1 
was purchased from Dharmacon. Lipofectamine 2000 (Invitrogen) was used 
for Atg5 transfections.
DharmaFECT Transfection Protocol
L929 mouse fibroblast cells (5x104 for 4cm2 dishes) were seeded the day 
before transfection and incubated at 37°C overnight. 50pmols siRNA was 
mixed in 250pl serum and antibiotic free DMEM (Invitrogen), at the same 
time 5pl DharmaFECT was mixed with 250pl serum and antibiotic free 
DMEM. After 5 minutes incubation at room temperature both solutions were 
mixed together creating a final siRNA concentration of 100nM, and incubated 
for a further 20 minutes at room temperature. The siRNA mix was then 
added to cells, which were incubated at 37°C for 4-5 hours with gentle
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agitation, after which 5mis normal growth medium was added to cells. Cells 
were then allowed to grow at 37°C for the appropriate time.
Lipofectamine Transfection Protocol
Vero or Hela cells (5x104 for 4cm2 dishes) were seeded in antibiotic free 
medium the day before transfection and incubated at 37°C overnight. 
50pmols siRNA was mixed in 250pl OptiMEM (Invitrogen), at the same time 
5pl DharmaFECT was mixed with 250pl OptiMEM. After 5 minutes 
incubation at room temperature both solutions were mixed together creating 
a final siRNA concentration of 100nM, and incubated for a further 20 minutes 
at room temperature. The siRNA mix was then added to cells, which were 
incubated at 37°C for 4-5 hours with gentle agitation, after which wells 5mls 
growth medium without antibiotics was added to cells. Cells were then 
allowed to grow at 37°C for the appropriate time.
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Chapter 3: Ultrastructure of membrane rearrangements 
produced during Picornavirus-infection
3.1. Introduction
The replication of positive strand RNA viruses is associated with the 
proliferation of membranes. These accumulate at perinuclear sites, and are 
called replication complexes, which are the sites of viral RNA replication and 
virus assembly (Egger et al., 2000). One of the best studied replication 
complexes is that of Poliovirus (PV) and as such is often used as a template 
to describe other less-well studied picornaviruses. Biochemical analysis of 
membranes induced by PV revealed markers for lysosomes, Golgi stacks, 
Trans-Golgi network and the endoplasmic reticulum (ER) (Schlegel et al., 
1996). Further EM work demonstrated that vesicles induced by PV had 
double membranes, apparently originating from the ER and therefore 
resembled autophagosomes (Suhy, Giddings, and Kirkegaard, 2000). These 
results prompted experiments to determine if autophagy provided the 
membranes for PV replication complexes. Using siRNA against the specific 
autophagy proteins, LC3 and Atg12, PV yields were reduced up to 20-fold 
(Jackson et al., 2005). This indicated that autophagy is beneficial to PV 
replication, and may represent the source for the double membrane vesicles 
observed.
The membrane rearrangements induced by FMDV-infection differ from those 
seen in PV infection. Vesicles are more dispersed and usually appear to
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have single membranes (Monaghan et al., 2004). This data indicates that 
the two viruses may utilise different membrane sources. This is substantiated 
by the observed difference in sensitivity of these viruses to Brefeldin A. 
Brefeldin A inhibits the formation of COP1 coated transport vesicles from the 
Golgi apparatus and is a potent inhibitor of PV replication (Cuconati, Molla, 
and Wimmer, 1998; Maynell, Kirkegaard, and Klymkowsky, 1992). FMDV on 
the other hand is resistant to Brefeldin A treatment (Monaghan et al., 2004), 
suggesting it does not require COP1 coated vesicles.
As illustrated by example from the Nidovirales, it is possible for different 
viruses of the same order to differ in the source of membranes they use as 
platforms for replication. Coronaviruses and Arteriviruses are both members 
of the order Nidovirales. Coronavirus infection induces the formation of 
double membraned vesicles, and appears to utilise autophagic membranes 
(Prentice et al., 2003), since viral yields are substantially decreased upon 
treatment of infected cells with 3-methyladenine, and in Atg5 knock out cells. 
Infection of cells with Equine Arterivirus also promotes the formation of 
double-membrane vesicles (Pedersen et al., 1999). These membranes 
labelled with PDI, an ER marker, and are thought to originate from the ER in 
a ‘protrusion and detachment’ model. In contrast, the replication complexes 
of Alphaviruses use membranes derived from endosomes and lysosomes 
(Froshauer, Kartenbeck, and Helenius, 1988). Whether these are recruited 
from the endocytic pathway or autophagy pathway is not known.
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We used Transmission Electron Microscopy (TEM) to study the membrane 
rearrangements induced by FMDV, with particular interest in identifying the 
origins of membrane vesicles produced during infection. As a comparison, 
the membrane rearrangements produced during Bovine Enterovirus (BEV) 
infection were also observed. BEV, like PV, is a member of the 
Enteroviruses, and as such, shares similarities with PV, including sensitivity 
to Brefeldin A (Monaghan et al., 2004).
3.2 Ultrastructure of cells infected with foot-and-mouth disease virus
BHK cells were grown on thermanox coverslips and infected with FMDV 
strain 01BFS for 3 hours. The cells were then fixed and processed for TEM. 
A typical FMDV-infected cell is shown in figure 3.1.A, and the replication area 
of the virus was observed in the cytoplasm next to the nucleus (N). The 
replication area took up a large part of the cell, and could be distinguished 
from the rest of the cytoplasm by the increased density of ribosomes. It is 
interesting to note that these ribosomes were not associated with the 
endoplasmic reticulum (ER) and appeared free in the cytoplasm. Vesicles 
induced by FMDV were seen throughout this area (arrows). In a typical 
FMDV infection, these vesicles had a single limiting membrane, which 
appeared more electron dense than other cellular membranes, and did not 
cluster together. Higher magnification of a FMDV-replication area from a 
different cell (figure 3.1.B.i) revealed that FMDV-induced vesicles 
occasionally clustered in small groups (black arrows). A double membrane 
vesicle was also present (black arrowhead), though their occurrence was
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rare. The high pressure frozen section in figure 3.1.B.H clearly demonstrates 
the vesicles have a single limiting membrane. This contrasts with the 
vesicles induced by PV, which typically have double membranes, and are 
seen in large clusters.
Fragmented ER (*) was also present and appears to have few ribosomes 
attached.
3.3 Ultrastructure of cells infected with Bovine Enterovirus.
The ultrastructural changes during BEV infection varied greatly from that of 
FMDV and more closely resembled those seen in PV infection. Figure 3.2.A. 
shows a BHK cell infected with BEV for 6 hours before being processed for 
TEM. The first distinguishing feature is the appearance of the nucleus (N), 
which resembles that of an apoptotic cell. Apoptotic nuclei were not seen in 
FMDV-infected cell (figure 3.1.A). The replication area was not as compact 
as seen in FMDV infected cells, and took up nearly the whole of the 
cytoplasm. Unlike FMDV infection, there was no accumulation of free 
ribosomes within the area of BEV replication. Many vesicles were seen, 
throughout the replication area in large clusters, and numerous lysosomes 
were apparent. At higher magnification, the virus particles can be seen in the 
cytoplasm (*) in clusters near the vesicles (figure 3.2.B). The membrane 
vesicles seen in BEV infected cells have multiple membranes and more 
closely resemble autophagosomes.
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Figure 3.3.A. shows an area of a BEV infected cell 6hpi with crescent-shaped 
vesicular structures (arrows). The formation of autophagosomes starts with 
an isolation membrane, similar in appearance to the membranes seen here. 
Figure 3.3.B. demonstrates that some of the vesicles in BEV-infection are not 
only double-membrane, but can also have multiple membrane layers. Of 
particular interest is the localisation of what appear to be BEV virions within 
vesicular structures (figure 3.4). These are highly organised dense 
structures that are slightly larger in diameter than ribosomes, and were not 
observed in uninfected cells, thus it is highly likely they represent virions.
3.4 Distribution of endoplasmic reticulum (ER) and Golgi apparatus in 
Infected Cells
The ER and Golgi apparatus are the most abundant membranous structures 
in the cell, and as such represent a potential source of membranes for viral 
replication. Indeed, the ER marker PDI has been shown to localise to the 
membrane vesicles induced in Equine Arterivirus infection (Pedersen et al., 
1999). ER and Golgi compartments were labelled using antibodies against 
the markers ERP60 and (3-COP respectively during FMDV and BEV 
infection. The distribution of both these cellular markers in uninfected cells 
can be seen in figure 3.5. The Golgi-apparatus is typically seen condensed 
into to stacks in a perinuclear location (figure 3.5.A), whereas the ER is a 
meshwork spreading throughout the cytoplasm of the cell (3.5.B).
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Figure 3.6 shows the effect of FMDV infection on these two organelles; Golgi, 
left-hand column, ER, right-hand column. Two and a half hours after FMDV 
infection the Golgi-apparatus fragmented into numerous smaller stacks, but 
remained clustered next to the nucleus (figure 3.6. left-hand column green). 
The FMDV replication area was labelled with an antibody against the 3A 
protein (figure 3.6. red) and was in a similar area to the fragmented Golgi. 
The signals were however separate, as is clear in the merged image (iii). As 
FMDV 3A is an essential part of the replication complex, this would suggest 
that the membranes required for replication do not contain the Golgi marker. 
The distribution of the ER marker ERP60 at 2.5 hpi did not appear to change 
considerably (figure 3.6. right-hand column green) and appeared as a 
meshwork throughout the cytoplasm. FMDV is again visualised with an 
antibody against the 3A protein (figure 3.6. red) and no co-localisation 
between the ER and FMDV marker was seen in the merged image (3.6.vi).
The effect of BEV infection on the distribution of ER and Golgi was more 
pronounced. The Golgi marker p-COP in a cell infected with BEV for 5 hours 
can be seen in figure 3.7. (left-hand column). Instead of distinct stacks 
condensed next to the nucleus, the Golgi (green) was dispersed throughout 
the cytoplasm, antibody labelling was even present in the nucleus (blue). 
BEV was labelled using the mouse antibody 11C5 and can be seen in red. 
Unfortunately our information on the BEV antibody is minimal, and its precise 
viral target unknown, so little can be concluded from the lack of co­
localisation between the two markers (merge). However, the antibody was 
raised against whole virus and detects a band at roughly 20kDa by Western
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blot, thus it is likely it recognises a capsid protein. As such, labelling with this 
antibody may indicate sites of virus assembly but not replication.
The redistribution of the ER marker at this stage of BEV infection was very 
similar to the Golgi (figure 3.7 right-hand column green). ERP60 no longer 
appeared as a fine meshwork but had a more punctate appearance 
throughout the cytoplasm (iv). Again the ER (green) and the BEV (red) 
signals were largely separate (vi).
3.5 Discussion
The origin of PV-induced membranes has been attributed to the autophagy 
pathway (Jackson et al., 2005). Certainly the vesicles seen in PV infected 
cells have double membranes, resembling autophagosomes, and are 
consistent with this model. Our TEM data showing that BEV increased the 
number of double membrane vesicles (figure 3.2 and 3.3.B), and suggests 
that BEV may also induce the formation of autophagosomes to generate 
membranes for the replication complex. We also observed a number of 
membrane structures with a crescent shape, a similar appearance to 
isolation membranes (figure 3.3.A), the starting point of autophagosome 
formation. The crescent-shape membranes observed in BEV-infected cells 
were approximately 200nM in length, a similar size to previously observed 
autophagy membranes. The size of autophagy vacuoles appears to vary 
between cell type, and can range from 100nM to 1pM, although these are not 
defining limits (Liou et al., 1997; Mizushima, 2004; Mizushima et al., 2001;
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Mizushima et al., 2004). The lack of co-localisation between BEV labelling 
and the markers for the ER and Golgi, suggest that the membranes used in 
replication do not contain these markers. Autophagosome membranes have 
been shown to contain very few protein markers, and although they may 
originate from ER or Golgi membranes (Dunn, 1990), they do not contain 
markers for either organelle. The observation of BEV virus particles inside 
vesicular structure (figure 3.4) could be consistent with the virus-exit strategy 
proposed for PV and Rhinovirus 14 (Jackson et al., 2005). These authors 
have proposed a model whereby virions accumulate within the lumen of 
autophagosomes, which subsequently fuse with the plasma membrane 
allowing viral release from the cell prior to cell lysis.
Both BEV and PV are sensitive to Brefeldin A, providing further evidence of 
their similarities in replication strategies. FMDV on the other hand is 
insensitive to Brefeldin A, and is thought to follow a different replication 
strategy to PV and BEV. Our TEM data support this theory. The vesicles 
produced in FMDV infection differ from those seen in PV and BEV in two 
ways; they do not cluster, instead appearing dispersed throughout the 
replication area, and they seem to have a single membrane. This dispersed 
appearance is inconsistent with typical autophagosomes. However, when 
autophagosomes fuse with a lysosome they mature into an autolysosome 
with a single membrane. Whilst it is possible that the vesicles seen in figures
3.1 A and B do represent mature autolysosome, it is highly unlikely that 
FMDV replication or virion-transport occurs on these vesicles. The FMDV 
capsid is extremely sensitive to acidic pH, and the maturation of an
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autophagosome into an autolysosome decreases the internal pH as it obtains 
acid hydrolases from the lysosome and proton pumps deliver protons (H+). 
Thus the acidic environment within the autolysosome would cause the 
deterioration of FMDV capsids and would be detrimental for the replication 
cycle.
We used immunofluoresence to see if membranes in the replication complex, 
labelled with antibodies against replicase protein 3A, contained ER and Golgi 
markers. Consistent with previous observations (Knox et al., 2005), the 
signal from 3A did not co-localise with the ER or Golgi markers used. This 
does not exclude the possibility that FMDV recruits membranes from these 
cellular organelles and subsequently depletes them of host cell markers.
In Summary, the membrane rearrangements seen in BEV infection strongly 
resemble those seen by PV infection, and the multiple membrane vesicles 
seen are indicative of autophagic origin. FMDV induces mostly single 
membrane vesicles and their origin is not yet clear. It is possible that these 
are mature autolysosomes, and if not used for virus replication, may 
represent a host cell response to clear FMDV. The occasional double 
membrane vesicles are predominantly seen late during FMDV infection. The 
timing of their appearance suggests their role during infection may differ to 
that of PV.
Chapter Four: Rearrangement of LC3 during FMDV infection
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Figure 3.1.A. Ultrastructure of FMDV-infected cells compared to uninfected cells
BHK cells were grown on thermanox coverslips, incubated with FM DV inoculum (01BFS) for 30 minutes 
at room temperature. Virus inoculum was then replaced with medium containing 2% FCS and incubated 
at 37°C for 3 hours when cells were processed for transmission electron microscopy. The FM DV  
replication area is located next to the nucleus (N). It takes up a large portion of the cytoplasm and has a 
high density of ribosomes compared to the surrounding areas. Numerous FMDV-induced vesicles 
(arrows) can be seen throughout the replication area. Bar 1uM
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Figure 3.1.B. Ultrastructure of FMDV-infected cells compared to uninfected cells
i. BHK cells were treated as in 3.1.A, and processed for transmission electron microscopy. FMDV- 
induced vesicles are depicted by black arrows. A double membrane vesicle (black arrowhead). 
Fragmented ER can also be seen (*). Bar 500nM
ii. BHK cells were grown on sapphire disks, and infected with FM DV as above. 3HPI, cells were high 
pressure frozen and processed for electron microscopy. Bar 100nM.
Figure 3.1.C. Ultrastructure of FMDV-infected cells compared to uninfected cells
BHK cells were grown on thermanox coverslips overnight. Uninfected cells were then processed for 
transmission electron microscopy. Bar 1um.
Figure 3.2.A. Ultrastructure of a BEV-infected cell.
BHK cells were grown on thermanox coverslips, washed with serum-free medium and incubated wih 
BEV inoculum for 30 minutes at room temperature. Virus inoculum was then replaced with medium 
containing 2% FCS and incubated at 37°C for 6 hours when cells were fixed and processed for 
transmission electron microscopy. The nucleus (N) is typical of an apoptotic cell. The replication area 
takes up much of the cytoplasm and is filled with BEV-induced vesicles (arrows). Bar 2500nM
Figure 3.2.B. Ultrastructure of a BEV-infected cell.
BHK cells were cultured and treated as in A. Virus particles can be seen (*), and vesicles have a double 
membrane appearence. Bar 250nM
Figure 3.3. Membrane structures in BEV infected cells resemble autophagic membranes
BHK cells were cultutred and treated as in figure 3.2.A. A. Arrows depict isolation membrane-like 
vesicular structures (top panel). B multiple membrane layers can be seen (bottom panal).
Bars 100nM
AB
Figure 3.4 BEV virus particles can be seen in vesicular structures.
A. BHK cells were cultured on thermanox coverslips, washed with serum-free medium and incubated with 
BEV inoculum for 30 mintues at room temperature. The inoculum was replaced with medium containing 
2% FCS and cells were returned to 37°C. Cells were fixed 6 hpi. microscopy. Arrow; a vesicle appeared 
to contain BEV virions (top panal) Bar 100nM. B. at higher magnification (bottom panal). Bar 100nM
BFigure 3.5 Immunolabelling of Golgi apparatus and endoplasmic reticulum in uninfected CHO 
cells.
CHO cells were grown on 13mm coverslips and fixed in 4% PFA. A. Golgi was labelled using an anti 
P COP antibody and a secondary antibody coupled to alexa 488 (top panel, green).
B ER was labelled using an anti ERP60 antibody and a secondary antibody coupled to alexa 488  
(bottom panel, green). Cellular DNAw as visualised with DAPI (blue). Bar 10uM
Figure 3.6. Distribution of ER and Golgi in FMDV infection
CHO cells were incubated with FMDV inoculum (01BFS) at room temperature for 30 minutes. The virus 
inoculum was then removed and replaced with media containing 2% FCS and cells were incubated at 
37°C for 2.5 hours when they were fixed in 4%  PFA and processsed for immunofluoresence. Golgi was 
labelled with an anti p COP antibody and a secondary antibody coupled to alexa 488 (left hand panels, 
green). ER was labelled using an anti ERP60 antibody and a secondary antibody coupled to alexa 488  
(right hand panels, red) FMDV was labelled with an anti 3A antibody followed by a secondary antibody 
coupled to alexa 568.(red) Cellular DNAw as labelled with DAPI (blue). Bar 10uM
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Figure 3.7. Distribution of ER and Golgi in BEV infected CHO cells
CHO cells were washed with serum-free medium and incubated with BEV inoculum at room temperature 
for 30 minutes. The virus inoculm was then removed and replaced with medium containing 2%  FCS and 
cells were incubated at 37°C for 5 hours when they were fixed with 4%  PFA. Golgi was labelled using an 
anti p COP antibody followed with a secondary antibody coupled to alexa 488 (left hand panels, green). 
ER was labelled using an anti ERP60 antibody and a secondary antibody coupled to alexa 488 (right 
hand panals, green). BEV was labelled with the mAb 11C5 and a secondary antibody coupled to alexa 
568 (red). Cellular DNAw as labelled with DAPI (blue). Bar 10uM
4.1 Introduction
The results recorded in chapter 3 suggest that the membranes induced 
during FMDV infection differ from both those induced by BEV, and from those 
described in the literature for PV. Recent work suggests that PV infection 
induces autophagy and autophagosomes may be used as sites of replication 
(Jackson et al., 2005). The failure to detect double-membraned 
autophagosomes in cells infected with FMDV suggests it may induce 
membranes from a different source, or the membrane vesicles may represent 
a later stage of the autophagy pathway such as autolysosomes which have a 
single-membrane. To investigate the role of autophagy in FMDV infection, 
the effect of FMDV infection on autophagy markers was studied.
There are only a small number of autophagy proteins that locate to 
autophagosomes. These can be difficult to detect by microscopy as the 
membranes of autophagosomes contain relatively low levels of protein, and 
many proteins involved in making autophagosomes and isolation membranes 
bind membranes transiently. LC3, the mammalian homologue of the yeast 
protein Atg8, is considered the most reliable marker for isolation membranes 
and autophagosomes. In resting cells LC3 is predominantly present as a 
cytosolic form, termed LC3-I. When autophagy is activated the C-terminus of 
LC3 is cleaved and conjugated to PE (phoshpatidylethanolamine) forming 
LC3-II which is anchored to autophagic membranes. Firstly LC3 is found on 
isolation membranes, autophagosomes and autolysosomes. Increased 
autophagic activity is indicated by an increase in LC3 processing, and
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secondly there are two methods for monitoring this. LC3 processing can be 
visualised by Western blot analysis where the conversion of LC3-I to LC3-II 
results in a mobility shift from 18kDa to 16kDa, and by immunofluorescence 
microscopy where membrane association results in an increase of punctate 
signals in the cytoplasm. The redistribution of LC3 during infection, and its 
association with viral proteins has frequently been used to ascertain the 
relationship between viral replication and autophagy (Jackson et al., 2005; 
Nakashima et al., 2006; Prentice et al., 2003; Prentice et al., 2004). To 
investigate whether autophagy played a role in FMDV infection, the effect of 
FMDV infection on the distribution of LC3 was studied by both 
immunofluorescence and Western blot.
4.2 Cellular distribution of GFPLC3 after activation of autophagy
The distribution of LC3 was followed by the expression of LC3 conjugated to 
GFP via its N terminus. CHO cells constitutively expressing GFPLC3 were a 
kind gift from Dr Zvulun Elazar of the Weizmann Institute of Science. To 
ensure a change in the distribution of GFPLC3 was attributable to autophagy, 
the distribution of GFPLC3 was also studied following stimulation or inhibition 
of autophagy.
In nutrient rich conditions, which suppress autophagy (figure 4.1.A Control), 
CHO cells showed a diffuse distribution of GFPLC3 throughout the cytoplasm 
with small numbers of punctate foci close to the nucleus. These foci 
resemble published images of autophagic vacuoles (Mizushima et al., 2004),
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A small amount of GFP was seen in the nucleus (labelled with DAPI, blue), 
this observation is attributed to this over-expression of GFP and not a 
function of LC3.
Autophagy is up-regulated by amino acid deprivation and these conditions 
can be reproduced in tissue culture with Hanks Balanced Salt Solution 
(HBSS). HBSS is a specially formulated medium devoid of amino acids and 
is commonly used to stimulate autophagy (Komatsu et al., 2005; Munafo and 
Colombo, 2001; Tassa et al., 2003). To examine the effect of amino acid 
deprivation on the distribution of GFPLC3, CHO cells expressing GFPLC3 
were incubated in HBSS for 2 hours, fixed and processed for 
immunofluorescence. As seen in figure 4.1 .A (top right panel), the number of 
cells with punctate GFPLC3 foci increased after nutrient deprivation. 
Furthermore the number of punctate GFPLC3 foci within each of the cells 
had also increased, indicating an increase in the number of 
autophagosomes.
3-Methyladenine (3-MA) inhibits the PI3 Kinases that are involved in the 
signalling cascade, which induces autophagy, and results in the inhibition of 
autophagosome formation. CHO cells expressing GFPLC3 were incubated 
in HBSS containing 10mM 3-MA for 2 hours. Figure 4.1.A (lower left), shows 
that GFPLC3 signal remained diffuse in the cytoplasm of the cells upon 
treatment with 3-MA, and no punctate dots were observed. Thus treatment 
with 3-MA inhibited the activation of autophagy by amino acid starvation.
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Autophagy can be up-regulated using rapamycin. Rapamycin inhibits the 
mTOR kinase that inhibits autophagy in resting cells. Incubation with 
rapamycin for 2 hours produced an increase in punctate foci of GFPLC3 
(figure 1A lower right) comparable to that seen after amino acid starvation. 
Activation of autophagy results in conversion of LC3-I to LC3-II. The 
processing of GFPLC3-I to GFPLC3-II under the conditions described above 
was therefore analysed by Western blot using an antibody to the GFP tag to 
detect the two forms of GFPLC3.
Two bands were detected migrating above the 35kDa marker (figure 4.1.B). 
GFP is a 27kDa protein, so when coupled to LC3-I (18kDa) or LC3-II 
(16kDa), would be expected to migrate at 45 and 43kDa respectively. This is 
consistent with the two bands detected by Western blot. The ratio of 
GFPLC3-II:GFPLC3-I increased slightly in response to amino acid 
deprivation and rapamycin treatment (figure 4.1.B). In contrast a slight 
decrease in LC3-II:LC3-I ratio was observed when autophagy was inhibited 
using 3-MA (figure 4.1.B). Dramatic differences in GFPLC3-II:GFPLC3-I 
ratios after stimulation of autophagy stimulation are not often seen because 
mature autophagosomes fuse with lysosomes where the processed LC3-II is 
released from the membrane or degraded in the lysosomes. Large 
accumulation of GFPLC3-II are not seen unless lysosome fusion is inhibited 
(Tanida etal.,2005).
4.3 Cellular distribution of GFPLC3 during FMDV infection
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The distribution of GFPLC3 during FMDV infection was determined. The 
tissue culture-adapted, strain of FMDV (01BFS) was chosen because it 
grows well in CHO cells, and the distribution of GFPLC3 was studied by live 
cell imaging (see supplementary material) and confocal microscopy.
For confocal microscopy, CHO cells expressing GFPLC3 were incubated for 
30 minutes at room temperature with FMDV inoculum. The virus inoculum 
was replaced with culture medium and cells were returned to 37°C and 
processed for immunofluorescence at the indicated times. Infected cells 
were identified using an antibody recognising the FMDV non-structural 
protein 3A and nuclear DNA was visualised using DAPI (blue). FMDV-3A 
labelling (red) was seen at 1.5-3hpi (figure 4.2.A). Infection had a dramatic 
effect on the distribution of GFPLC3. In uninfected cells, GFPLC3 showed a 
typical diffuse distribution throughout the cytoplasm and a few GFPLC3 
punctate foci can be seen indicative of a low level of autophagy (figure 4.2.A 
panel Uninfected). At 30 minutes after the infection was initiated (i.e. the 
cells were returned to 37°C), the number of punctate foci containing GFP- 
LC3 increased dramatically and were dispersed throughout the cytoplasm. 
At 1 hpi, in a small number of cells, GFPLC3 was seen to concentrate at 
perinuclear sites and there was a coincident decrease in cytoplasmic 
GFPLC3 signal. However, individual punctate foci could not be distinguished 
in these accumulations, and the edges of the accumulations were not clear 
having a ‘fuzzy’ appearance. The number of such accumulations of GFPLC3 
increased by 1.5hpi. At this time, FMDV 3A was detected (red), in a similar 
area of the cell. The GFPLC3 structures persisted up to 2hpi (figure 4.2.a
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2hpi). The amount of FMDV 3A labelling increased, and in most cases could 
be seen surrounding the accumulation of GFP signal. By 3hpi, the 
perinuclear accumulations of GFPLC3 were absent. FMDV 3A labelling had 
increased further and was detected in a large part of the cytoplasm, whereas 
a small number of punctate dots containing GFPLC3 were seen dispersed 
throughout the 3A labelling.
A higher magnification image of GFPLC3 seen at 2hpi is shown in figure 
4.2.B. Again individual foci of GFP signal could not be distinguished (4.2.B.i 
green) and the GFPLC3 signal appeared as, spherical structures with fuzzy 
edges. The individual red and green signals do not appear to overlap, 
indicating that GFPLC3 did not co-localise with FMDV non-structural protein 
3A, even though they occupy a similar area of the cell. Cells were also 
imaged with Differential interference Contrast (DIC) in order to define the 
limits of the plasma membrane (4.2.B.iv greyscale). The cells remained flat 
at this time point demonstrating that the perinuclear accumulation of GFPLC3 
was not due to cell rounding seen during late stages of infection.
FMDV infection inhibits host cell protein synthesis. As protein synthesis and 
the starvation response are closely related processes; it is possible that the 
redistribution of GFPLC3 during FMDV infection was a bystander effect of the 
inhibition of protein synthesis. To ensure the redistribution of GFPLC3 was a 
specific to FMDV, the effect of cyclohexamide on the distribution GFPLC3 
was tested. Cyclohexamide inhibits protein synthesis and can be used to 
mimic the effect of FMDV-induced inhibition of host cell protein synthesis. As
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seen in figure 4.3A i, a 2 hour incubation with 1|jg/ml cyclohexamide did not 
cause the perinuclear accumulation of GFPLC3 seen in FMDV infection.
To confirm the redistribution of GFPLC3 during FMDV infection was specific 
to the function of LC3, and not due to the conjugation of GFP, the effect of 
FMDV infection on the distribution of GFP fused to the internal ribosomal 
entry site (IRES) in the 5’ UTR of the FMDV genome was tested. The IRES 
allows translation of the FMDV genome in the absence of host cell CAP- 
binding complex function. CHO cells were transfected with the expression 
plasmid containing GFP-IRES using Transfast and incubated at 37°C for 24 
hours to allow for protein expression. Cells were subsequently infected with 
FMDV for 2 hours before being processed for immunofluorescence. As seen 
in figure 4.3.A.ii, there was no perinuclear accumulation of GFP in cells 
infected with FMDV showing that redistribution was dependent on LC3.
The appearance of the perinuclear GFPLC3 signal seen in FMDV infection 
was different from the punctate autophagosome labelling induced by amino 
acid starvation or rapamycin treatment (figure 4.1.A). This could mean either 
accumulation of cytosolic LC3 within a viral inclusion or recruitment of 
membrane bound LC3 into perinuclear sites. Membrane binding of LC3 
requires processing of LC3I to LC3 II. Processing of LC3 during FMDV 
infection was therefore studied using antibodies to GFP and Western Blot 
(figure 4.3.B). The ratio of GFPLC3-II-GFPLC3-I appeared to increase 
slightly at 0.5hpi concurrent with the increase of punctate GFPLC3 seen by 
immunofluorescence (figure 4.2.A). This increase was maintained at 1, 1.5
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and 2hpi, when the perinuclear accumulations of GFPLC3 are observed by 
immunofluorescence. A decrease in GFPLC3-II:GFPLC3-I ratio was seen at 
2.5hpi, this coincides with the loss of the concentrated GFPLC3 signal seen 
by immunofluorescence at 3hpi. It is not yet clear whether this represents 
the degradation of GFPLC3 in lysosomes or the reversal of the membrane 
bound GFPLC3-II to its cytoplasmic form GFPLC3-I mediated by Atg4. 
Quantitative analysis of the difference in ratio of LC3-I and LC3-II was 
unsuccessful, however the Western blot was repeated four times with 
consistent results. To ensure the processing of GFPLC3 observed did not 
result from inhibition of host cell protein synthesis that occurs during in FMDV 
infection, the experiment was repeated using cycloheximide (figure 4.3.B.ii), 
Comparison with untreated cells (U) showed that there was no obvious 
change in the ratio of GFPLC3-II:GFPLC3-I in cells treated with 
cyclohexamide. Thus the modest increase in GFPLC3 processing during 
FMDV infection was likely to result from FMDV protein expression rather than 
inhibition of host cell protein translation. The perinuclear concentration of 
GFPLC3 induced by FMDV infection was different from anything we could 
find in the literature, we have therefore termed these ‘fuzzy’ accumulations of 
GFPLC3 FMDV-Induced-LC3-Structures (FILS).
4.4 FMDV-lnduced LC3-Structures form next to the MTOC
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FILS consistently formed next to the nucleus, and often caused an 
indentation of the nuclear membrane resulting in a ‘kidney bean’ appearance 
(figure 4.2.B). This close association between the location of FILS and cell 
nuclei may indicate that FILS form next to the Microtubule Organising Centre 
(MTOC). The MTOC is a specific intracellular location where microtubules 
are tethered and nucleated, facilitating their growth out towards the cell 
periphery. To investigate whether FILS formed next to the MTOC, the 
location of the MTOC in cells containing FILS was identified by 
immunofluorescence labelling of y-tubulin. y-tubulin is involved in the 
nucleation of microtubule growth, as microtubule nucleation occurs at the 
MTOC, this protein can be used as a marker for the MTOC. CHO cells 
expressing GFPLC3 were infected with FMDV for 2.5 hours and processed 
for immunofluorescence. FILS were identified by the natural fluorescence of 
GFP and y-tubulin labelling was detected as a small punctate spot in a 
position between the FILS and the nucleus (figure 4.4), thus indicating that 
FILS do form next to the MTOC.
4.5 Formation of FILS is dependant upon an intact microtubule network
Live cell imaging of the formation of FILS suggests they form from an 
accumulation of individual GFPLC3 foci next to the nucleus (supplementary 
material S1 and figure 4.2.A). It is possible that FILS form from the 
retrograde microtubule transport of GFPLC3 towards the MTOC. In support 
of this theory, LC3 has been previously identified as a microtubule- 
associated protein, and is thought to traffic along the microtubule network
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(Kabeya et al., 2000). To test if microtubules were required for the 
perinuclear accumulation of GFP-LC3, cells infected with FMDV were 
incubated with Nocodazole. Infected cells were identified using an antibody 
against FMDV 3A followed by a secondary antibody conjugated to Alexa 568 
(red). In control cells incubated with DMSO (the Nocodazole solvent), 3A 
labelling was typically to one side of the nucleus (figure 4.5.i-iii.) surrounding 
the strong GFP signal characteristic of FILS. When the microtubule network 
was disrupted with Nocodazole (Figure 4.5.iv-vi), FMDV 3A and GFP-LC3 
were dispersed throughout the cytoplasm in numerous small punctate foci. 
These data show that treatment with Nocodazole inhibits both the perinuclear 
concentration of FMDV 3A, and the formation of FILS, suggesting that both 
processes are dependant upon an intact microtubule network.
4.6 Analysis of FILS by electron microscopy.
FILS appeared much larger than typical autophagosomes (compare GFPLC3 
structures in figure 4.1.A and figure 4.2.B) and their structure was 
investigated further using transmission electron microscopy (TEM).
CHO cells expressing GFPLC3 were cultured on thermanox coverslips and 
incubated with FMDV virus inoculum at room temperature for 30 minutes. 
Cells were examined by live-cell microscopy to follow the formation of FILS to 
and when 90% of cells had formed FILS (typically 2.5hpi) cell cultures were 
fixed and processed for TEM. In previous immunofluorescence data, FILS 
were shown to disperse by 3hpi, their persistence at 3hpi in these
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experiments may be due to the change in incubation conditions to allow live 
cell imaging, which may have slowed the infection process. The 
ultrastructure of an uninfected CHO cell expressing GFPLC3 can be seen in 
figure 4.6. Immunofluorescence data has shown that FILS form next to the 
MTOC, and cause an indentation of the nucleus. To allow for the best 
comparison of control and infected cells, a control cell with a slight 
indentation of the nucleus was imaged in figure 4.6. The MTOC (arrow) can 
be seen and a number of vesicles are dispersed throughout the cytoplasm. 
An infected cell is shown in figure 4.7.A and the area next to the indentation 
of the nucleus thought to represent FILS has been framed. In comparison to 
the rest of the cell, and the uninfected cell in figure 4.6, the framed area in 
figure 4.7.A had a more ‘dense’ appearance and contained numerous 
vesicles, almost certainly lysosomes, with dark content. In contrast to the 
FMDV replication area seen in figure 3.1.A, very few free ribosomes were 
seen in the framed area. A similar area is presented at higher magnification 
in figure 4.7.B and shows an accumulation of tubular structures with the 
appearance of smooth ER, and some vesicles with electron dense 
membranes. Typical autophagosomes with double membranes were not 
apparent in these areas, however autophagosomes do have electron dense 
limiting membranes.
To ensure that these tubular membranes were not due to the over­
expression of GFPLC3, CHO cells lacking GFPLC3 were infected with FMDV 
for 3 hours, fixed and processed for TEM. Similar accumulation of 
membrane tubules were observed close to the MTOC and accompanied by
85
an indentation of the cell nucleus (figure 4.8.A). A higher magnification of 
this area is shown in figure 4.8.B. clearly showing an accumulation of tubular 
structures, similar to those seen in figure 4.7. B. These data demonstrate that 
the tubular structures seen in FMDV-infected CHO cells expressing GFPLC3 
are not caused by the over expression of GFPLC3.
These tubular structures at the MTOC differed from the numerous single- 
membraned-vesicles seen in BHK cells infected with FMDV (figure 3.1.A and 
Monaghan et al. 2004). The previous TEM studies used BHK cells, whereas 
the tubular structures were observed in CHO cells and may indicate a 
difference in the life-cycle of FMDV in the two cell lines. Certainly the 
cytopathic effect is observed in BHK cells at 3-4 hpi, whereas in CHO cells 
changes in cell structure are slower and a CPE is not observed until about 5- 
6 hpi. The immunofluorescence data from figure 4.2 demonstrated that FILS 
formed early at about 1hpi and disappeared at about 3 hpi, just as large 
amounts of FMDV protein were detected, and about 2 hours before CPE was 
observed. The BHK cells infected with FMDV were processed for TEM at the 
relatively late time of 3 hpi, just before cell lysis. It is possible that tubules 
are produced in BHK cells, but they have been missed, and that the tubules 
are replaced by vesicles later in infection. To test this, CHO cells were 
examined at 4hpi, at a time when FILS seen by live cell imaging were starting 
to decline. Figure 4.9 shows that at this time point vesicles similar to those 
seen in BHK cells (figure 3.1.A and B) are also formed in CHO cells (arrows). 
In Summary, TEM analysis has demonstrated that FILS are a mass 
accumulation of tubular structures (figure 4.7), distinct in appearance from
typical autophagosomes. The appearance of FILS is relatively early in 
infection, as demonstrated by immunofluorescence (figure 4.2), and at later 
times of infection, typical FMDV-induced vesicles are formed (figure 4.9). 
TEM of structures similar to FILS have not been demonstrated previously in 
FMDV-infected BHK cells (Monaghan et al., 2004), and may be unique to 
CHO cells, possibly connected to the slower rate of infection of CHO cells to 
BHK cells. Alternatively, they may form in BHK cells but are not as 
prominent, or that they are present for a relatively short time, and therefore 
difficult to detect.
4.7 FILS co-localise with the FMDV capsid protein VP1 but not the non- 
structural proteins 3D or 2C.
Previous reports for poliovirus (PV) show that LC3 co-localises with 3A in 
infected cells. Since PV 3A is associated with the replication complex this 
suggests that PV replicates in association with autophagosomes (Jackson et 
al., 2005). The replicase proteins of both MHV and SARS are also found to 
co-localise with LC3 (Prentice et al., 2003; Prentice et al., 2004) which may 
indicate that coronavirus replication also occurs on autophagosomes. To 
investigate the role of autophagosomes in FMDV replication, the possible co­
localisation between GFPLC3 and the FMDV proteins 3D, 2C and VP1 was 
investigated. 3D and 2C are both non-structural proteins associated with the 
formation of the FMDV replication complex and VP1 is a structural protein 
and forms part of the viral capsid.
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FILS start to be lost from cells when large amounts of FMDV proteins are 
detected (figure 4.2.A). However, between 1.5 and 2.5 hpi, when FILS were 
still observed, small amounts of FMDV proteins can be detected allowing co­
localisation studies to be performed (Figure 4.10 i and iv). The 2C signal was 
seen concentrated in the perinuclear area containing FILS however very little 
overlap of GFPLC3 and 2C signals was observed (figure 4.10.i-iii). A similar 
result was observed for 3D labelling (figure 4.10 iv-vi). These data suggest 
that unlike PV, MHV and SARSV, FMDV proteins likely to be associated with 
the replication complex do not co-localise with the autophagy marker 
GFPLC3. A comparison of GFPLC3 signal and VP1 is shown in figure 4.11. 
Interestingly, the VP1 signal was concentrated next to the nucleus and much 
of the VP1 signal co-localised with GFPLC3 (i-iii). Co-localisation in specific 
punctate structures is indicated by the arrowheads, and was also observed in 
most cells. The GFPLC3 and VP1 signals were detected sequentially to 
ensure the co-localisation observed was not due to any signal bleed-through 
from the lasers. This is substantiated by the observation of individual green 
and red signals (figure 4.11. iii). When infection was allowed to continue for 
3 hours, FILS were no longer observed (figure 4.11. iv) and. VP1 labelling 
increased and filled a large part of the cytoplasm (figure 4.11. v). Co­
localisation of VP1 and the remaining GFPLC3 was not observed at this time 
(figure 4.11. vi).
To ensure the co-localisation of GFPLC3 and VP1 was specific to LC3, and 
not because of aggregation of VP1 with GFP, the distribution of VP1 was 
studied in cells expressing GFP from the FMDV IRES. The expression of
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GFP-IRES did not affect the distribution of VP1 labelling, which was located 
in an area close to the nucleus (figure 4.12.i and ii). GFP-IRES was seen 
throughout the cell cytoplasm and in the nucleus (figure 4.12.iii). GFP-IRES 
was not excluded from the areas that labelled for VP1, but no co-localisation 
was observed indicating that the co-localisation of GFPLC3 and VP1 is due 
to the association of GFP with LC3.
The results above showed that GFP-LC3 co-localises with VP1 and not 3D, 
or 2C at 2.5 hours pi. This suggested that VP1 would also show a separate 
signal from 2C and 3D replicase proteins. The distributions of VP1 and the 
non-structural protein 3A (used in initial immunofluorescence labelling 
experiments) were therefore investigated in more detail. The antibodies used 
to label VP1 and 3A were both mouse monoclonal antibodies and were 
detected using isotype-specific secondary antibodies. At 2.5 hours pi FMDV 
3A and VP1 labelling were detected in a similar area of the infected cell, but 
did not co-localise (figure 4.13). The results suggest that the structural 
proteins of FMDV, rather than replicase proteins, co-localise with GFPLC3.
Previous studies from the laboratory have suggested that at 4 hours post 
infection VP1 and non-structural protein 2C co-localise in CHO cells infected 
with FMDV (Knox et al., 2005). One explanation for this apparent 
discrepancy may lie in the different time points used. In this current study, 
FMDV protein distribution was examined relatively early in infection, when 
only small amounts of viral protein are present and GFP-LC3 is concentrated 
next to the nucleus. The previous study observed FMDV protein distribution
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at later times of infection (4hpi) when a greater amount of viral proteins were 
present, and the GFP-LC3 signal declines (figure 4.11). It is interesting to 
note that whilst a majority of VP1 and 3A was observed to co-localise in the 
previous report, a small sub-population of VP1 did not co-localised with 3A 
(Knox et al., 2005). Thus it appears the relationships between individual 
FMDV proteins may differ through the time-course of infection.
4.8 An intact microtubule network is not required for co-localisation of 
GFPLC3 and VP1
To test whether the association of GFPLC3 and VP1 was dependant upon an 
intact microtubule network, the effect of Nocodazole on distribution of VP1 
and LC3 was investigated. Cells were infected with FMDV for 30 minutes 
and then washed. Nocodazole was either added immediately after washing 
(i.e before FILS were detected), or 1.5 hours later at a time when ~80% of 
control cells contained FILS. In either case Nocodazole prevented or 
dispersed the perinuclear accumulation of GFP and VP1. The fluorescence 
signals were observed dispersed throughout the cytoplasm in numerous 
punctate foci (figure 4.14.i,ii) and in many cases VP1 and LC3GFP signals 
remained co-localised.(figure 4.14.iii arrowheads). These data indicated that 
an intact microtubule network was not required for the association of VP1 
and GFPLC3, and that association can occur independently of the formation 
of FILS. The results also show that VP1 and GFPLC3 remain co-localised if 
FILS are dispersed by Nocodazole.
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4.9 Depolymerisation of microtubules does not inhibit FMDV infection
To determine if FILS are necessary for virus replication one-step growth 
curves were performed in cells incubated in the presence or absence of 
Nocodazole. Cells were acid washed after internalisation of virus (see 
materials and methods) to remove excess virus to allow an accurate 
calculation of the amount of virus released from cells as a result of productive 
replication. Cell supernatants were removed and stored at -70°C every 2 
hours until extensive CPE was observed. The average virus titres calculated 
from triplet experiments are presented in figure 4.15.A as plaque forming 
units (pfu)/ml. The amount of virus in supernatants increased steadily as 
infection progressed however very little difference was observed in the virus 
titres produced from control or cells incubated with Nocodazole (figure 
4.15.A). Slight differences in virus titre could be seen when the data were 
presented as percentages (figure 4.15.B). If the virus titres produced by 
control cells were set at 100% treatment with Nocodazole actually resulted in 
a slight increase in virus release at 4 and 6 hpi. However, these differences 
were not found to be statistically significant using the Two-way analysis of 
variance test, (P = 0.694). Intact microtubules were not therefore necessary 
for FMDV replication and may actually increase virus yield.
4.10 Expression of FMDV proteins 2C or 2BC induces the formation of 
FILS in the absence of infection
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In a previous publication by Jackson et al. (2005) the redistribution of LC3 
seen during PV infection could be reproduced by the co-expression of PV 
proteins 2BC and 3A in the same cell (Jackson et al., 2005). To investigate 
whether the formation of FILS could be induced by the expression of 
individual FMDV proteins CHO cells expressing GFPLC3 were transfected 
with plasmids encoding individual FMDV proteins.
As seen in figure 4.16.i, the expression of 3A did not appear to alter the 
pattern of GFPLC3 in comparison to the surrounding cells which did not label 
for 3A expression. 3A labelling was observed in numerous punctate foci 
throughout the cell cytoplasm (figure 4.16.ii). GFPLC3 was generally diffuse 
throughout the cytoplasm and did not concentrate next to the nucleus, (figure 
4.16.iii). As in infected cells, no co-localisation between FMDV 3A and 
GFPLC3 was observed (figure 4.16.iv).
A V5 tag was added to the C-terminus of 2B to allow detection (Moffat et al., 
2005b) using a commercially available anti-V5 antibody. Previous work from 
the laboratory has shown that 2B expressed alone in monkey VERO cells 
associates with membranes and produces a punctate and reticular 
immunofluorescence stain that partially co-localises with ER markers (Moffat 
et al., 2005b). Figure 4.17 shows similar structures induced by 2B in CHO 
cells. It is assumed that these represent a modified ER but this was not 
verified directly by double labelling. The expression of 2B (red) caused a 
startling increase in the number of punctate GFPLC3 signals (figure 4.17.iii). 
Although the number varied from cell to cell, there were consistently more
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punctate GFPLC3 foci cells expressing 2BV5 cells than when cells were 
incubated with rapamycin or starved to induce autophagy (compare with 
figure 4.1.A). The foci also appeared larger or more clustered than the 
typical autophagosomes observed in figure 4.1.A. Very little overlap of 2BV5 
labelling and GFPLC3 was observed, indicated that GFPLC3 did not co- 
localise with 2BV5 (figure 4.17.iv).
When 2C was expressed alone in cells it associated with membranes and 
produced a punctate stain distributed throughout the cytoplasm. Some of 
these punctate structures concentrated to one side of the nucleus, and 
showed partial co-localisation with Golgi protein p-COP (Moffat et al., 2005b). 
Cells expressing FMDV 2C are shown in figure 4.18. In all cells that labelled 
positive for 2C expression, GFPLC3 was redistributed from a diffuse 
cytoplasmic pattern and accumulated next to the nucleus in a very similar 
pattern to FILS (figure 4.18.iii). An indentation of the nucleus was also 
observed (figure 4.18). 2C labelling was not excluded from this area, but no 
co-localisation of the two proteins was observed (figure 4.18.iv). The 
redistribution of GFPLC3 in cells expressing 2C differed from infected cells 
as although FILS were seen more individual GFPLC3 punctate forms were 
detected throughout the cytoplasm. This may indicate an additional step is 
required for the formation of FILS which is not provided by 2C, or that more 
time was required for FILS to fully form.
Expression of 2BC also caused a redistribution of GFPLC3, but the final 
distribution varied (figure 4.19J). One pattern (arrowheads) was similar to
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that seen in cells expressing 2BV5, where numerous large punctate foci of 
GFPLC3 were observed. The other pattern was similar to that seen in cells 
expressing 2C, where GFPLC3 was condensed in a large accumulation next 
to the nucleus (arrows). A higher magnification of a cell with this pattern of 
GFPLC3 is seen in figures 4.19.ii-iv. 2BC was detected throughout the 
cytoplasm (figure 4.19.ii) including the area where GFPLC3 accumulated, 
though no co-localisation was detected. Unlike the changes induced by 2C, 
no indentation of the nucleus was observed with 2BC expression. It is not 
clear whether the two patterns observed were two separate patterns, or 
whether the increase of GFPLC3 punctate foci preceded the formation of the 
pattern similar to FILS. This could be clarified with live cell imaging of 
transfected cells.
4.11 FILS do not co-localise with LAMP 3
An experiment was carried out to ascertain the relationship between FILS 
and lysosomal markers. The maturation of autophagosomes into 
autolysosomes involves fusion with vesicles that deliver lysosomal markers 
such as Jysosome associated membrane proteins (LAMPs) and acid 
hydrolases. Poliovirus and rhinovirus infection results an increased co­
localisation between LC3 and LAMP 1 (Jackson et al., 2005) suggesting 
increased maturation of autophagosomes. To see if FMDV also increased 
production of autolysosomes, CHO cells expressing GFPLC3 were infected 
with FMDV and analysed for distribution of LAMP3. In cells lacking FMDV 
protein, GFPLC3 gave a diffuse signal throughout the cytoplasm with a few
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punctate foci present (figure 4.20.i). LAMP 3 labelling surrounded the 
nucleus in individual foci, probably representing lysosomes (figure 4.20.ii). 
No co-localisation between GFPLC3 and LAMP 3 was observed, although a 
close association between the two markers was occasionally seen (figure 
4.20-iii).
In infected cells, GFPLC3 redistributed into FILS next to the nucleus (figure 
4.20.iv). The LAMP 3 signal concentrated to one side of the nucleus and 
was often seen in a similar area to FILS (figure 4.20.vi). A large portion of the 
LAMP 3 labelling appeared to surround the FILS and some of the LAMP 3 
signal co-localised with GFPLC3. The distribution of GFPLC3 and 
lysosomes was also observed by live cell microscopy using Lysotracker, 
which is an auto-fluorescent dye that localises to acidic compartments. CHO 
cells expressing GFPLC3 were cultured in a Petri dish containing a glass 
coverslip in its base so that fluorescent imaging of the cells could be done 
through optically clear glass. Cells were incubated with FMDV inoculum for 
30 minutes at room temperature. The virus inoculum was removed and 
replaced with medium containing 2% FCS, and the cells were returned to 
37°C. 90 minutes later, the medium was replaced with pre-warmed medium 
containing 50nM Lysotracker, and cells were incubated at 37°C for a further 
45 minutes, when the medium was replaced again with medium containing 
2% FCS. Cells were imaged every 30 seconds and a video produced from 
the resulting images (supplementary material S3). Consistent with the LAMP 
3 data, Lysotracker was not seen to co-localise with GFPLC3 in FILS, but 
Lysotracker-positive structures did accumulate in a similar area to FILS and
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surrounded these structures. As infection was allowed to progress, individual 
GFPLC3 punctate foci appeared to break away from FILS and associated 
closely with lysotracker-positive structures, this continued until FILS had 
completely dispersed. Thus it is likely that the loss of FILS from FMDV- 
infected cells is due to the fusion of individual GFPLC3 structures with 
lysosomes where they may be degraded. The observation of lysosomes 
surrounding FILS by TEM is consistent with this theory.
4.12 Discussion
As discussed previously, PV has recently been suggested to utilise 
components of the autophagy pathway during its replication cycle. To 
investigate whether FMDV may utilise a similar strategy, the effect of FMDV 
on autophagy was studied. The results presented in this chapter 
demonstrated that FMDV infection induces the formation of an autophagy- 
related structure termed FILS. To our knowledge FILS have not previously 
been described, making them a unique structure, and their relationship with 
FMDV replication is still unclear. The following discussion first deals with the 
formation of FILS themselves, and then discusses their possible implications 
in FMDV replication.
4.12.1 Overview of the Formation of FILS
Live cell imaging and confocal microscopy of fixed samples demonstrated 
that FMDV infection caused redistribution of GFPLC3, from a diffuse
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distribution throughout the cytoplasm, to a single large structure located next 
to the MTOC. These structures were called FILS. (FMDV induced LC3 
structures). FILS were formed by retrograde transport of small punctate foci 
of GFPLC3 along microtubules to the MTOC (diagram 1).
_____________________________________________ Time _________________________________________________
Numerous GFPLC3 punctate Movement of GFPLC3 foci Large GFPLC3 accumulations FILS are lost, due
foci appear throughout the towards the MTOC form, termed FILS to natural turnover?
cytoplasm
Diagram 4.1; Formation of FILS from numerous GFPLC3 punctate foci throughout the 
cell cytoplasm.
Visual representation of the formation of FILS from numerous individual GFPLC3 punctate 
foci throughout the cell cytoplasm. Numerous GFPLC3 punctate foci form and are observed 
throughout the cytoplasm of the cell. Individual GFPLC3 foci are transported towards the 
MTOC, facilitated by microtubules. GFPLC3 structures accumulate and form FILS. Late in 
infection FILS are lost, possibly due to the degradation of GFPLC3-strucutres in lysosomes
FILS formed relatively early in FMDV infection (1 hpi), but were no longer 
present at 3hpi. The mechanism of loss of FILS is unknown but since 
autophagosomes fuse with lysosomes it is likely that FILS may be degraded 
within lysosomes. This was supported by the observation that LAMP 3 was 
detected in a similar area to FILS, and there was some co-localisation 
between GFPLC3 and LAMP 3. Live cell imaging observing Lysotracker and 
GFPLC3 showed that at about 3hpi, FILS appeared to break up slowly into 
individual GFPLC3 structures, which then declined, in number suggesting
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degradation. The lack of transient co-localisation between GFPLC3 and 
Lysotracker may arise because of degradation of GFPLC3 within the 
Lysotracker-positive acidic vacuole. This would have to be confirmed by 
repeating the experiments in the presence of Concanamycin A to block 
lysosomal proteolysis.
4.12.2 FILS form in cells expressing FMDV 2C or 2BC.
FILS do not appear to form due to a bystander effect of infection, as they 
form in cells expressing individual FMDV proteins in the absence of infection. 
The expression of the PV proteins 2BC and 3A has been reported to induce 
the membrane rearrangements associated with PV-infection and replication 
(Suhy, Giddings, and Kirkegaard, 2000). FILS were formed when the FMDV 
proteins 2C or 2BC were expressed alone. Expression of FMDV 3A did not 
result in the rearrangement of GFPLC3 into FILS indicating that the effects of 
2C or 2BC were specific to protein function and not a side effect of 
expressing FMDV proteins. The rearrangement of GFPLC3 into FILS 
occurred in all cells detected expressing 2C. The expression of 2BC led to 
varied patterns of GFPLC3. It is possible that this is due to the processing of 
2BC into 2C and 2B by a non-specific host cell protease. Expression of 2B 
alone led to the rearrangement of GFPLC3 into numerous GFPLC3 punctate 
foci throughout the cytoplasm (figure 4.16). Thus it is likely that 2C is 
responsible for the formation of FILS, whereas 2B induces the formation of 
numerous GFPLC3 punctate foci. Why the expression of 2BC in cells leads 
to a mixture of these two patterns of GFPLC3 is not clear. The two different 
GFPLC3 patterns observed may be driven by the dual expression of both 2B
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and 2C and the different effects of the two proteins. It is possible that the 
pattern of GFPLC3 induced by 2B precedes the formation of FILS, and the 
observation of both patterns in the cell culture demonstrates cells and 
different stages of GFPLC3 rearrangement.
The rearrangement of GFPLC3 induced by 2B, does not appear to be a 
prerequisite for the formation of FILS, as FILS are formed when 2C is 
expressed alone. However, 2C was not observed to co-localise with 
GFPLC3 in infected cells or when expressed alone. Thus the redistribution 
of GFPLC3 does not appear to be facilitated by a direct interaction of the two 
proteins, but nonetheless it appears to be a function of 2C. The 2C encoded 
by PV has been reported to have ATPase and GTPase activities (Rodriguez 
and Carrasco, 1993). GTPases have been implicated in the regulation 
pathway of autophagy (Ogier-Denis et al., 1997), and thus it may be this 
function of 2C that initiates the redistribution of GFPLC3 into FILS.
4.12.3 FILS do not appear to be components of the replication complex 
It has been proposed that autophagy provides a source of membranes 
required in the formation of the replication complexes of PV, MHV and SARS 
(Jackson et al., 2005; Prentice et al., 2003; Prentice et al., 2004). During 
infection of these viruses, viral proteins associated with the replication 
complex were observed to co-localise with LC3 in punctate foci throughout 
the cytoplasm. It was not possible to detect co-localisation of FILS or 
punctate LC3-GFP signal with FMDV replicase proteins suggesting that the 
replicase proteins of FMDV do not bind to autophagosomes. This is
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supported by the observation that FILS formed transiently, early during 
infection and were rarely observed past 3hpi when large amounts of FMDV 
proteins are produced, as detected by an increase in immunofluorescence 
labelling. Thus it appears unlikely that FILS are either directly associated 
with, or essential for FMDV replication.
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Diagram 4.2. Timeline representing the appearance of FILS and FMDV protein 
production
The time line of FMDV infection in CHO and BHK cells is presented in black, ending in cell 
lysis when CPE is typically observed. The appearance of FILS is presented in green, the 
increase in height of the green line represents the increases number of cells containing FILS 
typically observed. The production of FMDV proteins is presented in red, the increase in 
height of the red line indicates an increase in the amount of FMDV protein detected within 
each cell.
FILS were present during early stages of replication and co-localised with the 
FMDV capsid protein VP1. This could indicate that the early assembly of 
FMD virions occurred in association with FILS, but as FILS disperse mid-way 
through infection, this appears unlikely. Another possibility is that GFPLC3 
associates with incoming virus. FMDV is known to enter cell via receptor- 
mediated endocytosis (Berryman et al., 2005), soon after entry, FMDV
FMDV PROTEIN 
EXPRESSION
CELL LYSIS
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escapes the endosome and enters the cytoplasm where replication occurs. 
The data show co-localisation of GFPLC3 with VP1, the antibody used to 
detect VP1 is not conformational-dependant and thus recognises both whole 
virions and individual VP1 proteins. Whether GFPLC3 co-localises with 
whole or assembling viruses, or the virus polyprotein cannot be distinguished 
from these data. Co-localisation analysis of GFPLC3 and VP1 at earlier 
timepoints would answer this question.
4.12.4 Ultrastructure of FILS and FMDV-induced membrane rearrangements 
FILS do not co-localise with replicase proteins 2C and 3D and thus do not 
appear to be a component of the replication complex, however they are 
closely associated with infection, as they co-localise with the capsid protein 
VP1. TEM of FILS provided evidence that FILS were not an accumulation of 
typical autophagosomes (double membrane vesicles), but a condensed mass 
of tubular membrane structures (figure 4.7 and 4.6). Many of the tubular 
membranes observed had the appearance of smooth ER, and some 
individual vesicles with electron dense membranes were also seen. 
Tubulovesicular structures were absent later during infection and this was 
consistent with disruption of FILS seen by live cell imaging. It is possible that 
the FMDV causes two distinct membrane rearrangements (diagram 4.2); the 
first occurs relatively early in infection and forms FILS. The second occurs 
later in infection and involves FMDV-induced vesicles. Whether FMDV- 
induced vesicles are formed from FILS is not known. However the presence 
of vesicles rather than tubulovesicular structures correlated with the major
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phase of FMDV protein production suggesting that FMDV-induced vesicles 
are closely linked with FMDV replication.
It is not yet known whether FILS are formed in BHK cells. FILS may be an 
aspect of FMDV infection specific to CHO cells. However it is also possible 
that FILS are formed in BHK cells and have not yet been identified. This may 
be because the FILS formed in BHK cells are not as dramatic as the FILS 
observed in CHO cells, or simply that BHK cells have not been studied early 
enough in infection. An ultrastructural study of FMDV-infected BHK cells 
early in infection would demonstrate whether this was the case. Considering 
the appearance and disappearance of FILS in CHO cells occurred prior to 
optimum FMDV-protein production, it is likely that if FILS are formed in BHK 
cells, this would also occur before optimum production of FMDV proteins 
(diagram 4.3), and could also be a short-lived phenomenon.
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Diagram 4.3 Representation of the appearance of virus-induced intracellular 
structures in CHO and BHK cells
The time line of FMDV infection in CHO and BHK cells is presented in black, ending in cell 
lysis when CPE is typically observed. The appearance of FILS is presented in green, the 
increase in height of the green line represents the increases number of cells containing FILS 
typically observed. The production of FMDV proteins is presented in red, the increase in 
height of the red line indicates an increase in the amount of FMDV protein detected within 
each cell. The appearance of typical virus-induced vesicles in depicted in blue, an increase 
in the height of the line indicates an increase in the number of cells containing these vesicles
The data presented in this chapter indicate that autophagy does not appear 
to provide the source of membranes required for FMDV replication. 
However, FMDV infection does cause the mass redistribution of LC3 into 
FILS. This redistribution does not appear to be essential for replication, 
because inhibiting the formation of FILS with Nocodazole did not have any 
adverse effects on productive infection. Interestingly, Nocodazole did not
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affect association of LC3 with VP1 thus it remains possible that an interaction 
between LC3 and VP1 is important for FMDV.
4.12.5 FILS may represent a host cell defence system 
The role of autophagy as a host cell defence system against intracellular 
pathogens has been demonstrated for HSV, Shigella and Group A 
Streptoccocus (Nakagawa et al., 2004; Ogawa et al., 2005; Talloczy et al., 
2002; Talloczy, Virgin, and Levine, 2006). The modest increase in FMDV 
yield observed after Nocodazole treatment is potentially interesting since it 
indicates that microtubules may be part of a natural defence that reduces 
virus yield. Nocodazole depolymerises microtubules, which play a role in 
numerous cellular processes, including the fusion of autophagosomes with 
lysosomes (Webb, Ravikumar, and Rubinsztein, 2004). The maturation of 
autophagosomes requires the acquisition of lysosomal hydrolases, which are 
obtained through fusion events between autophagosomes and lysosomes. 
These fusion events are thought to be facilitated by the transport of 
autophagosomes along microtubules to close proximity to lysosomes (Webb, 
Ravikumar, and Rubinsztein, 2004). Depolymerisation of microtubules 
reduces the efficiency by which autophagosomes fuse with lysosomes and 
thus inhibits autophagosome maturation. This makes it possible that the 
increased virus yields observed after Nocodazole treatment, though not 
statistically significant, could mean that FMDV is targeted for degradation in 
autophagosomes, and this would be consistent with co-localisation of LC3 
and VP1.
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Whole FMD virions have not been observed previously within vesicles 
resembling autophagosomes by EM analysis. Although it should be noted 
that FMDV virions are difficult to detect in conventional EM, and may have 
prevented previous detection. It is also possible that FMDV proteins not 
whole virions are sequestered by autophagosomes, these would not be 
observed by EM without immuno-gold labelling of the specific proteins.
The association of FILS and lysosome markers during FMDV infection differs 
from the association of LC3 and the lysosomal marker LAMP 1, as reported 
in PV-infected cells (Jackson et al., 2005). PV induced the co-localisation of 
LC3 and LAMP1, which increased during infection. These LC3 positive 
structures have smaller diameters than FILS and are thought to be mature 
autophagosomes that may provide a source of membranes for PV-replication 
and/or egress. If FILS were associated with FMDV replication, the difference 
in association between LC3 and lysosomal markers in FMDV and PV- 
infected cells would be expected. Unlike PV, FMDV is very sensitive to 
changes in pH, and is denatured by changes in pH. Mature 
autophagosomes gain lysosomal hydrolases and have a lower pH compared 
to earlier autophagosomes. Thus whilst PV can withstand the lower pH of 
mature autophagosomes, FMDV would be denatured. If FMDV does utilise 
autophagosomes, then it would probably use autophagosomes at an earlier 
stage of maturation.
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4.12.6 FILS share characteristics with aggresomes
Further insight into the function of FILS during FMDV infection may be 
obtained through their shared similarities with another cellular structure; the 
aggresome. Aggresomes are perinuclear inclusions containing mis-folded 
proteins, and form when the amount of mis-folded proteins exceeds the rate 
at which they can be degraded by the proteasome. Mis-folded proteins form 
aggregates which are potentially toxic to the cell. The cell minimises the 
toxic effects by retaining the aggregates in one large accumulation next to 
the MTOC.
The data presented here demonstrates that FILS form next to the 
microtubule organising centre, and their presence causes an indentation of 
the nucleus resulting in a ‘kidney bean’ appearance; two characteristics 
associated with the presence of aggresomes. The formation of FILS and 
aggresomes are also both dependant upon an intact microtubule network. 
Thus FILS share similar characteristics with aggresomes, and their formation 
requires similar machinery.
Aggresomes facilitate the degradation of mis-folded proteins to protect the 
cell from potentially toxic effects. Autophagy has been reported to facilitate 
the degradation of mis-folded proteins in these structures (Iwata et al., 
2005a; Ravikumar, Duden, and Rubinsztein, 2002). Thus the similarities 
between aggresomes and FILS may further support the idea that autophagy 
is acting to degrade FMDV, provided a cellular defence mechanism. 
However, viruses such as African Swine Fever Virus (ASFV) and Frog Virus
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3 have been suggested to hijack the aggresome machinery to concentrate 
their replication machinery in one area of the cytoplasm (Heath, Windsor, and 
Wileman, 2001). Thus it is also possible that FMDV also utilises the 
aggresome pathway in a similar manner. This relationship between FILS, 
FMDV replication areas and aggresomes is studied further in the next 
chapter.
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Figure 4.1. Effect of Autophagy Regulatory Treatments on GFPLC3 expressed in CHO cells.
A. CHO cells expressing GFPLC3 were incubated for 2 hours in either; growth medium as normal 
control (FCS), Hanks Balanced Salt Solution (HBSS) for starvation treatment, Hbss containing 10mM  
3-Methyladenine to inhibit auotphagy (HBSS + 3MA), or growth media containing 2ug/ml rapamycin 
to stimulate autophagy. Cells were fixed and processed for immunofluoresence. Cellular DNA was 
labelled using DAPI (blue) and GFPLC3 was visualised by the natural fluoresence of G FP (green)
Bar 10uM.
B. CHO cells expressing GFPLC3 were cultured as described above and lysed in IPB lysis buffer at 
4°C for 1 hour. Lysates were run on 10% SDS PAGE and analysed by Western blot. G FPLC3 was 
detected using an anti-GFP antibody followed by a secondary antibodly coupled to HRP
Figure 4.2.A. Effect of FMDV infection on GFPLC3 distribution
CHO cells expressing GFPLC3 were washed in serum-free medium and incubated with FM DV (01BFS) 
inoculum at room temperature for 30 minutes.The virus inoculum was then replaced with 
medium containing 2%  FCS and incubated at 37°C for the appropriate times.Cells were fixed and 
processed for immunofluorescence. The FMDV non-structural protein 3A w as detected using the 
mouse antibody 2C2 followed by a secondary antibody coupled with Alexa 568 (red). G FPLC3 was 
visualised by the natural fluoresence of GFP (green), and cellular DNA was labelled using DAPI (blue). 
Bar 20uM
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Figure 4.2.B. Effect of FMDV infection on GFPLC3 distriution
CHO cells expressing GFPLC3 were incubated with FMDV inoculum (01BFS) for 30 minutes at 
room temperature. The virus inoculum was then replaced with medium containing 2%
FCS and incubated at 37°C for 2 hours when the cells were fixed and processed for 
immunofluoresence. The FMDV non-structural protein 3A w as detected using the mouse antibody 
2C2 followed by a secondary antibody coupled with Alexa 568 (red). GFPLC3 was visualised by the 
natural fluoresence of GFP(green), and cellular DNA was labelled using DAPI (blue). Cells were imaged 
by Differential Interference Contrast (DIC) in order to define the outline of the cells(iv). Bar 10uM
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Figure 4.3. Rearrangement of GFPLC3 in FMDV infection is not due to the shutdown of protein 
synthesis or expression of GFP, and is concurrent with LC3 processing.
A.i. Top left; CHO cells expressing GFPLC3 were incubated in serum-free media for 30 minutes at 
room temperature, the medium was replaced with medium containing 1ug/ml cyclohexamide and 
incubated at 37°C for 2 hours when cells were fixed and processed for immunofluoresence.
ii. Top right; CHO cells were transfected with a plasmid containing GFP-IRES. Cells were incubated 
at 37°C overnight then incubated with FMDV inoculum (01BFS) at room temperature for 30 minutes. 
The inoculum was replaced with 2%  FCS medium and incubated for a further 2 hours at 37°C when 
cells were fixed and processed for immunofluoresence. FMDV proetin 3A was detected using the 
mouse antibody 2C2 followed by a secondary antibody coupled to Alexa 568 (red). G FP-IR E S  and 
GFPLC3 were visualised by the natural fluoresence of GFP (green), and cellular DNA labelled with 
DAPI (blue). Bar 10uM.
B. CHO cells expressing GFPLC3 were incubated with either FMDV inoculum (10 M O I) (i) or serum  
free media (ii) for 30 minutes at room temperature (except U, untreated). The cells were then 
incubated with with 2%  FCS medium, containing 1ug/ml cyclohexamide, at 37C. At the indicated 
times cells were lysed with IPB. Lysates were run on 10% SDS PAGE and analysed by Western blot 
with an anti-GFP antibody followed by a secondary antibody coupledto HRP to detect GFPLC3.
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Figure 4.4 FILS locate next to the microtubule organising centre (MTOC)
CHO cells expressing GFPLC3 were incubated with FMDV (01BFS) inoculum for 30 minutes at room 
temperature. The virus inoculum was then replaced with media containing 2%  FCS and returned to 
37°C. Infection was allowed to continue to 2.5 hours at 37°C when the cells were fixed and 
processed for immunofluoresence. The MTOC was detected using an anti-y tubulin antibody followed 
by a secondary antibody coupled to alexa 568 (red). GFPLC3 was visualised by the natural 
fluorescence of GFP (green). Cellular DNA was labelled with DAPI (blue). Bar 5uM.
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Figure 4.5 Nocodazole inhibits the accumulation of FMDV non-structural proteins and GFPLC3
CHO cells expressing GFPLC3 were incubated with FMDV inoculum (01BFS) for 30 minutes at room 
temperature. The inoculum was replaced with medium containing either 10uM Nocodazole ( right 
hand panals) or equal w/v DMSO (left hand panals). Cells were returned to 37°C for 1.5 hours when 
cells were fixed with 4% PFA and processed for immunofluoresence. FMDV protein 3A was labelled 
using the 2C2 antibody followed by a secondary antibody coupled to Alexa 568 (red),
GFPLC3 was visualised by the natural fluoresence of GFP (green). Cellular DNA was labelled with 
DAPI (blue). Bar = 10uM
Figure 4.6. Ultrastructure of an uninfected CHO cell expressing GFPLC3
CHO cells expressing GFPLC3 were cultured on Thermanox coverslips and processed for transmission 
electron microscopy. The microtubule organising centre is depicted by the black arrow near to the 
nucleus (N). Bar2.5uM .
Figure 4.7.A. Ultrastructure of an FMDV infected CHO cell expressing GFPLC3
CHO cells expressing GFPLC3 were cultured on Thermanox coverslips and incubated with FMDV  
(01BFS) inoculum for 30 minutes at room temperature. The virus inoculum was replaced with medium 
containing 2% FCS and returned to 37°C for 2 and a half hours. Cells were then processed for 
transmission electron microscopy. The area thought to represent the GFPLC3 accumulation seen in 
FMDV infection by immunofluoresence has been framed. Nucleus (N). Bar 2.5uM
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Figure 4.7.B. Ultrastructure of an FMDV infected CHO cell expressing GFPLC3
CHO cells expressing GFPLC3 were cultured on Thermanox coverslips and incubated with FM DV  
(01BFS) inoculum for 30 minutes at room temperature. The virus inoculum was replaced with medium 
containing 2% FCS and returned to 37°C for 2 and a half hours. Cells were then processed for 
transmission electron microscopy. A higher power image of a similar area framed in Figure 4.7.A. 
is shown Bar 0.5uM
Figure 4.8. Ultrastructure of an FMDV infected CHO cell
CHO cells were cultured on Thermanox coverslips and infected as described in Figure 4.7.A. Cells 
were then processed for transmission electron microscopy. A. An area similar to the tubular area 
seen in FM DV infected CHO cells expressing GFPLC3 is framed. B. higher powered image of the 
area framed in A. Nucleus (N). Bar 500nM
Figure 4.9. FMDV induces similar vesicular structures in CHO cells to those seen in BHK cells
CHO cells were cultured on Thermanox coverslips and incubated with FM DV inoculum (01BFS) at 
room temperature for 30 minutes. The inoculum was replaced with medium containing 2% FCS and 
incubated at 37°C for 2 hours, when cells were fixed and processed for transmission electron 
microscopy. Typical FMDV-induced vesicles (arrows). Bar 500nM
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Figure 4.10. GFPLC3 does not colocalise with FMDV non-structural proteins 2C or 3D
CHO cells expressing GFPLC3 were washed wtih serum-free medium and incubated with FM DV inoculum 
(01BFS) for 30 minutes at room temperature. The virus inoculum was then replaced with medium 
containing 2% FCS and incubated at 37°C for 2 hours when the cells were fixed and processed for 
immunofluoresence. Cells were labelled with antibodies agaisnt either FMDV 2C (left hand column) or 
FMDV 3D (right hand column), followed by a secondary antibody coupled to Alexa 568 (red). GFPLC3 
was visualised by the natural fluoresence of GFP. (green) Cellular DNA was labelled with DAPI (blue).
Bar 10uM
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Figure 4.11 GFPLC3 co-localises with FMDV structural proein VP1 in FILS
CHO cells expressing GFPLC3 were incubated with FMDV inoculum (01BFS) for 30 minutes at room 
temperature. The virus inoculum was then replaced with media containing 2%  FCS and incubated at 
37°C for 3 hours (right column) or 2 hours (left column) when the cells were fixed in 4%  PFA and 
processed for immunofluoresence. Cells were labelled with an antibody agaisnt FMDV VP1 (ii and v) 
followed by a secondary antibody coupled to Alexa 568 (red). GFPLC3 (i and iv) was visualised by 
the natural fluoresence of GFP (green) Cellular DNA was labelled with DAPI (blue). W hite arrow  
heads dipict points of co-localisation in the merged images (iii vi). Bar 5uM
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Figure 4.12. FMDV capsid protein VP1 does not colocalise with GFP expressed without LC3
CHO ceils were transfected wtih pcDNA containing G FP-IRES using Transfast. They were then 
incubated at 37°C overnight to allow for protein expression. Cells were then washed wtih serum-free 
medium and incubated with FMDV inoculum (01BFS) at room temperature for 30 minutes. The 
inoculum was removed and replaced with medium containing 2%  FCS and incubated at 37°C for a 
further 2 hours. Cells were then fixed and processed for immunofluoresence. The FM DV capsid 
protein VP1 was detected using a mouse antibody (B2) coupled to Alexa 568 (red), G FP was 
visualised by the naturalfluoresence of GFP (green) and DAPI was used to label cellular DNA (blue) 
Bar 10uM
Figure 4.13. FMDV structual protein VP1 does not colocalise with the non-structural protein 3A
CHO cells were incubated with FMDV inoculum(01 BFS) at room temperature for 30 minutes. The inoculum was 
removed and replaced with medium containing 2% FCS and incubated at 37°C for 2.5 hours when they were 
fixed in 4% PFA and processed for immunofluoresence.FMDV capsid protein VP1 was detected using the B2 
followed by a secondary antibody coupled to Alexa 488 (green). FMDV non-structural protein 3A was 
detected using the mouse antibody 2C2 followed by a secondary antibody coupled to Alexa 568 (red). DAPI was 
used to label cellular DNA (blue). Bar 5uM.
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Figure 4.14 Nocodazole does not prevent colocalisation of VP1 and GFPLC3 whether added 
before or after the formation of FDMV replication areas FILS
CHO cells expressing GFPLC3 were infected with FMDV inoculum (01FBS) and infection was allowed to 
continue at 37°C. The incubation medium was changed for medium containing 10mM Nocodazole at 
either Ohpi and fixed at 1,5hpi (left hand column), or at 1,5hpi and fixed at 2hpi (right hand column) 
and processed for immunofluoresence. FMDV VP1 was dected with VP1 antibody followed by a 
secondary antibody coupled to Alexa-568 (red) GFPLC3 was visualised through the natural 
fluoresence of GFP (green) and cellular DNA was labelled with DAPI (blue). Bar = 10uM
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Figure 4.15. Effect of Nocodazole on productive FMDV infection
CHO cells grown in 12-well plates were washed with serum-free RPMI medium, virus 
inoculum of 01BFS was added and the cells were incubated at room temperature for 45 minutes 
before acid washing (see materials and methods). Cells were left with 1ml of 2% FCS RPMI media 
containing either 10mM Nocodazole or equal v/v DMSO at 37°C, 50ul samples of supernatent taken at 
appropriate times and frozen at -70 °C. The virus yield of the supernatants was subsequently determined 
by plaque assays using BHK cells as described in materials and methods. A. The average virus yield 
obtained from triplicate experiments. B. Percentage difference of FM DV virus yield claculated as control 
DMSO treated cells representing 100%. Error bars represent standard error of the mean.
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Figure 4.16. Expression of FMDV non-structural protein 3Adoes not cause a rearrangement 
of GFPLC3.
CHO cells expressing GFPLC3 were transfected with pcDNA containg FMDV 3A using lipofectamine 2000. 
The cells were incubated overnight at 37°C to allow for adequate protein expression. Cells were fixed and 
processed for immunofluoresence. FMDV 3A w as detected using an anti-3A antibody (2C 2) followed by 
a secondary antibody conjugated to Alexa 568 (red). GFPLC3 was visualised by the natural fluoresence of 
GFP (green), and cellular DNAw as labelled with DAPI (blue). Bar 10uM.
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Figure 4.17. Transfection of FMDV protein 2B causes an increase in GFPLC3 punctate dots.
CHO cells expressing GFPLC3 were transfected with pcDNA containg FMDV 2B with a V5 tag using 
lipofectamine 2000. The cells were incubated overnight at 37°C to allow for adequate protein 
expression. Cells were fixed and processed for immunofluoresence. FMDV 2BV5 was detected 
using an anti-V5 antibody followed by a secondary antibody conjugated to Alexa 568 (red). G FPLC3  
was visualised by the natural fluoresence of GFP (green), and cellular D N Aw as labelled with DAP 
(blue). Bar 10uM.
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Figure 4.18. Expression of FMDV protein 2C causes rearrangement of GFPLC3 similar to that 
seen in FMDVinfection.
CHO cells expressing GFPLC3 were transfected with pcDNA containg FMDV 2C using lipofectamine 
2000. The cells were incubated overnight at 37°C to allow for adequate protein expression. Cells were 
fixed and processed for immunofluorescence. FMDV 2C was detected using an anti-2C antibody (3F7) 
followed by a secondary antibody conjugated to Alexa 568 (red). GFPLC3 was visualised by the 
natural fluoresenceof GFP (green), and cellular DNAw as labelled with DAPI (blue). Bar 10uM.
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Figure 4.19. Expression of FMDV protein 2BC causes an increase in GFPLC3 punctate dots and some 
similar structures to FILS seen in FMDV infection.
CHO cells expressing GFPLC3 were transfected with pcDNA containg FMDV 2BC using lipofectamine 2000. 
The cells were incubated overnight at 37°C to allow for adequate protein expression. Cells were fixed and 
processed for immunofluorescence. FMDV 2BC was detected using an anti-2C antibody (3F7) followed by a 
secondary antibody conjugated to Alexa 568 (red). GFPLC3 was visualised by the natural fluoresence of GFP 
(green), and cellular DNAwas labelled with DAPI (blue). Bar 10uM.
Uninfected FMDV-infected
i GFPLC3 iv GFPLC3
ii LAMP 3 v LAMP 3
iii Merge vi Merge
+ -
♦
Figure 4.20 Comparison of GFPLC3 and LAMP distribution in FMDV infection
CHO cells expressing GFPLC3 were incubated with FM DV inoculum (01BFS) for 30 mintues at room 
temperature (iv-vi). The inoculum was then replaced with medium containing 2% FCS and incubated for 
a further 2 hours at 37°C. Cells were fixed and processed for immunofluoresence. The mouse antibody 
(UH1) followed by a secondary antobody coupled to Alexa 568 was used to detect LAMP 3 (red). 
GFPLC3 was visualised by the natural fluoresence of GFP (green), and cellular DN Aw as labelled 
using DAPI (blue). Merged images are shown (iii and vi). Bar 10uM.
Chapter 5: Relationship between FMDV, Autophagy and
Aggresomes
5.1. Introduction
Work in previous chapters has shown that FMDV infection causes the 
rearrangement of the autophagosome marker GFPLC3 into FILS (chapter 4). 
FILS appear to form from the retrograde transport of numerous GFPLC3- 
punctate foci along microtubules towards the MTOC. GFPLC3 was observed 
to co-localise with the non-structural protein VP1 (figure 4.10), and the 
formation of FILS can be induced by the expression of the FMDV proteins 2C 
or 2BC in the absence of infection (figure 4.17 and 4.18). These data 
suggest an intricate association between autophagy (FILS) and FMDV 
infection. We have noticed a passing resemblance between FILS and 
aggresomes, including their location near to the MTOC and the dependence 
of their formation upon an intact microtubule network.
Recent publications have reported a cyto-protective role for autophagy in the 
removal of protein aggregates associated with conformational disease and 
stimulation of autophagy reduces disease symptoms in mouse and fly 
models of Huntington’s disease (Bjorkoy et al., 2005; Ravikumar, Duden, and 
Rubinsztein, 2002; Ravikumar et al., 2004). More recent studies have 
demonstrated an association between LC3 and mis-folded protein
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aggregates such as Huntingtins (Iwata et al., 2005a; Iwata et al., 2005b; 
Ravikumar et alM 2004).
Aggresomes form when the ability of the ubiquitin-proteasome pathway to 
degrade misfolded proteins is exceeded and the resulting protein aggregates 
are transported along microtubules to an inclusion that forms next to the 
MTOC (see introduction). The inclusions produce an indentation of the 
nucleus forming a ‘kidney bean* appearance (Kegel et al., 2000) and this was 
also seen after the formation of FILS. To help clarify the role of FILS in 
FMDV infection, the relationship between autophagy, FMDV infection and 
aggresomes was investigated further.
5.2 LC3 relocates to GFP-tagged aggresomes
Recent evidence indicates that autophagy markers such as LC3 and Atg5, 
are recruited to aggresomes (Iwata et al., 2005a; Iwata et al., 2005b; 
Ravikumar et al., 2004). The ability of aggresomes to recruit LC3 was tested 
by expressing misfolded proteins fused to GFP. Rhodopsin is a membrane 
protein that is transported to the plasma membrane. The mutant p23- 
rhodopsin, associated with retinitis pigmentosa, mis-folds in the ER and is 
delivered to the cytoplasm where it aggregates and forms aggresomes. The 
huntingtin protein associated with Huntington’s disease contains a 
polyglutamine tract, which is variable in length. When the polyglutamine 
repeats exceed 37, the protein misfolds and is delivered to aggresomes.
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In the following experiments, wild type and misfolded forms of rhodopsin and 
huntingtin proteins fused to GFP were expressed in cells with LC3 
conjugated to red fluorescence protein (LC3RFP). Wild type rhodopsin fused 
to GFP located at the plasma membrane (figure 5.1.i). RFPLC3 was 
associated with numerous punctate dots in the cytoplasm (figure 5.1.ii), and 
did not co-localise with rhodopsin (figure 5.1.iii). GFP p23-rhodopsin 
however produced an intracellular inclusion that predominantly co-localised 
with RFPLC3 (figure 5.1 iv, v, and vi (yellow)). This showed that aggresomes 
containing misfolded rhodopsin recruited LC3. Similar results were observed 
with the expression of huntingtin (figure 5.1 vii-xii green). GFP-huntingtin- 
Q17 (17 glutamine repeats) was seen throughout the cytoplasm and 
RFPLC3, gave a strong nuclear and cytoplasmic signal (figure 5.1 vii and viii 
red). Nuclear staining of LC3RFP in the presence of was GFP-huntingtin- 
Q17 was observed in a number of experiments, but the reasons for this are 
unknown. GFP-huntingtin-Q72 (72 glutamine repeats), formed and 
aggresome that recruited LC3. Interestingly, the LC3 was recruited into a 
ring at the periphery of the aggresome (figure 5.1 .x-xii) as has been 
demonstrated previously for Huntingtin-Q103 (Iwata et al., 2005b).
5.3 FMDV replication sites are recruited to aggresomes
The results above show that aggresomes and FMDV replication sites recruit 
LC3 and therefore recruit autophagosomes. The ability of aggresomes to act 
as sites of FMDV replication was therefore tested. CHO cells expressing p23
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rhodopsin or huntingtin Q72 were incubated for 48 hours to allow aggresome 
formation and then infected with FMDV for 2 hours and processed for 
immunofluorescence. Viral replication sites were detected using an antibody 
for the FMDV non-structural protein 3A. 3A labelling (red) was detected in 
cells expressing p23-rhodopsin (figure 5.2 i-vi) or huntingtin-Q72 or (figure
5.2.v-viii). This indicated that cells with preformed aggresomes were still 
susceptible to FMDV infection. Interestingly 3A labelling surrounded the 
aggresome, as seen for LC3 (figure 5.1). This was most evident for p23- 
rhodopsin where the distribution of 3A around the GFP signal from the 
protein aggregates closely resembled that seen for 3A around FILS (compare 
figures 5.2.A.vi and 4.2.B.iii). In contrast, in cells expressing correctly folded 
versions of these proteins there was no co-distribution of 3A (figure 5.3.).
5.4 Rearrangement of vimentin into a cage-like structure around 
GFPLC3 FILS
Formation of aggresomes invariably results in rearrangement of intermediate 
filaments. In tissue culture cells this is characterized by collapse of vimentin 
into a cage surrounding the aggresome (Johnston, Ward, and Kopito, 1998). 
To see if a similar rearrangement of vimentin is seen around FILS, CHO cells 
expressing GFPLC3 were infected with FMDV (01BFS) for 2 hours. Cells 
were fixed and processed for immunofluorescence, vimentin was labelled 
using a commercially available antibody. In order to obtain a true image of 
vimentin distribution throughout the cell, a series of sections in the z-plane 
were imaged and subsequently merged together (using Leica software), to 
create a single optical representation. Figure 5.3 left-hand column, shows
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that in control cells GFPLC3 and vimentin filaments were distributed 
throughout the cytoplasm. Cells infected with FMDV were identified by the 
presence of FILS, and in these cells (figure 5.3. right-hand column) much of 
the vimentin signal collapsed into a cage around the GFPLC3 signal. Taken 
together with the localisation of FILS next to the MTOC, the dependence on 
an intact microtubule network for its formation, and the induction of ‘kidney 
bean’ appearance of the nucleus, these data suggests that FILS are 
structurally very similar to aggresomes.
5.5 Scriptaid partially inhibits FILS formation
The formation of aggresomes requires dynein-dependent retrograde 
transport of aggregates along microtubules. Work on the formation of 
aggresomes shows that their formation requires a cytoplasmic tubulin 
deacetylase called histone deacetylase 6 (HDAC6); HDAC6, binds ubiquitin 
on protein aggregates and forms a complex with dynein motors facilitating 
transport to the MTOC (Kawaguchi et al., 2003). It was recently shown with 
the use of interfering-RNA, that HDAC6 is also required for the recruitment of 
LC3 to aggresomes (Iwata et al., 2005b). To test whether the formation of 
FILS required HDAC6, the effect of Scriptaid, a known inhibitor of HDAC6, on 
FILS formation was investigated. Scriptaid inhibits the formation of 
aggresomes without disrupting the whole microtubule network (Iwata et al., 
2005b; Kawaguchi et al., 2003).
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CHO cells expressing GFPLC3 were pre-incubated in RPMI containing 
50mM Scriptaid for 2 hours prior to infection. Scriptaid (figure 5 right-hand 
column) greatly reduced the formation of FILS compared to control cells 
treated with DMSO (figure 5.5.left-hand column), and led to the dispersal of 
VP1 labelling into individual punctate foci throughout the cytoplasm (figure 
5.4.i and iv, red). In a small number of infected cells (about 15%), FILS still 
formed in the presence of Scriptaid, but a reduction in the total number of 
FILS upon Scriptaid treatment was consistent in a number of experiments.
A higher magnification of cells incubated with Scriptaid shows that GFPLC3 
and FMDV VP1 were dispersed but still co-localised (figure 5.6.A 
arrowheads) but the incidence of co-localisation was greatly reduced after 
Scriptaid treatment. This contrasts with experiments with Nocodazole in the 
previous chapter (figure 4.14) where VP1 and LC3 remained co-localised. 
Co-immunoprecipitation experiments were used to try to quantify the 
association between GFPLC3 and the FMDV capsid protein. Protein A 
Sepharose coupled to an antibody recognising GFP was used to pull down 
GFPLC3 and associated proteins from infected cells. Proteins were 
separated by 10% SDS PAGE and transferred to nitrocellulose and probed 
with an anti-VP2 (4A3) antibody to detect the FMDV capsid protein. The VP1 
antibody used for immunofluorescence did not work for Western blotting, but 
the VP2 antibody displayed a similar distribution and co-localisation with 
GFPLC3 as seen with VP1 labelling by confocal microscopy (data not 
shown). Whilst no VP2 was detected in the control un-infected lysates (figure 
5.6.B lanes U), VP2 was pulled down by the anti-GFP beads in CHO cells not
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expressing GFPLC3 (figure 5.6.B lane CHO-I). This indicated that the anti- 
GFP beads cross-reacted with FMDV VP2 non-specifically, preventing the 
quantification of GFPLC3 association with FMDV capsid proteins. 
Unfortunately, it was not possible in the time frame available to generate 
conditions that prevented non-specific adsorption of VP2 to the beads coated 
in antibody to GFP
5.6 Effect of Scriptaid on productive FMDV infection
The data above show that Scriptaid caused dispersal of FILS and VP1 and 
this led us to test whether Scriptaid affected replication of FMDV. CHO cells 
were pre-treated with Scriptaid or DMSO control for 2 hours at 37°C and then 
incubated with FMDV inoculum for 1 hour at room temperature. Cells were 
acid washed to remove excess virus and returned to 37°C with media 
containing either Scriptaid or DMSO. Samples of supernatant were removed 
and stored at -70°C every 2 hours. The virus titre of the supernatants was 
determined by plaque assays using BHK cells. The virus titres calculated 
from triplet experiments are presented in figure 3.3.6.A as plaque forming 
units (PFU) per pi. Scriptaid caused a consistently lower virus titre compared 
to control and were reduced by roughly one log at 4, 6, and 8 hours post 
infection. When expressed as a percentage (figure 5.6.B), virus titres were 
reduced to at least 15% of controls. The difference between the Scriptaid- 
treated virus titre data and the control, DMSO-treated virus titre data was 
found to be significant using Two-way analysis of variance (P<0.001).
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5.7 Discussion
This chapter has focussed on understanding the relationship between FILS, 
sites of FMDV replication and aggresomes. FILS form when viral infection 
induces microtubule-dependent redistribution of LC3 to a compact structure 
close to the MTOC. The function of this structure within infected cells is not 
yet clear. Similarly, aggresomes are microtubule dependent inclusions that 
form next to the MTOC, and recruit LC3 (Bjorkoy et al., 2005; Iwata et al., 
2005b; Ravikumar et al., 2003; Ravikumar et al., 2004; Thoreen and 
Sabatini, 2004; Webb et al., 2003).
The recruitment of LC3 to aggresomes was replicated in our lab using 
expression of RFPLC3 and GFP-tagged misfolded proteins. In FMDV- 
infected cells expressing misfolded proteins, FMDV non-structural protein 3A 
accumulated close to aggresomes suggesting a similarity between FILS and 
aggresomes.
This was supported by the observation that FILS, in common with 
aggresomes, are surrounded by a cage of vimentin intermediate filaments 
and that FILS are dispersed by Scriptaid. Interestingly, Scriptaid prevented 
accumulation of both LC3 and VP1 at the MTOC and compared to control 
cells, less co-localisation of LC3 and VP1 was observed. This suggests that 
the co-distribution of GFPLC3 and VP1 is somehow facilitated by HDAC6.
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One-step growth curves demonstrated that Scriptaid caused a significant 
reduction in FMDV titres suggesting that association of FMDV, or at least 
VP1, with LC3 and/or transport to the MTOC is important for replication. 
Association with LC3 seems most important because Nocodazole prevents 
redistribution of LC3 and viral proteins to the MTOC, but does prevent co­
localisation of LC3 with VP1, and does not affect replication
The similarities between FILS and aggresomes are clear from these data, but 
the question still remains; are FILS actually virus-induced aggresomes? 
There are some differences between FILS and classical aggresomes. Firstly, 
pre-formed FILS were dispersed by Nocodazole while aggresomes are stable 
structures unaffected by the disruption of the microtubule network (Johnston, 
Ward, and Kopito, 1998). The recruitment of LC3 to aggresomes is 
microtubule-dependent, and as such the dispersal of GFPLC3 from pre­
formed FILS following the addition of Nocodazole (figure 4.14), may not 
indicate loss of an aggresome-structure, just the loss of GFPLC3 from this 
structure. However, the dispersal of VP1 upon treatment with Nocodazole 
indicates that it is either not the main component of the aggresome-structure, 
which would be resistant to Nocodazole treatment, and is recruited in a 
similar manner to GFPLC3. Alternatively FILS may not represent classical 
aggresome.
Secondly, the TEM data in chapter 4 showed that FILS contain a mass of 
tubular membranes while aggresomes contain an accumulation of electron- 
dense particles (Garcia-Mata et al., 1999; Iwata et al., 2005b; Johnston,
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Ward, and Kopito, 1998). The electron-dense particles seen in aggresomes 
represent the insoluble aggregates they contain. No such particles are seen 
in the EM of FILS, suggesting that these structures do not contain insoluble 
protein aggregates. It is therefore proposed that FILS are not classical 
aggresomes per se, but it may be more accurate to describe them as FMDV 
Induced Aggresome-Like LC3 Structures (FIALLS).
The role of FIALLS in FMDV infection is still unclear, and there are three 
main explanations. 1. The formation of FIALLS may be advantageous for 
replication, where aggresomes concentrate host and viral factors required for 
replication in one area, in a similar manner to African Swine Fever Virus 
(Heath, Windsor, and Wileman, 2001). 2. Conversely, infection may
inadvertently activate the formation of aggresomes as a host cell defence 
mechanism, confining viral proteins in preparation for degradation by 
autophagosomes. 3. FIALLS may be a bystander effect of infection but 
plays no role in controlling replication. This third explanation appears unlikely 
as the inhibition of FIALLS formation correlates with a decrease in FMDV 
yield. This observation also suggests that FIALLS are not associated with 
the degradation of FMDV, if this were the case an increase of FMDV yield 
would be expected with their inhibition. Thus it is likely that FIALLS are 
advantageous for FMDV replication, possibly involved in the formation of the 
replication complex. However, FIALLS do not appear to be physically linked 
to viral replication, as they do not label with replicase proteins 3D or 2C, and 
inhibition of their formation with Nocodazole does not inhibit replication. The 
reduction in virus yield and interacting LC3 and VP1 following Scriptaid
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treatment may suggest that association of VP1 with LC3, rather than 
transport to the MTOC, is beneficial for infection. As autophagy and HDAC6 
are both associated with the aggresome pathway, it is possible that FMDV 
only requires these early components of the aggresome-machinery for 
efficient replication, and the formation of an actual aggresome or FIALLS is 
not essential in this process. This may explain why the EM of FIALLS is 
inconsistent with a typical aggresome structure. It is also possible that 
HDAC6 functions independently of aggresome formation in the autophagy 
pathway, and it is this function that FMDV utilises, although this does not 
explain why FIALLS share so many characteristics with aggresomes.
At this time the functional aspects of the autophagy and aggresome 
pathways in FMDV infection cannot be distinguished. The function and the 
roles of the individual autophagy and aggresome pathways in FMDV infection 
is not yet understood, but links between all three processes are clear.
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Figure 5.1 Relocalisation of RFPLC3 to GFP-Aggroprobes in CHO cells
CHO cells were simultaneously transfected with an expression plasmid for RFPLC3 and one of four 
aggroprobe expression plasmids; Row 1, non-aggresome forming Wild Type Rhodopsin. Row 2, 
aggresome forming p23 Rhodopsin. Row 3, non-aggresome forming Huntingtin Q17. Row 4, 
aggresome forming Huntingtin Q72. Cells were incubated at 37°C for 24-48 hours and fixed then 
processed for immuno-fluoresence. Protein distributoin was detected by the natural fluoresence of 
RFP (red) and GFP (green), nuclear DNA was labelled with DAPI (blue). Bar = 10oM.
Figure 5.2. FMDV Replication area forms in a similar area of the cell as a pre-formed 
aggresome.
CHO cells were transfected with an aggroprobe plasmid expressing either GFP-Huntingtons Q72  
(bottom panels) or GFP-rhodopsin p23 (top panels). Cells were cultured at 37C for 24-48 hours 
before being infected with FMDV (01BFS). Infection was allowed to continue for 2.5 hours at 37°C  
before cells were fixed and processed for immunofluoresence. FMDV replication area was labelled 
with an antibody against FMDV 2C (3F7) followed by a secondary antibody couplced to alexa 568 
(red). Aggroprobe protein distribution was seen by the natural fluoresence of GFP (green) and 
cellular DNAw as labelled with DAPI (blue). Bar = 10oM.
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Figure 5.3 FMDV Replication area is not affected by the expression of non-aggresome forming 
aggroprobes.
CHO cells were transfected with an aggroprobe plasmid expressing either; GFP-Huntingtons Q 17  
(bottom panels), or GFP-wild type rhodopsin (top panels). Cells were incubated at 37°C for 24-48  
hours before being infected with FMDV (01BFS). Infection was allowed to continue for 2.5hours at 37°C  
before cells were fixed with 4% PFAand processed for immunofluoresevce and labelled as in 5.2.
Bar 10uM.
i. GFPLC3 iv. GFPLC3
m
ii. Vimentin
ft
I
$  ai , /
v. Vimentin
iii. Uninfected Merge vi. FMDV Infected Merge
Figure 5.4. Reaarangement of vimentin around FILS.
CHO cells expressing GFPLC3 were incubated in FMDV inoculum (01BFS) for 30 minutes at room 
temperature, the inoculum was then replaced with media containing 2%  FCS and incubated at 37°C  
for 2 hours when cells were fixed in 4%  PFA and processed for immunofluoresence. G FPLC3 was 
detected by the natural fluoresence of GFP (green) The intermediate filament vimentin was labelled 
with a mouse monoclonal antibody followed by a secondary antibody coupled to Alexa 568 (red) 
and cellular DNAw as labelled with DAPI (blue). Left hand panels are uninfected cells, right hand 
panels are FMDV-infected cells. Bar 10uM
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Figure 5.5. The drug Scriptaid inhibits the formation of FMDV replication area and FILS
CHO cells expressing GFPLC3 were incubated in medium containing 50.uM scriptaid or equal w/v 
DMSO for 2 hours. Cells were incubated with FMDV inoculum (01BFS) at room temperature for 30 
minutes which was then replaced with media containing scriptaid or DMSO as above and incubated 
at 37°C for 2 hours before the cells were fixed and processed for immunofluoresence FM DV replication 
area was labelled with an anti-VP1 antibody followed by a secondary antibody coupled to alexa 568 
(red), cellular DNA was labelled with DAPI (blue). LC3 visualised by natural fluoresence of G FP  
(green). B arlO uM .
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Figure 5.6 Some GFPLC3 and VP1 puncta are found colocalised after treatment with Scriptaid, 
biochemical quantification of colocalisation by co-immunoprecipitaion was not possible
A.CH O  cells expressing GFPLC3 were incubated in medium containing 5 0 u M  scriptaid for 2 hours. 
Cells were then incubated with FMDV inoculum (inoculum) at room temperature for 30 minutes,
the inoculum was replaced with medium containing either scriptaid or DMSO as above and incubated 
at 37°C for 2 hours when cells were fixed and processed for immunofluoresence. FMDV was labelled 
with anti-VP1 coupled to alexa 568 (red), cellular DNAwith DAPI (blue). LC3 visualised by natural 
fluoresence of GFP (green) Arrows mark areas of colocalisation. Bar 10uM.
B. CHO and CHOG FPLC3 cells were infected with 01BFS and lysed 2 hours post infection.
Lysates were tumbled with protein A beads coupled to anti-GFP antibody overnight. Beads were 
washed and analysed by Western blot with an anti-VP2 antibody followed by a secondary HRP  
coupled antibody. (U, uninfected cells).
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Figure 5.7 Effect of Scriptaid on productive FMDV infection
CHO cells were incubated at 37°C with FCS free RPMI media containing either 50uiM Scriptaid or equal 
w/v DMSO for one hour. The medium was then replaced with FM DV inoculum (01BFS) also 
containing either Scriptaid or DMSO, cells were incubated at 37°C for a further hour before acid washing 
(see materials and methods). Cells were left with 1ml of drugged media at 37°C, and 50ul samples of 
supernatent taken at appropriate times and frozen at -70°C. The virus yield of the supernatants was 
subsequently determined by plaque assays using BHK cells as described in materials and methods.
A. The average yield obtained from triplicate experiments.
B. Percentage knockdown of FM DV yield calculated as control DMSO treated cells representing 
100%. Error bars represent standard error of the mean
Chapter 6: The role of autophagy in BEV infection
6.1 Introduction
BEV is a member of the enterovirus family and is therefore similar to PV. 
Unlike FMDV, both PV and BEV are sensitive to Brefeldin A, which 
decreases virus yield (Maynell, Kirkegaard, and Klymkowsky, 1992; 
Monaghan et al., 2004), suggesting that BEV may follow a replication 
strategy more in common with PV than FMDV. In addition, PV and BEV 
induce similar membrane rearrangements during infection, causing the 
accumulation of double- and multiple- membrane vesicles in clusters 
throughout the cytoplasm. In contrast, FMDV infection typically induces only 
loose clusters of single membrane vesicles (refer to chapter 3). PV 
replication has recently been reported to require components of the 
autophagy pathway, as a decrease in intracellular and extracellular yields 
was observed in cells where essential autophagy genes had been silenced 
using siRNA (Jackson et al., 2005). It was proposed that PV may use 
autophagy as a source of membranes for replication, and also subvert 
autophagosomes as a transport mechanism to the plasma membrane, 
facilitating the pre-lytic release of virions. To ascertain whether BEV subverts 
the autophagy pathway in a similar manner to PV, the role for autophagy in
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BEV infection was investigated using CHO cells constitutively expressing the 
autophagy marker GFPLC3.
6.2 Redistribution of GFPLC3 during BEV infection
CHO cells expressing GFPLC3 were infected with BEV inoculum and 
processed for immunofluorescence microscopy at different times post 
infection. Images representative of the cell cultures at each time point are 
displayed in figure 6.1.A. BEV was labelled with a mouse antibody raised 
against whole virus (red).
In uninfected cells, GFPLC3 was typically observed in adiffuse throughout 
the cytoplasm, with a few punctate foci. A similar pattern of GFPLC3 was 
observed in cells infected with BEV up to 3hpi. At 4 hpi, disperse BEV 
labelling was observed in some cells throughout the cytoplasm, and the 
number of distinct GFPLC3 punctate foci increased compared to uninfected 
cells.
The amount of punctate GFPLC3 foci continued to increase at 5 and 6 hpi, 
and accumulated on one side of the nucleus in an area of the cells which 
labelled positive for BEV (red). The nuclei of the infected cells at these times 
were smaller compared to the nuclei of uninfected cells in the same culture, 
and this was indicative of the cells undergoing the first stages of apoptosis. 
High magnification images of these GFPLC3 rearrangements are shown in
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figure 6.1.B. At both 5 and 6-hour time-points BEV labelling (red) was seen 
next to the nucleus, possibly representing the virus replication area. 
GFPLC3 was predominantly observed in numerous punctate foci throughout 
the area labelled with the BEV antibody. Some of the GFPLC3 signal formed 
large structures, which may suggest clustering or even fusion of 
autophagosomes. Even so, these did not become as large as the FIALLS 
observed during FMDV infection and the merged images failed to detect co­
localisation between GFPLC3 and the BEV proteins visualised using the 
antibody.
BEV in not an economically important disease, and is not widely studied. As 
a consequence there are few reagents available for studying BEV. The 
specific viral antigens recognised by the 11C5 antibody used is not known 
but is likely that it recognises a BEV capsid protein as it was raised against 
whole virus. Western blots of infected cell lysates showed the antibody 
detects a band of approximately is 25kDa, suggesting that the antibody 
recognises an individual capsid component. If the 11C5 antibody does 
recognise capsid components of BEV, the lack of co-localisation observed 
with GFPLC3 suggests the relationship between BEV and autophagosomes 
is different from FMDV because in chapter 4, GFPLC3 was shown to co- 
localise with the FMDV capsid protein VP1 (figure 4.11).
The processing of GFPLC3-I to GFPLC3-II was examined by Western blot to 
see if autophagy was up-regulated during BEV infection (figure 6.2.A). In 
uninfected cells, the intensity of GFPLC3-II protein band detected was much
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less than the band representing GFPLC3-I, indicating GFPLC3 was 
predominantly present in the cytoplasmic form (figure 6.2.B). The GFPLC3-I 
and -II bands detected in BEV infected cells at 1, 2 and 3hpi were weaker 
than those detected in uninfected cells. This could be due to virus shut down 
of host protein synthesis or unequal loading. However, the ratio between 
GFPLC3-II:GFPLC3-I in these samples was similar to uninfected cells, 
indicating that autophagy was not up-regulated at these times. At 4 hpi a 
slight increase in the ratio of GFPLC3-II:GFPLC3-I was observed (figure
6.2.A), indicating an increase in LC3 processing. A significant increase in 
ratio of GFPLC3-II:GFPLC3-I was observed at 5 hpi, consistent with the 
further increase in the number of GFPLC3 punctate foci observed by 
immunofluorescence (figure 6.1.A). Thus autophagy appears to be up- 
regulated by BEV infection at 4-5hpi.
To confirm the rearrangement of GFPLC3 was specific to the function of LC3, 
and not due to the conjugation of LC3 to GFP, the effect of BEV infection on 
the distribution of GFP fused to FMDV-IRES was investigated. FMDV-IRES 
is the Internal Ribosomal Entry Site encoded in the 5’ UTR of FMDV and 
expression of GFP-IRES results in a diffuse cytoplasmic pattern of GFP.
CHO cells expressing GFP-IRES, were infected with BEV for five hours and 
processed for immunofluorescence. As seen in figure 6.2.B, the distribution 
of GFP-IRES (green) in a BEV-infected cell (red) remains primarily diffuse 
throughout the cytoplasm, with a little in the same area as the nucleus. This 
is very similar to the distribution of GFP-IRES in an uninfected cell in the
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same culture, which does not contain BEV labelling, thus indicating that the 
redistribution of GFPLC3 seen in BEV infection is not due to the expression 
of GFP and is specific to the function of LC3.
6.3 Effect of BEV infection on the distributions of GFPLC3 and LAMP 3
In FMDV infection, LAMP 3 was seen in a similar area to the GFPLC3 
FIALLS. It has been reported that co-localisation between GFPLC3 and 
LAMP 1 increases during PV infection suggesting that PV promotes the 
fusion of autophagosomes with lysosomes. CHO cells expressing GFPLC3 
were infected with BEV for 5 hours and processed for immunofluorescence 
with an anti LAMP 3 antibody. Due to technical difficulties we were unable to 
label for BEV at the same time as labelling for LAMP 3. Cells with small 
apoptotic nuclei were therefore used as a marker for BEV infection. The 
association between GFPLC3 (green) and LAMP 3 (red) in BEV infection is 
shown in figure 6.3. Two different patterns were observed in roughly equal 
numbers. In cells with smaller punctate foci (left-hand column) of GFPLC3, 
co-localisation with LAMP3 (arrow) was rare. In cells, where GFPLC3 had 
formed large vesicular structures (right-hand column), the GFPLC3 co­
localised with LAMP 3. Co-localisation was not complete and there were still 
LAMP positive structures that were GFPLC3 negative and vice versa. Even 
so the results suggested that in common with PV, BEV promoted 
autophagosome/lysosome fusion.
6.4 BEV proteins do not appear to be degraded
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TEM studies demonstrated that BEV particles could be found within vesicles 
that resembled autophagosomes. Coupled with the co-localisation of 
GFPLC3 and LAMP 3 in infected cells led us to investigate whether BEV 
proteins were degraded.
CHO cells infected with BEV for 3 hours, were incubated with cycloheximde 
and lysed at increasing times and the levels of viral antigen remaining were 
determined by Western blot. Cyclohexamide inhibited the production of viral 
proteins and allowed the destination of the viral proteins already present to 
be followed. Cellular actin was probed to check for equal loading. In the 
absence of cycloheximide the levels of BEV protein detected increased as 
infection progressed (figure 6.4.i). When cycloheximide was added at 3 hpi, 
the levels of BEV protein detected remained constant during the chase 
(figure 6.4.ii). There was however, no evident decrease in the level of BEV 
protein detected, suggesting that the protein was not degraded during the 
time course of the experiment.
6.5 Discussion
It has been suggested that PV up-regulates autophagy and uses 
autophagosomes for replication and non-lytic release of virions (Jackson et 
al., 2005). BEV belongs to the same family as PV, and the data in this 
chapter show similarities between the way BEV and PV affect the autophagy 
pathway. BEV infection increased processing of LC3 and caused a
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redistribution of GFPLC3 into numerous punctate foci, which localise to the 
same area of the cell that label with virus antibody (figure 6.1). Unlike FMDV, 
the GFPLC3 pattern induced by BEV did not result in one large accumulation 
of LC3, however, later in BEV infection, vesicles containing GFP-LC3 did 
increase in size, and this correlated well with the clustering of BEV-induced 
vesicles seen by EM.
Unfortunately co-localisation studies between GFPLC3 and non-structural 
proteins involved in replication were precluded by the lack of suitable 
antibodies. It would be interesting to know if replicase proteins co-localise 
with GFPLC3 as has been reported for PV, which may suggest a link 
between autophagosomes and virus replication complexes. It is likely that 
the antibody used to label BEV detects a capsid protein. Thus it would 
appear that unlike FMDV, GFPLC3 does not co-localise with BEV capsid 
proteins. Taken together the results suggest that BEV increases the number 
of autophagosomes. This could be due to the up-regulation of autophagy, or 
an inhibition of autophagosome-lysosome fusion.
Labelling of LAMP 3 in cells infected with BEV suggested that as with PV- 
infection, the amount of co-localisation between LC3 and the lysosomal 
markers increased as infection progressed. Interestingly, in PV-infection, 
LAMP 1 and LC3 began to co-localise at the start of viral RNA synthesis 
(Jackson et al., 2005). During BEV infection of CHO cells, co-localisation of 
GFPLC3 and LAMP 3 began between 5 and 6 hpi. At this time, replication 
has already started since there was evidence of cytopathic effect. This
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suggests that GFPLC3 and LAMP 3 co-localisation occurs after the major 
part of viral RNA replication has taken place. The different timing of LC3 and 
LAMP co-localisation in PV and BEV infection is a significant observation, 
and may indicate a divergence in the role of autophagy in different 
Picornavirus infections.
Poliovirus and MHV have been reported to subvert the autophagy pathway to 
aid virus replication. On the other hand, a role for autophagy as a host cell 
defence system during intracellular infections has been well documented 
(Ogawa et al., 2005; Talloczy, Virgin, and Levine, 2006). In this manner 
autophagy sequesters the intracellular pathogen in the cytoplasm and 
facilitating its degradation by fusing with lysosomes; this may be the role of 
autophagy in BEV infection. TEM data in chapter three demonstrated that 
BEV virions could be detected inside vesicles with that resembled 
autophagosomes, raising the possibility that BEV is degraded via the 
autophagosome pathway. Interestingly, there was no evidence of 
degradation of the BEV protein recognised by the 11C5 antibody when 
analysed by Western Blot. This either means that BEV inhibits degradation 
by interfering with lysosome function, or that the antigen detected (likely to be 
the capsid protein), is resistant to degradation in lysosomes. Resistance to 
acid proteases is certainly possible because BEV is an enterovirus and, like 
poliovirus, is resistant to the low pH and proteases present in the gut. It is 
also possible that small amounts of virus proteins were degraded, but 
Western blot analysis was not sensitive enough to detect this decrease.
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Alternatively, the appearance of BEV inside vesicles may nevertheless 
indicate that BEV utilises a similar exit strategy as has been suggested for 
PV. (Jackson et al 2005), where PV transits through autophagosomes that 
fuse with the plasma membrane, thus facilitating the exit of virus prior to cell 
lysis.
Whether GFPLC3 co-localises with BEV replicase proteins is not known, but 
the later timing of GFPLC3 and LAMP 3 co-localisation in BEV infection 
compared to PV infection may indicate a role for autophagy as a host cell 
defence system in BEV infection, or as a pre-lytic exit strategy for mature 
virions. It is also possible that in complete contrast to PV and FMDV, 
autophagy plays no significant role in BEV infection, and is up-regulated 
purely as a side-effect of infection. Further studies are needed to establish 
what part if any, autophagy has in BEV infection.
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Figure 6.1.A. Redistribution of GFPLC3 during BEV infection
CHO cells expressing GFPLC3 were washed with serum-free RPMI and incubated with BEV inoculum for 
30 minutes at room temperature. Virus inoculum was replaced with RPMI containing 2%  FCS and cells 
were returned to 37°C. Cells were fixed at approriate times with 4%  PFA and processed for immuno­
fluorescence. BEV was detected using the anti-BEV mAb 11C5, followed by a secondary antibody 
coupled to Alexa 568 (red). GFPLC3 was detected by the natural fluorescence of GFP (green), and 
cellular DNA was labelled with DAPI (blue). Bar 20uM
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Figure 6.1.B. Redistribution of GFPLC3 during BEV infection
CHO cells expressing GFPLC3 were were washed with serum-free RPMI and incubated with BEV 
inoculum for 30 minutes at room temperature. Virus inoculum was replaced with RPMI containing 2%  
FCS and the cells were returned to 37°C. Cells were fixed at 5hpi (lefthand panels) or 6hpi (righthand 
panels) with 4%  PFAand processed for immunofluorescence. BEV was detected using the anti-BEV 
mAb 11C5, followed by a secondary antibody coupled to Alexa 568 (red). GFPLC3 was detected by the 
natural fluorescence of GFP (green), and cellular DN Aw as labelled with DAPI (blue). Bar 10uM
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Figure 6.2. Rearrangem ent of GFPLC3 during BEV infection is concurrent w ith G FPLC3  
processing and not an artefact of GFP expression
A .CHO cells were washed with serum-free medium and incubated with BEV inoculum for 30 
minutes at room temperature. The virus inoculum was replaced with RPMI containing 2% FCS and 
returned to 37°C. Cells were lysed at indicated times with IPB lysis buffer. Lysates were analysed by 
Western blot with an anti-GFP antibody followed by a secondary antibody coupled to HRP.
Proteins were detected using an ECL reagent. B CHO cells were transfected with a plasmid containing 
GFP-IRES using Lipofectamine 2000. Cells were incubated at 37°C overnight, washed with serum-free 
medium and incubated with BEV inoculum for 30 minutes at room temperature. The virus inoculum was 
replaced with RPMI containing 2% FCS and the cells were returned to 37°C for 5 hours when cells were 
fixed with 4% PFAand processed for immunofluorescence. BEV was labelled using the mAb 11C5 
followed by a secondary antibody coupled to Alexa 568 (red). G FP-IRES was detected through the 
natural fluorescence of GFP (green), and cellular DNA was labelled using DAPI (blue). Bar 10uM.
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Figure 6.3 Colocalisation of GFPLC3 and LAMP in BEV infection
CHO cells expressing GFPLC3 were incubated with BEV inoculum for 30 minutes at room temperature. 
The inoculum was then replaced with medium containing 2% FCS and incubated for a further 5 hours at 
37°C. Cells were fixed with 4% PFAand processed for immunofluoresence. LAMP 3 was labelled with the 
mAb UH1 and a secondary antibody coupled to Alexa 568 (red). GFPLC3 was 
visualised by the natural fluoresence of GFP (green), and nuclear DNAw as labelled using DAPI (blue). 
Merged images are shown (iii and vi). Bar 10uM.
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Figure 6.4. BEV viral proteins are not degraded as detectab le by W estern blot
CHO cells were were washed with serum-free medium and incubated with BEV ioculum (10M O I) for 30 
minutes at room temperature. The virus inoculum was then replaced with medium containing 2%  FCS  
and incubated at 37°C. 3 hours later (*) the medium was replaced with fresh medium containing either 
1ug/ml cylohexamide to inhibit protein synthesis (ii), or equal v/v DMSO as a control (i). Cells were then 
returned to 37°C and lysed in IPB lysis buffer at the indicated times. Lysates were analysed by Western  
blot with the anti-BEV mAb 11C5 followed by a secondary antibody coupled to HRP and exposed with 
ECL. Membranes were re-probed with an anti-actin mAb followed by a secondary antibody coupled with 
HRP to check for equal loading
Chapter 7: Manipulation of autophagy; effect on Picornavirus
infection
7.1 Introduction
The rearrangement of GFPLC3 during FMDV and BEV infection of CHO 
cells, suggests that autophagy is stimulated in infected cells, however the 
role of autophagy in these infections is not yet clear. Much of the work 
implicating a role for autophagy in different processes has involved the 
inhibition or up-regulation of the autophagy pathway. Autophagy is controlled 
by PI3-Kinases (discussed in the introduction) and this allows autophagy to 
be inhibited by PI3-kinase inhibitors such as Wortmannin, LY294002 
(Blommaart et al., 1997) and 3-methyladenine (Seglen and Gordon, 1982). 
Conversely, rapamycin inhibits mTOR, and this action has been shown to 
stimulate autophagy.
PV yield was shown to increase when cells were incubated with rapamycin 
and decrease after 3-MA treatment (Jackson et al., 2005), This was 
consistent with autophagy being beneficial for PV infection. Rapamycin and 
3-MA are commonly used to modulate autophagy but the results can be 
unreliable. For example, incubation of cells with 3-MA has no effect on MHV 
yield, yet autophagy is still thought to be required for optimal infection as
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MHV replication is reduced in cells which lack Atg5 expression (Prentice et 
al., 2003). It is thought that MHV is able to stimulate autophagy in a manner 
independent of the PI3-Kinases inhibited by 3-MA, or possibly complement 
the steps inhibited by 3-MA. It should also be noted that both rapamycin and 
3-MA can affect pathways other than autophagy. The PI3-Kinases are also 
involved in signalling cascades affecting a number of cellular processes 
including endocytosis, and mTOR is central to the regulation of cell growth 
and proliferation (Sarbassov, Ali, and Sabatini, 2005). Whilst these two 
drugs can give a good indication of the role of autophagy in a process, the 
inhibition of autophagy by silencing autophagy-essential genes can give a 
more definitive answer.
Silencing of essential genes in the autophagy pathway with siRNAs (short 
interfering RNAs) leads to the inhibition of autophagosome formation, and 
has been used to provide evidence of the direct involvement of autophagy 
during PV and Mouse Hepatitus Virus infection (Jackson et al., 2005; 
Prentice et al., 2003). siRNAs are designed to specifically complement the 
messenger RNA (mRNA) of a targeted gene. siRNAs introduced into a 
mammalian cell, bind to the complementary mRNA in the cytoplasm. 
Mammalian cells have an enzyme called RNA-lnduced Silencing Complex 
(RISC), of which double-stranded RNAs are substrates. RISC binds to 
double-stranded RNA and cleaves it, preventing the translation of the protein 
encoded by the mRNA and hence silencing of the protein itself.
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In this chapter 3-MA, rapamycin, and siRNA silencing of Atg5 and beclin are 
used to determine whether autophagy facilitates or inhibits BEV and FMDV 
infection.
The function of Atg5 in the formation of the isolation membrane has been 
described in the introduction. The specific role of beclin in the autophagy 
pathway is less clear. Beclin is the mammalian homologue of Atg6 and 
rescues autophagy in Atg6 deleted yeast cells (Liang et al., 1998). 
Interestingly in Atg6-depleted yeast cells, autophagy is completely inhibited 
after starvation, thus it is an essential part of the yeast autophagy pathway. 
In mammalian cells with a mono-allelic deletion of the beclin gene rendering 
beclin protein undetectable, a basal low level of autophagy can still occur 
(Liang et al., 1998). So it’s possible that beclin has a slightly different role in 
mammalian autophagy than its yeast counterpart.
Beclin binds PI3 kinase vps34 in yeast and amino acid deprivation increases 
PI3-kinase activity complexed with beclin and increases protein degradation 
Thus it would appear that the role of Beclin in autophagy is linked to PI3- 
kinase activity (Tassa et al., 2003). The beclin-PI3-kinase complex appears 
to function at the Trans-Golgi network (Kihara et al., 2001) and it is possible 
that the beclin complex functions in sorting of specific proteins required for 
isolation membrane formation from the TGN. Although the specific role of 
beclin during the autophagy pathway is still under investigation, it is clear that 
a reduction in beclin protein levels renders cells autophagy-deficient.
130
7.2 Effect of 3-MA and rapamycin on FMDV and BEV infection
The effects of 3-MA and rapamycin on virus yield were investigated by one- 
step growth curves. The effectiveness of these drugs on GFPLC3 
processing has already been demonstrated (figure 4.1). Cells were 
incubated for 2 hours in media containing either 10mM 3-MA, 2pg/ml 
rapamycin or DMSO, and then incubated with virus for 1 hour at 37C. To 
ensure accurate calculations of virus release, non-internalised virus was 
inactivated after incubation with the virus inoculum. FMDV was inactivated 
using an acid wash and FCS was used to inactivate non-internalised BEV. 
After extensive washing, cells were returned to 37°C with the appropriate 
medium. Supernatants were taken immediately after washing, and 
subsequently every 2 hours until CPE was observed. Supernatants were 
immediately frozen at -70°C to preserve virus and later titrated using plaque 
assays with BHK cells. Figure 7.1.A shows the virus titres obtained from 
triplicate experiments, the same data are presented as average virus in figure 
7.1.B. Very little difference between the yields obtained from each drug 
treatment was seen. Thus it does not appear that the up-regulation or 
inhibition of autophagy with these drugs affects productive FMDV infection.
The experiment repeated for BEV is shown in figures 7.2.A and B. Again 3- 
MA and rapamycin did not appear to have any affect on BEV yields.
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Therefore the effect of siRNA directed against Atg6 (beclin) and Atg5 were 
therefore tested. Preliminary experiments were carried out to optimise the 
silencing experiments.
7.3 Optimisation of Beclin silencing
The design and use of beclin siRNA has been previously successful (Yu et 
al., 2004), and an antibody against beclin was commercially available. The 
siRNA previously by Yu, Alva et al was targeted against the mouse sequence 
of beclin, hence mouse L929 cells were used for all beclin silencing 
experiments.
7.3.1 Transfection Efficiency
A vital aspect for assessing the effects of gene silencing by siRNA is the 
transfection efficiency, which can vary depending on the transfection reagent 
used. Three different transfection reagents were tested for their efficiency to 
transfect siGLO RISC-Free siRNA into mouse L929 cells. siGLO RISC-Free 
siRNA is a non-functional siRNA, with a fluorescent label allowing transfected 
cells to be identified by confocal microscopy. 24 hours prior to transfection, 
mouse L929 cells were cultured in 4cm2 dishes containing glass coverlips to 
closely resemble the transfection conditions used for one-step growth curves. 
A 100nM siGLO RISC-Free RNA solution was transfected into cells using 
Transfast, Lipofectamine 2000 or DharmaFECT, according to manufacturers’ 
instructions and incubated at 37°C for a further 24-48 hours. Glass 
coverslips were then removed, incubated in 4% PFA for one hour to fix the 
attached cells and subsequently processed for immunofluorescence.
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Nuclear DNA was labelled with DAPI and was used to indicate the number of 
cells present. Transfast produced the lowest transfection efficiency as very 
few blue nuclei were accompanied by red fluorescence (figure 7.3.A). When 
DharmaFECT was used, the transfection efficiency was greatly increased 
and nearly all nuclei detected were accompanied by red fluorescence. 
Lipofectamine was equally efficient as DharmaFECT, but the number of cells 
present on the coverslips was reduced, indicating a higher incidence of cell 
death. Since Lipofectamine reduced cell survival, DharmaFECT was used 
for subsequent experiments.
7.3.2 Incubation Time
The incubation time required for knock-down of protein expression after initial 
siRNA transfection can vary between different cell lines and the gene 
targeted. In a previous study, beclin silencing was studied 96 hours post 
transfection (Yu et al., 2004). Western blots were used to ensure that 96 
hours was sufficient for loss of protein production. Mouse L929 cells were 
plated and transfected with 100nM beclin siRNA. At 24, 48, 72 and, 96 hours 
post transfection, cells were lysed in IPB lysis buffer, and analysed by 
Western blot. An anti-beclin antibody was used to detect protein knock­
down, and an anti-actin antibody was used to check for equal loading. Figure
7.3.B shows the relative protein expression of siRNA-transfected cells and 
control un-transfected cells. The level of actin protein expression remained 
relatively constant in all lanes indicated an equal amount of lysate was 
loaded in each lane. Beclin protein expression was slightly reduced in 
siRNA-transfected cells compared to control cells at 24, 48 and 72 hours post
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transfection, but almost un-detectable after 96 hours, suggesting the 
reduction of beclin protein expression is optimum at this time.
7.3.3 siRNA Concentration
Adverse effects of siRNA transfections can be minimised by using as low a 
concentration of functional siRNA as possible. To this end, transfections 
were carried out to find the minimum concentration of beclin siRNA required 
for beclin protein silencing. The ratio of siRNA to transfection reagent was 
kept constant by diluting beclin siRNA with the siGLO RISC-Free siRNA and 
cells were analysed after 96 hours. Figure 7.3.C demonstrates that 50nM 
beclin siRNA was as effective at silencing beclin protein expression as 
100nm siRNA, whereas 10nM beclin siRNA had very little effect on the level 
of beclin protein detected. 50nM of Beclin siRNA supplemented with 50nM 
siGLO RISC-Free siRNA was therefore used in all subsequent transfections, 
to keep the functional siRNA concentration to a minimum, whilst retaining 
transfection efficiency.
7.3.4 Control siRNA
To ensure the reduction in beclin protein expression detected by Western 
blot was due to the specific targeting of beclin and not a general effect of the 
introduction of siRNA, the effects of two control siRNAs on beclin protein 
expression was tested. Non-functioning siGLO RISC-Free siRNA was used 
to detect off-target effects as a consequence of the transfection, and a 
functional but non-targeting siRNA (siCONTROL Non-Targeting siRNA) were 
used to detect adverse effects caused by the stimulation of RISC and the
134
RNAi pathway. This siRNA activates RISC, but does not complement/bind to 
any known mammalian mRNA and does not silence any known mammalian 
gene. As seen in figure 7.3.D transfection with either of the control siRNAs 
had no effect on beclin protein expression as detected by Western blot, 
indicating that its reduction after beclin siRNA transfection is a specific effect.
7.4 Effect of Beclin silencing on the virus yields of FMDV and BEV
To determine whether beclin silencing had an effect on the productive virus 
infection of FMDV, one-step growth curves were performed in mouse L929 
cells in the absence or presence of beclin siRNA. To ensure beclin silencing 
was successful in all one-step growth curve transfections, parallel siRNA 
transfections were performed for Western blot analysis of protein expression 
(figures 7.4.A and 7.5.A). The virus titres calculated from the supernatant 
samples are plotted in figures 7.4.B. and C. and 7.5.B and C. Little 
difference was seen between FMDV titres released from cells in the 
presence or absence of siRNA, control non-targeting siRNA or un-transfected 
cells, and the data was not found to be statistically significant by two-way 
analysis of variance (figure 7.4.B and C). Thus beclin silencing did not 
diminish or enhance productive FMDV infection, suggesting that autophagy is 
not essential for FMDV infection.
In contrast, beclin siRNA did appear to affect yields of BEV (figures 7.5.B and 
7.5.C). At 4 and 6 hpi, the virus titres calculated from the two control cell 
populations remain similar, but virus titres from cells transfected with beclin
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siRNA increased 5 fold at four hours and 10 fold at 6 hours. Two-way 
analysis of variance determined that the overall effect of beclin silencing on 
virus titre was not statistically significant (P = 0.130).
7.5 Optimisation of Atg5 silencing
Antibodies to Atg5 and as well as pre-designed siRNA were commercially 
available and the effect of Atg5 silencing on productive FMDV and BEV virus 
infections was investigated. Optimisation of Atg5 silencing was carried out 
as described for beclin. The antibody available was raised against human 
Atg5 and its reactivity against other species of Atg5 was not known, therefore 
subsequent siRNA experiments were carried out in human Hela cells.
7.5.1 Transfection Efficiency
As a new cell line was being used, the transfection efficiency for the 
transfection reagents was reassessed using HeLa cells. In contrast to the 
transfection efficiencies seen with mouse L929 cells, transfection with 
DharmaFECT resulted in low transfection efficiency, (figure 7.6.B). 
Lipofectamine 2000 produced the best transfection efficiency and was
chosen for subsequent transfections to optimise silencing of Atg5.
!
7.5.2 Incubation Time
To ensure cells were incubated for the minimal time needed for adequate 
Atg5 silencing, a time-course of silencing using 100nM Atg5 siRNA is shown 
in figure 7.6.B. The Atg5 antibody used detected multiple bands on Western 
blot, but a major band thought to represent Atg5 migrated closely to the 30
\
136
kDa marker consistent with the documented size of 33kDa for Atg5. 
Importantly, this band was lost in the presence of Atg5 siRNA (T) compared 
to un-transfected cells (U). An optimum reduction in Atg5 protein expression 
was seen at 72 hours post transfection, and this incubation time was 
therefore used for all subsequent transfections.
7.5.3 siRNA Concentration
To identify the minimum concentration of Atg5 siRNA required for protein 
knock down, the efficiencies of 100, 50 and 10nM of Atg5 siRNA were tested 
by Western blot. Figure 7.6.C shows that 50nM was as efficient as 100nM at 
knocking down Atg5 protein expression and subsequently used in all further 
Atg5 transfections. A small amount of Atg5 could still be detected in 50 and 
100nm lanes, indicating knock-down was not complete. Whether this is due 
to a low level of silencing in each cell, or that Atg5 is silenced completely in 
only a few cells is not clear. However, the overall level of protein present is 
greatly reduced and should have enough of an adverse effect on the 
autophagy pathway to be reflected by a difference in virus yield should 
autophagy be a requirement for infection or a defensive mechanism.
7.6 Effect of Atg5 silencing on the virus yields of FMDV and BEV
Preliminary experiments showed poor replication of FMDV in HeLa cells. 
Vero, African Green Monkey cells were used as an alternative primate cell 
line since they are more susceptible to FMDV. The Atg5 sequence is highly
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conserved throughout different species, and siRNA gave efficient knock 
down of Atg 5 in Vero cells 72 hours following transfection (Figure 7.7A).
The yields of FMDV produced in the presence or absence of siRNA are 
shown in figure 7.7.B. and C. As recorded for beclin silencing very little 
difference was seen between the virus yields produced by either Atg5 or non­
targeting siRNA, and the data was not found to be statistically significant 
using Two-way analysis of variance.
The effect of reduced Atg5 protein expression on productive BEV infection 
was studied in the same manner as above, except Hela cells were used 
which are easily infected with BEV. An example of the reduction of Atg5 
protein expression in one of the transfections can be seen in figure 7.8.A, 
indicating that the reduction of Atg5 protein expression is consistent after 
Atg5 siRNA transfection. The effect of the loss of Atg5 protein expression on 
BEV virus yield was not as dramatic as seen for beclin but virus yields were 
slightly increased later during infection (figure 7.8.B and figure 7.8.C.). Again 
the data were not found to be statistically significant using Two-way analysisn 
of variance.
7.7 Discussion
In this chapter the effects of drugs and siRNA reagents able to modulate 
autophagy on productive virus production was investigated. The effects on 
FMDV and BEV will be discussed separately.
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7.7.1 FMDV
3-MA is a pharmacological drug that can be used to inhibit the autophagy 
pathway. A decrease in virus yield from cells treated with 3-MA has been 
reported for PV infection, which has been postulated to require components 
of the autophagy pathway during infection (Jackson et alM 2005). One-step 
growth curves were performed to test the effect of 3-MA and rapamycin on 
productive FMDV infection, in these experiments the term infection covers all 
steps from virus entry to replication and exit. No decrease in virus yield was 
observed after 3-MA treatment (figure 7.1), suggesting that autophagy is not 
essential for FMDV infection. Rapamycin also had little effect on productive 
FMDV infection was observed (figure 7.1). These observations suggest that 
autophagy does not have great impact on FMDV infection.
The role of autophagy in FMDV infection was still not clear from these data, 
and may be due to non-specific effects of the drugs used. Silencing RNA 
was used as an alternative approach to study whether autophagy was a 
requirement for FMDV infection. SiRNA silencing of beclin and Atg5 had 
very little affect on FMDV yields, and may have slightly increased yields 
(figures 7.4 and 7.7). As the silencing of Atg5 and beclin inhibit autophagy, 
this indicates that unlike PV and MHV, FMDV does not require activation of 
autophagy for optimum virus production. This is consistent with the 
observation that unlike PV and MHV, the autophagy marker LC3 did not co- 
localise with FMDV replication-associated proteins (figure 4.10). The slightly
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increased virus yields make it possible that autophagy has a role in reducing 
virus production, functioning as a host cell defence system possibly 
facilitating the degradation of virus. This theory ties in nicely with the 
observed rearrangement of GFPLC3 into an aggresome-like structure 
(FIALLS) during FMDV infection (chapter 5). Aggresomes are associated 
with a host cell defence system against protein aggregates (Johnston, Ward, 
and Kopito, 1998), and autophagy facilitates the degradation of protein 
aggregates by transferring them to lysosomes (Lee et al., 2004; Ravikumar, 
Duden, and Rubinsztein, 2002; Webb et al., 2003).
The very small increase in virus yields observed following inhibition of 
autophagy with siRNA does however suggest that if it is a defence system, it 
is not very effective against FMDV infection. It may nevertheless explain the 
slight increase in virus yield observed after Nocodazole treatment (figure 
4.15); disruption of the microtubule network has been reported to inhibit 
autophagosome-lysosome fusion (Webb, Ravikumar, and Rubinsztein,
2004), thus depolymerisation of microtubules with Nocodazole may inhibit the 
degradation of FMDV targeted to lysosomes by autophagy.
Even though autophagy has little effect on FMDV production several 
experiments show that autophagy is activated in cells infected with FMDV. 
Punctate foci containing GFPLC3 increase soon after infection and 
GFPLC3-I is processed to GFPLC3-II. Most interestingly, FMDV infection 
causes the rearrangement of GFPLC3 into a distinct pericentriolar structure 
which we have called FIALLS. These data raise the possibility that FMDV is
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unable to inhibit the stimulation of autophagy following infection, but is able to 
avoid autophagic degradation by subverting autophagy components into a 
unique, aggresome-like structure, away from areas of viral replication, thus 
reducing the sequestration of virus products into autophagosomes.
The data presented here does not exclude the possibility that FIALLS form 
from structures separate from typical autophagosomes. Ultra-structural 
analysis of FIALLS (figure 4.7) did not demonstrate typical double- 
membraned autophagosomes present within FIALLS, which appear as a 
mass of tubular membranes. Unfortunately, due to the species restrictions of 
the siRNA and antibodies available, we were unable to ascertain whether 
Atg5 or beclin siRNA inhibited the formation of FIALLS in CHO cells. Thus 
the formation of FIALLS may still play a beneficial role in FMDV infection, as 
supported by the decrease in virus yield observed with Scriptaid treatment, 
which inhibits the formation of FIALS (figures 5.5 and 5.7).
To rule out the possibility that LC3 was functioning in a pathway independent 
of autophagy, specific silencing of LC3 with siRNA was attempted, however 
sufficient protein knock down was not achieved (data not shown), possibly 
due to consistently low transfection efficiency. An alternative method to 
investigate this theory would be to transfect cells with either Atg5 or beclin 
siRNA, cells would later be transfected with the expression plasmid 
containing RFPLC3 (chapter 5). The formation of FIALLS in FMDV infected 
cells defective in autophagy could then be followed using confocal 
microscopy.
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Herpes Simplex Virus (HSV) has been reported to be targeted for autophagic 
degradation, in a PKR-dependant manner (Talloczy et al., 2002; Talloczy, 
Virgin, and Levine, 2006). Under normal conditions, HSV is able to inhibit the 
activation of autophagy by encoding a protein; ICP134.5, which inhibits the 
activation of PKR, and subsequent stimulation of autophagy (Talloczy, Virgin, 
and Levine, 2006). It could be postulated that FMDV is capable of inhibiting 
the activation of autophagy in a similar manner to HSV, however the studies 
of GFPLC3 in FMDV infected cells (chapter 4) are not in support of this 
theory.
7.7.2 BEV
BEV and PV are both enteroviruses and at the outset we anticipated that 
BEV would respond to autophagy in a manner similar to PV. Both PV and 
BEV induce vesicles with multiple limiting membranes, many of which appear 
to have double membranes; a common characteristic of autophagosomes. 
Furthermore, TEM analysis of BEV-infected cells demonstrated that BEV 
virus particles can be observed within double membrane vesicles (figure 3.4). 
It was recently postulated that autophagy provides a source of membranes 
for PV replication, and that the fusion of autophagosomes containing 
infectious particles, engulfed within the cytoplasm with the plasma membrane 
would provide an exit strategy for virus prior to cell lysis (Jackson et al.,
2005). If autophagy was similarly required during BEV infection, then 
inhibition of autophagy with 3-MA would be expected to reduce BEV yield. 3-
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MA had very little affect on BEV yields, suggesting that autophagy is not 
required for replication. However, up-regulation of autophagy by BEV via a 
3-MA independent pathway could not be excluded from this data.
Silencing of beclin produced a pronounced 5-10 fold increase in BEV yields 
at 4 and 6hpi. A less clear-cut increase in yields was produced by silencing 
of Atg5. This may result from the higher efficiency in beclin silencing than 
Atg5. We do not know whether silencing failed in just a few cells or whether 
the protein was only partially silenced in all cells. If Atg5 silencing failed in a 
sub population of the cells these could produce high virus yields and mask 
the full effect of Atg5 silencing on BEV infection. FACS analysis would 
provide further insight to the efficiency of silencing in the cell population.
The increased virus titre produced by beclin-silenced cells was not found to 
be statistically significant using two-way analysis of variance. This could be 
due to the time points of infection analysed in the experiment. The increase 
in virus titre appeared to occur late on in infection. It is possible that if the 
experiment was repeated and later time points analysed, that a statistically 
significant difference would be observed.
The data presented in this chapter suggest that unlike PV, where virus yields 
fall after inhibition of autophagy, (Jackson et al., 2005), BEV yields increase 
suggesting that autophagy acts as a host cell defence system during BEV 
infection. The TEM images of BEV particles in vesicles that resemble 
autophagosomes (figure 3.4) may represent the trafficking of the BEV
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particles through the autophagy pathway to lysosomes where they are 
degraded. Consistent with this theory was the observation that GFPLC3 
structures co-localised with the lysosomal marker LAMP 3 in cells infected 
with BEV (figure 6.3). We were however unable to provide evidence for 
degradation of BEV proteins (figure 6.4), but as explained previously this 
does not mean that capsid proteins are not delivered to lysosomes (see 
chapter 6 discussion). It is also important to consider that the BEV can still 
replicate within cells with functioning autophagy, and virus is still released. 
Thus degradation of BEV via the autophagy pathway is not totally efficient 
and the small amount that is degraded may not be detectable by Western 
blot.
The data presented in this chapter provide evidence that the inhibition of 
autophagy with siRNA targeted to autophagy-specific genes is advantageous 
for both FMDV and BEV infection, increasing the virus yields produced. This 
was more pronounced with BEV infection, and may indicate a role for 
autophagy in the degradation of virus. This is in complete contrast to PV 
which is thought to utilise autophagy components during infection.
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Figure 7.1. Effect of 3-Methyladenine and Rapamycin on productive FMDV infection
CHO cells were incubated in serum-free RPMI medium containing either 10mM 3MA, 2ug/ml 
Rapamycin of equal v/v DMSO for 2 hours at 37°C. Cells were then incubated with FM DV inoculum 
(01BFS) for 45 minutes at 37°C, non-internalised virus was then innactivated by acid washing. Cells 
were left with 1ml of 2% FCS RPMI medium containing either 10mM 3MA, 2ug/ml Rapamycin or equal 
v/v DMSO at 37°C, 50ul samples of supernatent taken at appropriate times and the virus yield of the 
supernatants was subsequently determined by plaque assay.
A. Virus yields obtained from triplicate experiments (see graph legend in B). B. Mean virus yields 
obtained from triplicate experiments, pfu = plaque forming units.
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Figure 7.2. Effect of 3-Methyladenine and Rapamycin on productive BEV infection
CHO cells were incubated in serum free RPMI medium containing either 10mM 3MA, 2ug/ml Rapamycin 
of equal v/v DMSO for 2 hours at 37°C. Cells were then incubated with BEV inoculum for 45  
minutes at r37°C, non-internalised virus was innactivated by FCS washing. Cells were left with 1ml of 
2% FCS RPMI medium containing either 10mM 3MA, 2ug/ml Rapamycin or equal v/v DM SO at 37°C, 
50ul samples of supernatent taken at appropriate times and the virus yield of the supernatants was 
subsequently determined by plaque assay.
A. Individual virus titres obtained from triplicate experiments (see graph legend from B). B. Mean 
virus titres obtained from triplicate experiments, pfu = plaque forming units
p.-p
o
Ivxir •• [>•:•» t in *  ctlai
i.ceo:
 ►
Hours Post Infection
A
Transfast Dharmafect Lipofectamine 2000
B 24
U T
48 
U T
72 
U T
96 
U T
Beclin
Actin
U 100 50 10 nM siRNA
Beclin
Actin
D
oa)
CD
a)a)
u_o
CO
O'
0a>
|2 0c
oz
Beclin
Actin
Figure 7.3. O ptim isation o f beclin silencing in m ouse L929 cells.
A. L929 cells were transfected with siGLOW  RNA and fixed with 4%  PFA 48 hours post transfection. 
Cellular DNA was labelled with DAPI and transfected cells identified by the natural fluoresence of the 
siGLOW  RNA (red). B. L929 cells were transfected with beclin siRNA and lysed at 24, 48, 72 and 96 
hours post transfection. Effects on beclin protein expression were analysed by western blot using an 
anti-Beclin antibody (U, untransfected, T, transfected). C. L929 cells were transfected with either 100, 
50 or 10nM beclin siRNA, lysed 96 hours post transfection, and beclin protein expression was analysed 
by western blot with an anti-Beclin antibody. D. L929 cells were transfected with either beclin siRNA or 
control siRNA (rise free or non-target). 96 hours post transfection, cells were lysed and the effect on 
beclin protein expression was analysed by western blot using an anti-Beclin antibody.
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Figure 7.4. Effect of Beclin silencing on productive FMDV infection
A. Mouse L929 cells were transfected with either beclin siRNA, or control s iR N A . 96 hours post 
transfection, cells were lysed and the effect on beclin protein expression was analysed by Western blot 
using an anti-Beclin antibody. B. Mouse L929 cells were transfected with either beclin siRNA, or control 
s iR N A . 96 hours post transfection,cells were incubated with FM DV inoculum (01BFS) at room 
temperature for 45 minutes, when excess virus was removed by acid washing. Cells were incubated 
in medium containing 2% FCS and returned to 37°C. 50ul samples of supernatant were taken at 
appropriate times and the virus yields of the supernatants were subsequently determined by plaque 
assay. Virus yeilds obtained from triplicate experiments shown (see graph legend in C) C. Mean virus 
yields obtained from triplicate experiments, pfu = plaque forming units.
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Figure 7.5. Effect of Beclin silencing on productive BEV infection
A. Mouse L929 cells were transfected with either beclin siRNA, or control s iR N A . 96 hours post 
transfection, cells were lysed and the effect on beclin protein expression was analysed by Western blot 
using and anti-Beclin antibody. B. Mouse L929 cells were transfected with either beclin siRNA, or control 
s iR N A . 96 hours post transfection,cells were incubated with BEV inoculum at room temperature for 45  
minutes, when excess virus was removed by FCS washing. Cells were incubated in medium containing 
2% FCS and returned to 37°C. 50ul samples of supernatant were taken at appropriate times and the 
virus yields of the supernatants were subsequently determined by plaque assay. C. Percentage 
difference of BEV yields were calculated, control cells were plotted as 100%. Error bars represent 
standard error of the mean.
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Figure 7.6. Optimisation of Atg5 silencing in HELA cells.
A. HELA cells were transfected with siGLOW  RNA and fixed with 4% PFA 48 hours post transfection. 
Cellular DNA was visualised with DAPI staining (blue) and transfected cells were identified by the natural 
fluoresence of the siGLOW  RNA (red). B. HELA cells were transfected with Atg5 siRNA and lysed at 
24, 48, and 72 hours post transfection. Effects on Atg5 protein expression were analysed by W estern blot 
using and anti-Atg5 antibody (U, untransfected.T, transfected) C. HELA cells were transfected with either 
100, 50 or 10nM Atg5 siRNA, lysed 72 hours post transfection, and Atg5 protein expression was analysed 
by Western blot with an anti-Atg5 antibody.
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Figure 7.7. Effect of Beclin silencing on productive FMDV infection
A. Vero cells were transfected with either beclin siRNA, or control siRNA . 72 hours post transfection, 
cells were lysed and the effect on beclin protein expression was analysed by Western blot using an anti- 
Beclin antibody. B. Vero cells were transfected with either beclin siRNA, or control s iR N A . 72 hours 
post transfection, cells were incubated with FM DV inoculum at 37°C for 45 minutes, non-internalised 
virus was then innactivated by acid washing. Cells were incubated in medium containing 2%  FCS and 
returned to 37°C. 50ul samples of supernatant were taken at appropriate times and the virus yields of 
the supernatants were subsequently determined by plaque assay. Results from triplicate experiments are 
shown (see graph legend for C). C. Mean virus yields obtained from triplicate experiments (B). pfu = 
plaque forming units
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Figure 7.8. Effect of Beclin silencing on productive BEV infection
A. Hela cells were transfected with either beclin siRNA, or control siRNA . 72 hours post transfection, 
cells were lysed and the effect on beclin protein expression was analysed by Western blot using an 
anti-Beclin antibody. B. Hela cells were transfected with either beclin siRNA, or control s iR N A . 72 hours 
post transfection, cells were incubated with BEV inoculum at 37°C for 45 minutes, then non-internalised 
virus was innactivated by FCS washing. Cells were incubated in medium containing 2%  FCS and 
returned to 37°C. 50ul samples of supernatant were taken at appropriate times and the virus yield of the 
supernatant was subsequently determined by plaque assay. Results from triplicate experiments shown, 
(see graph legend for C) C. Mean virus yields from triplicate experiments (B). pfu = plaque forming units.
Chapter 8: Final Discussion
We have investigated the role played by autophagy during the replication of 
two different picornaviruses, FMDV and BEV. BEV is an acid-stable 
enterovirus that infects via the faecal oral route while FMDV is an acid- 
sensitive apthovirus which infects via the upper respiratory tract. Our data 
indicate that both viruses up-regulated autophagy during infection but 
autophagy was not required for either FMDV or BEV replication. This 
contrasts with recent work on PV which suggests autophagosomes provide a 
platform for replication and facilitate non-lytic release of virus from cells. The 
data suggest that different picornaviruses may affect autophagy in different 
ways.
8.1 FMDV
Infection with FMDV caused the rearrangement of LC3 into large perinuclear 
structures, which when examined by EM, appeared as a mass of tubular- 
vesicular membranes. These structures differed from the 500-1 OOOnm 
diameter vesicles commonly described as autophagosomes, and suggests 
these structures are distinct from typical autophagosomes. The structures 
induced by FMDV infection were also surrounded by a cage of vimentin 
filaments and located close to the MTOC, and in this way closely resembled 
aggresomes. They were therefore called FIALLS (FMDV-induced 
aggresome-like LC3 structures).
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The FIALLS did not appear to provide a membrane scaffold for the replication 
complex, as they did not co-localise with viral proteins commonly associated 
with replication. Furthermore, FIALLS formed transiently during FMDV 
infection, and were lost before the maximum production of new FMDV 
proteins was detected. The loss of LC3 signal before the onset of the major 
phase of virus replication suggested that active autophagy may not be 
needed for the late stages of FMDV replication. This was further 
substantiated when siRNA knock-down of proteins important for the 
production of autophagosomes had little effect on virus yields. However, as 
a result of problems with antibody cross-reactivity and species differences in 
origin of cell lines and time restraints of this project, we were unable to see if 
FIALLS were affected by siRNA against Atg5 or beclin. We cannot rule out 
the possibility that FIALLS have an important role at the start of infection, for 
example by securing the first replicase proteins produced in cells, 
independently from Atg5 and beclin. LC3-targeted siRNA was attempted 
during this project, however efficient protein knockdown was not obtained.
Autophagy is a fluid process, and autophagosomes are continuously 
degraded within lysosomes. By over-activating autophagy early in infection 
to produce FIALLS, FMDV may cause the degradation of proteins required to 
form new autophagosomes. Picornaviruses are known to inhibit host cell 
protein synthesis and this would prevent replenishment with newly 
synthesised proteins. This would explain why FIALLS slowly disappear 
during infection. We suspect they may be degraded following fusion with
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lysosomes following our observations with lysotracker and LAMP 3 labelling. 
This could be confirmed with the use of lysomotropic agents.
FMDV replicates within the cytoplasm, and as such is susceptible to 
autophagic sequestration. Instead of inhibiting the autophagy pathway, or 
like PV utilising autophagy membranes for the formation of the replication 
complex, FMDV may over-activate the autophagy pathway early in its 
infection cycle. By over-activating the autophagy pathway early in infection 
and inducing the formation of FIALLS, FMDV creates a ‘diversion’ causing 
the cell to use the reserve proteins in the cytoplasm. In combination with the 
inhibition of protein synthesis, the formation of new autophagosomes is 
eventually prevented, essentially inhibiting autophagy. At this time FMDV is 
able to replicate freely within the cytoplasm. This may explain the loss of 
FIALLS prior to optimum FMDV protein production seen by 
immunofluorescence.
Interestingly, perinuclear accumulation of LC3 was also observed in cells 
expressing FMDV 2C or 2BC alone. We have not carried out EM work to 
confirm that 2BC produces tubular membranes similar to FIALLS. It is 
possible that 2BC stimulates the formation of vesicles distinct from those 
observed in FMDV-infected cells. The mechanism by which 2B and 2BC 
stimulate autophagy has not yet been established. Formation of 
autophagosomes by PV requires expression of 2BC and 3A. This again 
points to a difference between PV and FMDV, since FMDV does not appear 
to need 3A to relocate LC3 to membranes.
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It is also possible that FIALLS are not related to autophagosomes. FIALLS 
were initially identified as an accumulation of the autophagy marker LC3, it 
was therefore concluded that they form from components of the autophagy 
pathway. As the inhibition of autophagy activity did not decrease FMDV 
yield, it was further concluded that FIALLS were not essential for FMDV 
infection. However, it is possible that LC3 functions independently from the 
autophagy pathway, thus the effect of FIALLS on FMDV infection may differ 
from the rest of the autophagy pathway.
There are two LC3 homologues, a 16kDa Golgi-associated ATPase 
enhancer, GATE-16 and a gamma aminobutyric-acid-type-a (GABAa)- 
receptor associated protein (GABARAP). Both proteins appear to localise to 
isolation membranes and autophagosomes (Kabeya et al., 2004), but also 
function independently of autophagy. GATE-16 localises to the Golgi 
apparatus and is thought to be involved in intra-Golgi transport and, 
GABARAP is thought to be involved in the regulation of intracellular receptor 
transport. Although an alternative role for LC3 independent of the autophagy 
pathway has not been proven, the possibility has not been excluded.
8.2 BEV
Autophagy was up-regulated during BEV infection, in a similar manner to that 
seen for PV. However, siRNA experiments indicated that inhibition of 
autophagy led to an increase in virus yield. These data indicated that
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autophagy may be a defence against infection leading to degradation of BEV 
in lysosomes. This was supported by the observation of virus-like structures 
in double membraned vesicles suggestive of autophagosomes in TEM. It is 
not known whether BEV is specifically targeted by autophagy, or non- 
specifically sequestered along with bulk degradation of the cytoplasm. Cells 
infected with BEV appeared to undergo apoptosis. Autophagy is up- 
regulated during the early steps of apoptosis and the up-regulation of 
autophagy observed during BEV infection may result from virus-induced 
apoptosis. Under these conditions BEV would be non-specifically engulfed 
by autophagosomes as a component of cytoplasmic contents, and then 
degraded in lysosomes.
Alternatively, it is possible that autophagy is able to actively target BEV for 
sequestration and degradation. The method by which pathogens are 
specifically targeted for sequestration in autophagosomes is still unclear. A 
recent study of Shigella bacteria demonstrated an interaction between Atg5 
and a bacterial component; Vir G which may recruit autophagosomes to an 
area of the cytoplasm enriched with Shigella bacteria. Interactions of Atg5 
with BEV or other pathogen components have not yet been reported, but it is 
possible that other proteins associated with the membranes of 
autophagosomes (Atg12, Atg16 and, LC3) could facilitate the recognition of 
BEV.
As BEV is able to replicate productively within cells whilst autophagy is not 
inhibited, this suggests that the degradation of BEV(Ogawa et al., 2005) via
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the autophagy pathway is not effective in preventing productive BEV 
infection. Partial degradation of intracellular pathogens has been previously 
reported for mycobacterium tuburculosis, salmonella and sindbis virus. It is 
possible that these pathogens are able to mostly inhibit the autophagy 
pathway in a yet unidentified manner, preventing their degradation. 
However, in the case of BEV-infected cells it would appear that if autophagy 
is inhibited, it is able to overcome this inhibition towards the end of infection 
and sequester a proportion of BEV for degradation.
8.3 Future Experiments
The formation of FIALLS during FMDV infection is an intriguing one, and 
raises further questions about their formation and involvement during FMDV 
infection. Some unanswered questions from this thesis and possible future 
experiments are highlighted below.
> Optimisation of LC3-targeted siRNA to establish the whether of 
LC3/FIALLS are required for FMDV infection.
> Determine if the formation of FIALLS is cell-specific, or if they occur in 
other cell systems. Analyse the timing of their appearance.
> Immunogold labelling of LC3 and FMDV proteins, observe their 
relationship with FIALLS in infection and in cells expressing FMDV 
proteins 2C or 2BC in the absence of infection.
> Immunofluorescence labelling of newly synthesised viral RNA to analyse 
the relationship with FIALLS/FMDV-induced vesicles.
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> Further analyse the relationship between HDAC6 and the interaction of 
LC3 and VP1
> Study the effects of autophagy-specific siRNAs on intracellular virus 
yields versus extracellular yields
> Investigate whether sequestration of BEV is specific, if so what signals 
BEV as a target
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